id	sid	tid	token	lemma	pos
ajlm-435	1	1	abstract	abstract	ADJ
ajlm-435	1	2	introduction	introduction	NOUN
ajlm-435	1	3	research	research	NOUN
ajlm-435	1	4	method	method	NOUN
ajlm-435	1	5	and	and	CCONJ
ajlm-435	1	6	design	design	NOUN
ajlm-435	1	7	results	result	NOUN
ajlm-435	1	8	discussion	discussion	NOUN
ajlm-435	1	9	acknowledgements	acknowledgement	NOUN
ajlm-435	1	10	references	reference	NOUN
ajlm-435	1	11	about	about	ADP
ajlm-435	1	12	the	the	DET
ajlm-435	1	13	author(s	author(s	PROPN
ajlm-435	1	14	)	)	PUNCT
ajlm-435	1	15	joseph	joseph	PROPN
ajlm-435	1	16	m.	m.	PROPN
ajlm-435	1	17	ochieng	ochieng	PROPN
ajlm-435	1	18	’	'	PUNCT
ajlm-435	1	19	oduor	oduor	NOUN
ajlm-435	1	20	institute	institute	PROPN
ajlm-435	1	21	of	of	ADP
ajlm-435	1	22	primate	primate	PROPN
ajlm-435	1	23	research	research	NOUN
ajlm-435	1	24	(	(	PUNCT
ajlm-435	1	25	ipr	ipr	PROPN
ajlm-435	1	26	)	)	PUNCT
ajlm-435	1	27	,	,	PUNCT
ajlm-435	1	28	nairobi	nairobi	PROPN
ajlm-435	1	29	,	,	PUNCT
ajlm-435	1	30	kenya	kenya	PROPN
ajlm-435	1	31	school	school	NOUN
ajlm-435	1	32	of	of	ADP
ajlm-435	1	33	medicine	medicine	NOUN
ajlm-435	1	34	,	,	PUNCT
ajlm-435	1	35	kenyatta	kenyatta	PROPN
ajlm-435	1	36	university	university	PROPN
ajlm-435	1	37	,	,	PUNCT
ajlm-435	1	38	nairobi	nairobi	PROPN
ajlm-435	1	39	,	,	PUNCT
ajlm-435	1	40	kenya	kenya	PROPN
ajlm-435	1	41	nyamongo	nyamongo	PROPN
ajlm-435	1	42	onkoba	onkoba	PROPN
ajlm-435	1	43	institute	institute	PROPN
ajlm-435	1	44	of	of	ADP
ajlm-435	1	45	primate	primate	PROPN
ajlm-435	1	46	research	research	NOUN
ajlm-435	1	47	(	(	PUNCT
ajlm-435	1	48	ipr	ipr	PROPN
ajlm-435	1	49	)	)	PUNCT
ajlm-435	1	50	,	,	PUNCT
ajlm-435	1	51	nairobi	nairobi	PROPN
ajlm-435	1	52	,	,	PUNCT
ajlm-435	1	53	kenya	kenya	PROPN
ajlm-435	1	54	fredrick	fredrick	PROPN
ajlm-435	1	55	maloba	maloba	PROPN
ajlm-435	1	56	school	school	NOUN
ajlm-435	1	57	of	of	ADP
ajlm-435	1	58	pure	pure	ADJ
ajlm-435	1	59	and	and	CCONJ
ajlm-435	1	60	applied	applied	ADJ
ajlm-435	1	61	sciences	science	NOUN
ajlm-435	1	62	,	,	PUNCT
ajlm-435	1	63	kenyatta	kenyatta	PROPN
ajlm-435	1	64	university	university	PROPN
ajlm-435	1	65	,	,	PUNCT
ajlm-435	1	66	nairobi	nairobi	PROPN
ajlm-435	1	67	,	,	PUNCT
ajlm-435	1	68	kenya	kenya	PROPN
ajlm-435	1	69	atunga	atunga	PROPN
ajlm-435	1	70	nyachieo	nyachieo	PROPN
ajlm-435	1	71	institute	institute	PROPN
ajlm-435	1	72	of	of	ADP
ajlm-435	1	73	primate	primate	PROPN
ajlm-435	1	74	research	research	NOUN
ajlm-435	1	75	(	(	PUNCT
ajlm-435	1	76	ipr	ipr	PROPN
ajlm-435	1	77	)	)	PUNCT
ajlm-435	1	78	,	,	PUNCT
ajlm-435	1	79	nairobi	nairobi	PROPN
ajlm-435	1	80	,	,	PUNCT
ajlm-435	1	81	kenya	kenya	PROPN
ajlm-435	1	82	citation	citation	PROPN
ajlm-435	1	83	ochieng	ochieng	PROPN
ajlm-435	1	84	’	'	PUNCT
ajlm-435	1	85	oduor	oduor	PROPN
ajlm-435	1	86	jm	jm	PROPN
ajlm-435	1	87	,	,	PUNCT
ajlm-435	1	88	onkoba	onkoba	PROPN
ajlm-435	1	89	n	n	PART
ajlm-435	1	90	,	,	PUNCT
ajlm-435	1	91	maloba	maloba	PROPN
ajlm-435	1	92	f	f	PROPN
ajlm-435	1	93	,	,	PUNCT
ajlm-435	1	94	nyachieo	nyachieo	ADJ
ajlm-435	1	95	a.	a.	NOUN
ajlm-435	1	96	experimental	experimental	ADJ
ajlm-435	1	97	phage	phage	NOUN
ajlm-435	1	98	therapy	therapy	NOUN
ajlm-435	1	99	against	against	ADP
ajlm-435	1	100	haematogenous	haematogenous	ADJ
ajlm-435	1	101	multi	multi	ADJ
ajlm-435	1	102	-	-	ADJ
ajlm-435	1	103	drug	drug	ADJ
ajlm-435	1	104	resistant	resistant	ADJ
ajlm-435	1	105	staphylococcus	staphylococcus	NOUN
ajlm-435	1	106	aureus	aureus	NOUN
ajlm-435	1	107	pneumonia	pneumonia	NOUN
ajlm-435	1	108	in	in	ADP
ajlm-435	1	109	mice	mouse	NOUN
ajlm-435	1	110	.	.	PUNCT
ajlm-435	2	1	afr	afr	PROPN
ajlm-435	2	2	j	j	PROPN
ajlm-435	2	3	lab	lab	PROPN
ajlm-435	2	4	med	med	PROPN
ajlm-435	2	5	.	.	PROPN
ajlm-435	2	6	2016;5(1	2016;5(1	NUM
ajlm-435	2	7	)	)	PUNCT
ajlm-435	2	8	,	,	PUNCT
ajlm-435	2	9	a435	a435	PROPN
ajlm-435	2	10	.	.	PUNCT
ajlm-435	3	1	http://dx.doi.org/10.4102/ajlm.v5i1.435	http://dx.doi.org/10.4102/ajlm.v5i1.435	PROPN
ajlm-435	3	2	note	note	NOUN
ajlm-435	3	3	:	:	PUNCT
ajlm-435	3	4	this	this	DET
ajlm-435	3	5	article	article	NOUN
ajlm-435	3	6	was	be	AUX
ajlm-435	3	7	republished	republish	VERB
ajlm-435	3	8	with	with	ADP
ajlm-435	3	9	the	the	DET
ajlm-435	3	10	cfu	cfu	PROPN
ajlm-435	3	11	and	and	CCONJ
ajlm-435	3	12	pfu	pfu	NOUN
ajlm-435	3	13	dosages	dosage	NOUN
ajlm-435	3	14	missing	miss	VERB
ajlm-435	3	15	superscripts	superscript	NOUN
ajlm-435	3	16	‘	'	PUNCT
ajlm-435	3	17	108	108	NUM
ajlm-435	3	18	cfu	cfu	NOUN
ajlm-435	3	19	/	/	SYM
ajlm-435	3	20	ml	ml	NOUN
ajlm-435	3	21	and	and	CCONJ
ajlm-435	3	22	108	108	NUM
ajlm-435	3	23	pfu	pfu	NOUN
ajlm-435	3	24	/	/	SYM
ajlm-435	3	25	ml	ml	AUX
ajlm-435	3	26	’	'	PUNCT
ajlm-435	3	27	corrected	correct	VERB
ajlm-435	3	28	to	to	ADP
ajlm-435	3	29	‘	'	PUNCT
ajlm-435	3	30	108	108	NUM
ajlm-435	3	31	cfu	cfu	NOUN
ajlm-435	3	32	/	/	SYM
ajlm-435	3	33	ml	ml	NOUN
ajlm-435	3	34	and	and	CCONJ
ajlm-435	3	35	108	108	NUM
ajlm-435	3	36	pfu	pfu	NOUN
ajlm-435	3	37	/	/	SYM
ajlm-435	3	38	ml	ml	NOUN
ajlm-435	3	39	’	'	PUNCT
ajlm-435	3	40	in	in	ADP
ajlm-435	3	41	the	the	DET
ajlm-435	3	42	abstract	abstract	NOUN
ajlm-435	3	43	.	.	PUNCT
ajlm-435	4	1	the	the	DET
ajlm-435	4	2	publisher	publisher	NOUN
ajlm-435	4	3	apologises	apologise	VERB
ajlm-435	4	4	for	for	ADP
ajlm-435	4	5	any	any	DET
ajlm-435	4	6	inconvenience	inconvenience	NOUN
ajlm-435	4	7	caused	cause	VERB
ajlm-435	4	8	.	.	PUNCT
ajlm-435	5	1	original	original	ADJ
ajlm-435	5	2	research	research	NOUN
ajlm-435	5	3	experimental	experimental	ADJ
ajlm-435	5	4	phage	phage	NOUN
ajlm-435	5	5	therapy	therapy	NOUN
ajlm-435	5	6	against	against	ADP
ajlm-435	5	7	haematogenous	haematogenous	ADJ
ajlm-435	5	8	multi	multi	ADJ
ajlm-435	5	9	-	-	ADJ
ajlm-435	5	10	drug	drug	ADJ
ajlm-435	5	11	resistant	resistant	ADJ
ajlm-435	5	12	staphylococcus	staphylococcus	NOUN
ajlm-435	5	13	aureus	aureus	NOUN
ajlm-435	5	14	pneumonia	pneumonia	NOUN
ajlm-435	5	15	in	in	ADP
ajlm-435	5	16	mice	mice	PROPN
ajlm-435	5	17	joseph	joseph	PROPN
ajlm-435	5	18	m.	m.	PROPN
ajlm-435	5	19	ochieng	ochieng	PROPN
ajlm-435	5	20	’	'	PUNCT
ajlm-435	5	21	oduor	oduor	NOUN
ajlm-435	5	22	,	,	PUNCT
ajlm-435	5	23	nyamongo	nyamongo	NOUN
ajlm-435	5	24	onkoba	onkoba	NOUN
ajlm-435	5	25	,	,	PUNCT
ajlm-435	5	26	fredrick	fredrick	PROPN
ajlm-435	5	27	maloba	maloba	PROPN
ajlm-435	5	28	,	,	PUNCT
ajlm-435	5	29	atunga	atunga	PROPN
ajlm-435	5	30	nyachieo	nyachieo	NOUN
ajlm-435	5	31	received	receive	VERB
ajlm-435	5	32	:	:	PUNCT
ajlm-435	5	33	10	10	NUM
ajlm-435	5	34	mar	mar	PROPN
ajlm-435	5	35	.	.	PROPN
ajlm-435	5	36	2016	2016	NUM
ajlm-435	5	37	;	;	PUNCT
ajlm-435	5	38	accepted	accept	VERB
ajlm-435	5	39	:	:	PUNCT
ajlm-435	5	40	02	02	NUM
ajlm-435	5	41	aug	aug	PROPN
ajlm-435	5	42	.	.	PROPN
ajlm-435	5	43	2016	2016	NUM
ajlm-435	5	44	;	;	PUNCT
ajlm-435	5	45	published	publish	VERB
ajlm-435	5	46	:	:	PUNCT
ajlm-435	5	47	30	30	NUM
ajlm-435	5	48	sept	sept	PROPN
ajlm-435	5	49	.	.	PROPN
ajlm-435	5	50	2016	2016	NUM
ajlm-435	5	51	;	;	PUNCT
ajlm-435	5	52	republished	republish	VERB
ajlm-435	5	53	:	:	PUNCT
ajlm-435	5	54	26	26	NUM
ajlm-435	5	55	aug	aug	NOUN
ajlm-435	5	56	.	.	PROPN
ajlm-435	5	57	2022	2022	NUM
ajlm-435	5	58	copyright	copyright	NOUN
ajlm-435	5	59	:	:	PUNCT
ajlm-435	5	60	©	©	PROPN
ajlm-435	5	61	2016	2016	NUM
ajlm-435	5	62	.	.	PUNCT
ajlm-435	6	1	the	the	DET
ajlm-435	6	2	author(s	author(s	PROPN
ajlm-435	6	3	)	)	PUNCT
ajlm-435	6	4	.	.	PUNCT
ajlm-435	7	1	licensee	licensee	NOUN
ajlm-435	7	2	:	:	PUNCT
ajlm-435	7	3	aosis	aosis	NOUN
ajlm-435	7	4	.	.	PUNCT
ajlm-435	8	1	this	this	PRON
ajlm-435	8	2	is	be	AUX
ajlm-435	8	3	an	an	DET
ajlm-435	8	4	open	open	ADJ
ajlm-435	8	5	access	access	NOUN
ajlm-435	8	6	article	article	NOUN
ajlm-435	8	7	distributed	distribute	VERB
ajlm-435	8	8	under	under	ADP
ajlm-435	8	9	the	the	DET
ajlm-435	8	10	terms	term	NOUN
ajlm-435	8	11	of	of	ADP
ajlm-435	8	12	the	the	DET
ajlm-435	8	13	creative	creative	ADJ
ajlm-435	8	14	commons	common	NOUN
ajlm-435	8	15	attribution	attribution	NOUN
ajlm-435	8	16	license	license	NOUN
ajlm-435	8	17	,	,	PUNCT
ajlm-435	8	18	which	which	PRON
ajlm-435	8	19	permits	permit	VERB
ajlm-435	8	20	unrestricted	unrestricted	ADJ
ajlm-435	8	21	use	use	NOUN
ajlm-435	8	22	,	,	PUNCT
ajlm-435	8	23	distribution	distribution	NOUN
ajlm-435	8	24	,	,	PUNCT
ajlm-435	8	25	and	and	CCONJ
ajlm-435	8	26	reproduction	reproduction	NOUN
ajlm-435	8	27	in	in	ADP
ajlm-435	8	28	any	any	DET
ajlm-435	8	29	medium	medium	NOUN
ajlm-435	8	30	,	,	PUNCT
ajlm-435	8	31	provided	provide	VERB
ajlm-435	8	32	the	the	DET
ajlm-435	8	33	original	original	ADJ
ajlm-435	8	34	work	work	NOUN
ajlm-435	8	35	is	be	AUX
ajlm-435	8	36	properly	properly	ADV
ajlm-435	8	37	cited	cite	VERB
ajlm-435	8	38	.	.	PUNCT
ajlm-435	9	1	abstract	abstract	ADJ
ajlm-435	9	2	background	background	NOUN
ajlm-435	9	3	:	:	PUNCT
ajlm-435	9	4	community	community	NOUN
ajlm-435	9	5	-	-	PUNCT
ajlm-435	9	6	acquired	acquire	VERB
ajlm-435	9	7	haematogenous	haematogenous	ADJ
ajlm-435	9	8	staphylococcus	staphylococcus	NOUN
ajlm-435	9	9	aureus	aureus	NOUN
ajlm-435	9	10	pneumonia	pneumonia	NOUN
ajlm-435	9	11	is	be	AUX
ajlm-435	9	12	a	a	DET
ajlm-435	9	13	rare	rare	ADJ
ajlm-435	9	14	infection	infection	NOUN
ajlm-435	9	15	,	,	PUNCT
ajlm-435	9	16	though	though	SCONJ
ajlm-435	9	17	it	it	PRON
ajlm-435	9	18	can	can	AUX
ajlm-435	9	19	be	be	AUX
ajlm-435	9	20	acquired	acquire	VERB
ajlm-435	9	21	nosocomially	nosocomially	ADV
ajlm-435	9	22	.	.	PUNCT
ajlm-435	10	1	currently	currently	ADV
ajlm-435	10	2	,	,	PUNCT
ajlm-435	10	3	antibiotics	antibiotic	NOUN
ajlm-435	10	4	used	use	VERB
ajlm-435	10	5	against	against	ADP
ajlm-435	10	6	s.	s.	PROPN
ajlm-435	10	7	aureus	aureus	PROPN
ajlm-435	10	8	pneumonia	pneumonia	NOUN
ajlm-435	10	9	have	have	AUX
ajlm-435	10	10	shown	show	VERB
ajlm-435	10	11	reduced	reduced	ADJ
ajlm-435	10	12	efficacy	efficacy	NOUN
ajlm-435	10	13	.	.	PUNCT
ajlm-435	11	1	thus	thus	ADV
ajlm-435	11	2	,	,	PUNCT
ajlm-435	11	3	there	there	PRON
ajlm-435	11	4	is	be	VERB
ajlm-435	11	5	need	need	NOUN
ajlm-435	11	6	for	for	ADP
ajlm-435	11	7	an	an	DET
ajlm-435	11	8	alternative	alternative	ADJ
ajlm-435	11	9	therapy	therapy	NOUN
ajlm-435	11	10	against	against	ADP
ajlm-435	11	11	multidrug	multidrug	NOUN
ajlm-435	11	12	-	-	PUNCT
ajlm-435	11	13	resistant	resistant	ADJ
ajlm-435	11	14	s.	s.	PROPN
ajlm-435	11	15	aureus	aureus	PROPN
ajlm-435	11	16	(	(	PUNCT
ajlm-435	11	17	mdrsa	mdrsa	NOUN
ajlm-435	11	18	)	)	PUNCT
ajlm-435	11	19	strains	strain	VERB
ajlm-435	11	20	in	in	ADP
ajlm-435	11	21	the	the	DET
ajlm-435	11	22	community	community	NOUN
ajlm-435	11	23	.	.	PUNCT
ajlm-435	12	1	objective	objective	NOUN
ajlm-435	12	2	:	:	PUNCT
ajlm-435	12	3	we	we	PRON
ajlm-435	12	4	sought	seek	VERB
ajlm-435	12	5	to	to	PART
ajlm-435	12	6	determine	determine	VERB
ajlm-435	12	7	the	the	DET
ajlm-435	12	8	efficacy	efficacy	NOUN
ajlm-435	12	9	of	of	ADP
ajlm-435	12	10	environmentally	environmentally	ADV
ajlm-435	12	11	-	-	PUNCT
ajlm-435	12	12	obtained	obtain	VERB
ajlm-435	12	13	s.	s.	PROPN
ajlm-435	12	14	aureus	aureus	PROPN
ajlm-435	12	15	lytic	lytic	ADJ
ajlm-435	12	16	phage	phage	NOUN
ajlm-435	12	17	against	against	ADP
ajlm-435	12	18	haematogenous	haematogenous	ADJ
ajlm-435	12	19	mdrsa	mdrsa	PROPN
ajlm-435	12	20	pneumonia	pneumonia	NOUN
ajlm-435	12	21	in	in	ADP
ajlm-435	12	22	mice	mouse	NOUN
ajlm-435	12	23	.	.	PUNCT
ajlm-435	13	1	methods	method	NOUN
ajlm-435	13	2	:	:	PUNCT
ajlm-435	13	3	phages	phage	NOUN
ajlm-435	13	4	and	and	CCONJ
ajlm-435	13	5	mdrsa	mdrsa	NOUN
ajlm-435	13	6	were	be	AUX
ajlm-435	13	7	isolated	isolate	VERB
ajlm-435	13	8	from	from	ADP
ajlm-435	13	9	sewage	sewage	NOUN
ajlm-435	13	10	samples	sample	NOUN
ajlm-435	13	11	collected	collect	VERB
ajlm-435	13	12	within	within	ADP
ajlm-435	13	13	nairobi	nairobi	PROPN
ajlm-435	13	14	county	county	PROPN
ajlm-435	13	15	,	,	PUNCT
ajlm-435	13	16	kenya	kenya	PROPN
ajlm-435	13	17	.	.	PUNCT
ajlm-435	14	1	isolated	isolate	VERB
ajlm-435	14	2	s.	s.	PROPN
ajlm-435	14	3	aureus	aureus	PROPN
ajlm-435	14	4	bacteria	bacteria	NOUN
ajlm-435	14	5	were	be	AUX
ajlm-435	14	6	screened	screen	VERB
ajlm-435	14	7	for	for	ADP
ajlm-435	14	8	resistance	resistance	NOUN
ajlm-435	14	9	against	against	ADP
ajlm-435	14	10	ceftazidime	ceftazidime	NOUN
ajlm-435	14	11	,	,	PUNCT
ajlm-435	14	12	oxacillin	oxacillin	PROPN
ajlm-435	14	13	,	,	PUNCT
ajlm-435	14	14	vancomycin	vancomycin	PROPN
ajlm-435	14	15	,	,	PUNCT
ajlm-435	14	16	netilmicin	netilmicin	NOUN
ajlm-435	14	17	,	,	PUNCT
ajlm-435	14	18	gentamicin	gentamicin	NOUN
ajlm-435	14	19	,	,	PUNCT
ajlm-435	14	20	erythromycin	erythromycin	NOUN
ajlm-435	14	21	,	,	PUNCT
ajlm-435	14	22	trimethroprim	trimethroprim	NOUN
ajlm-435	14	23	-	-	PUNCT
ajlm-435	14	24	sulfamethoxazole	sulfamethoxazole	NOUN
ajlm-435	14	25	and	and	CCONJ
ajlm-435	14	26	cefuroxime	cefuroxime	ADJ
ajlm-435	14	27	.	.	PUNCT
ajlm-435	15	1	thirty	thirty	NUM
ajlm-435	15	2	balb	balb	ADJ
ajlm-435	15	3	/	/	SYM
ajlm-435	15	4	c	c	NOUN
ajlm-435	15	5	mice	mouse	NOUN
ajlm-435	15	6	aged	age	VERB
ajlm-435	15	7	six	six	NUM
ajlm-435	15	8	to	to	PART
ajlm-435	15	9	eight	eight	NUM
ajlm-435	15	10	weeks	week	NOUN
ajlm-435	15	11	were	be	AUX
ajlm-435	15	12	randomly	randomly	ADV
ajlm-435	15	13	assigned	assign	VERB
ajlm-435	15	14	into	into	ADP
ajlm-435	15	15	three	three	NUM
ajlm-435	15	16	groups	group	NOUN
ajlm-435	15	17	:	:	PUNCT
ajlm-435	15	18	the	the	DET
ajlm-435	15	19	mdrsa	mdrsa	NOUN
ajlm-435	15	20	-	-	PUNCT
ajlm-435	15	21	infection	infection	NOUN
ajlm-435	15	22	group	group	NOUN
ajlm-435	15	23	(	(	PUNCT
ajlm-435	15	24	n	n	NOUN
ajlm-435	15	25	=	=	NUM
ajlm-435	15	26	20	20	NUM
ajlm-435	15	27	)	)	PUNCT
ajlm-435	15	28	,	,	PUNCT
ajlm-435	15	29	the	the	DET
ajlm-435	15	30	phage	phage	NOUN
ajlm-435	15	31	-	-	PUNCT
ajlm-435	15	32	infection	infection	NOUN
ajlm-435	15	33	group	group	NOUN
ajlm-435	15	34	(	(	PUNCT
ajlm-435	15	35	n	n	NOUN
ajlm-435	15	36	=	=	SYM
ajlm-435	15	37	5	5	NUM
ajlm-435	15	38	)	)	PUNCT
ajlm-435	15	39	and	and	CCONJ
ajlm-435	15	40	the	the	DET
ajlm-435	15	41	non	non	ADJ
ajlm-435	15	42	-	-	ADJ
ajlm-435	15	43	infection	infection	ADJ
ajlm-435	15	44	group	group	NOUN
ajlm-435	15	45	(	(	PUNCT
ajlm-435	15	46	n	n	NOUN
ajlm-435	15	47	=	=	SYM
ajlm-435	15	48	5	5	NUM
ajlm-435	15	49	)	)	PUNCT
ajlm-435	15	50	.	.	PUNCT
ajlm-435	16	1	mice	mouse	NOUN
ajlm-435	16	2	were	be	AUX
ajlm-435	16	3	infected	infect	VERB
ajlm-435	16	4	with	with	ADP
ajlm-435	16	5	either	either	CCONJ
ajlm-435	16	6	mdrsa	mdrsa	NOUN
ajlm-435	16	7	or	or	CCONJ
ajlm-435	16	8	phage	phage	NOUN
ajlm-435	16	9	(	(	PUNCT
ajlm-435	16	10	108	108	NUM
ajlm-435	16	11	cfu	cfu	NOUN
ajlm-435	16	12	/	/	SYM
ajlm-435	16	13	ml	ml	NOUN
ajlm-435	16	14	)	)	PUNCT
ajlm-435	16	15	and	and	CCONJ
ajlm-435	16	16	treated	treat	VERB
ajlm-435	16	17	after	after	ADP
ajlm-435	16	18	72	72	NUM
ajlm-435	16	19	hours	hour	NOUN
ajlm-435	16	20	with	with	ADP
ajlm-435	16	21	a	a	DET
ajlm-435	16	22	single	single	ADJ
ajlm-435	16	23	dose	dose	NOUN
ajlm-435	16	24	of	of	ADP
ajlm-435	16	25	clindamycin	clindamycin	NOUN
ajlm-435	16	26	(	(	PUNCT
ajlm-435	16	27	8	8	NUM
ajlm-435	16	28	mg	mg	NUM
ajlm-435	16	29	/	/	SYM
ajlm-435	16	30	kg	kg	PROPN
ajlm-435	16	31	/	/	SYM
ajlm-435	16	32	bwt	bwt	PROPN
ajlm-435	16	33	)	)	PUNCT
ajlm-435	16	34	or	or	CCONJ
ajlm-435	16	35	108	108	NUM
ajlm-435	16	36	pfu	pfu	NOUN
ajlm-435	16	37	/	/	SYM
ajlm-435	16	38	ml	ml	NOUN
ajlm-435	16	39	of	of	ADP
ajlm-435	16	40	phage	phage	NOUN
ajlm-435	16	41	or	or	CCONJ
ajlm-435	16	42	a	a	DET
ajlm-435	16	43	combination	combination	NOUN
ajlm-435	16	44	therapy	therapy	NOUN
ajlm-435	16	45	(	(	PUNCT
ajlm-435	16	46	clindamycin	clindamycin	NOUN
ajlm-435	16	47	and	and	CCONJ
ajlm-435	16	48	phage	phage	NOUN
ajlm-435	16	49	)	)	PUNCT
ajlm-435	16	50	.	.	PUNCT
ajlm-435	17	1	the	the	DET
ajlm-435	17	2	efficacy	efficacy	NOUN
ajlm-435	17	3	of	of	ADP
ajlm-435	17	4	phage	phage	NOUN
ajlm-435	17	5	,	,	PUNCT
ajlm-435	17	6	clindamycin	clindamycin	NOUN
ajlm-435	17	7	or	or	CCONJ
ajlm-435	17	8	clindamycin	clindamycin	NOUN
ajlm-435	17	9	with	with	ADP
ajlm-435	17	10	phage	phage	NOUN
ajlm-435	17	11	combination	combination	NOUN
ajlm-435	17	12	was	be	AUX
ajlm-435	17	13	determined	determine	VERB
ajlm-435	17	14	using	use	VERB
ajlm-435	17	15	resolution	resolution	NOUN
ajlm-435	17	16	of	of	ADP
ajlm-435	17	17	lung	lung	NOUN
ajlm-435	17	18	pathology	pathology	NOUN
ajlm-435	17	19	and	and	CCONJ
ajlm-435	17	20	bacterial	bacterial	ADJ
ajlm-435	17	21	load	load	NOUN
ajlm-435	17	22	in	in	ADP
ajlm-435	17	23	lung	lung	NOUN
ajlm-435	17	24	homogenates	homogenate	NOUN
ajlm-435	17	25	.	.	PUNCT
ajlm-435	18	1	results	result	NOUN
ajlm-435	18	2	:	:	PUNCT
ajlm-435	18	3	the	the	DET
ajlm-435	18	4	viable	viable	ADJ
ajlm-435	18	5	mdrsa	mdrsa	NOUN
ajlm-435	18	6	count	count	NOUN
ajlm-435	18	7	was	be	AUX
ajlm-435	18	8	0.5	0.5	NUM
ajlm-435	18	9	±	±	NUM
ajlm-435	18	10	0.2	0.2	NUM
ajlm-435	18	11	log10	log10	PROPN
ajlm-435	18	12	cfu	cfu	PROPN
ajlm-435	18	13	/	/	SYM
ajlm-435	18	14	gm	gm	PROPN
ajlm-435	18	15	in	in	ADP
ajlm-435	18	16	the	the	DET
ajlm-435	18	17	phage	phage	NOUN
ajlm-435	18	18	-	-	PUNCT
ajlm-435	18	19	treated	treat	VERB
ajlm-435	18	20	group	group	NOUN
ajlm-435	18	21	,	,	PUNCT
ajlm-435	18	22	4.4	4.4	NUM
ajlm-435	18	23	±	±	NUM
ajlm-435	18	24	0.2	0.2	NUM
ajlm-435	18	25	log10	log10	PROPN
ajlm-435	18	26	cfu	cfu	PROPN
ajlm-435	18	27	/	/	SYM
ajlm-435	18	28	gm	gm	PROPN
ajlm-435	18	29	in	in	ADP
ajlm-435	18	30	the	the	DET
ajlm-435	18	31	clindamycin	clindamycin	NOUN
ajlm-435	18	32	-	-	PUNCT
ajlm-435	18	33	treated	treat	VERB
ajlm-435	18	34	group	group	NOUN
ajlm-435	18	35	and	and	CCONJ
ajlm-435	18	36	4.0	4.0	NUM
ajlm-435	18	37	±	±	NUM
ajlm-435	18	38	0.2	0.2	NUM
ajlm-435	18	39	log10	log10	PROPN
ajlm-435	18	40	cfu	cfu	PROPN
ajlm-435	18	41	/	/	SYM
ajlm-435	18	42	gm	gm	PROPN
ajlm-435	18	43	in	in	ADP
ajlm-435	18	44	the	the	DET
ajlm-435	18	45	combination	combination	NOUN
ajlm-435	18	46	-	-	PUNCT
ajlm-435	18	47	treated	treat	VERB
ajlm-435	18	48	group	group	NOUN
ajlm-435	18	49	.	.	PUNCT
ajlm-435	19	1	the	the	DET
ajlm-435	19	2	efficacy	efficacy	NOUN
ajlm-435	19	3	of	of	ADP
ajlm-435	19	4	phage	phage	NOUN
ajlm-435	19	5	therapy	therapy	NOUN
ajlm-435	19	6	was	be	AUX
ajlm-435	19	7	significantly	significantly	ADV
ajlm-435	19	8	different	different	ADJ
ajlm-435	19	9	from	from	ADP
ajlm-435	19	10	other	other	ADJ
ajlm-435	19	11	therapeutic	therapeutic	ADJ
ajlm-435	19	12	modes	mode	NOUN
ajlm-435	19	13	(	(	PUNCT
ajlm-435	19	14	p	p	NOUN
ajlm-435	19	15	=	=	NOUN
ajlm-435	19	16	0	0	NUM
ajlm-435	19	17	<	<	X
ajlm-435	19	18	0.0001	0.0001	NUM
ajlm-435	19	19	)	)	PUNCT
ajlm-435	19	20	.	.	PUNCT
ajlm-435	20	1	histology	histology	NOUN
ajlm-435	20	2	showed	show	VERB
ajlm-435	20	3	that	that	SCONJ
ajlm-435	20	4	the	the	DET
ajlm-435	20	5	mice	mouse	NOUN
ajlm-435	20	6	treated	treat	VERB
ajlm-435	20	7	with	with	ADP
ajlm-435	20	8	phage	phage	NOUN
ajlm-435	20	9	did	do	AUX
ajlm-435	20	10	not	not	PART
ajlm-435	20	11	develop	develop	VERB
ajlm-435	20	12	pneumonia	pneumonia	NOUN
ajlm-435	20	13	.	.	PUNCT
ajlm-435	21	1	conclusion	conclusion	NOUN
ajlm-435	21	2	:	:	PUNCT
ajlm-435	21	3	phage	phage	NOUN
ajlm-435	21	4	therapy	therapy	NOUN
ajlm-435	21	5	is	be	AUX
ajlm-435	21	6	effective	effective	ADJ
ajlm-435	21	7	against	against	ADP
ajlm-435	21	8	haematogenous	haematogenous	ADJ
ajlm-435	21	9	mdrsa	mdrsa	NOUN
ajlm-435	21	10	infection	infection	NOUN
ajlm-435	21	11	.	.	PUNCT
ajlm-435	22	1	thus	thus	ADV
ajlm-435	22	2	,	,	PUNCT
ajlm-435	22	3	it	it	PRON
ajlm-435	22	4	can	can	AUX
ajlm-435	22	5	be	be	AUX
ajlm-435	22	6	explored	explore	VERB
ajlm-435	22	7	as	as	ADP
ajlm-435	22	8	an	an	DET
ajlm-435	22	9	alternative	alternative	ADJ
ajlm-435	22	10	treatment	treatment	NOUN
ajlm-435	22	11	method	method	NOUN
ajlm-435	22	12	.	.	PUNCT
ajlm-435	23	1	introduction	introduction	NOUN
ajlm-435	23	2	during	during	ADP
ajlm-435	23	3	lung	lung	NOUN
ajlm-435	23	4	infection	infection	NOUN
ajlm-435	23	5	with	with	ADP
ajlm-435	23	6	bacteria	bacteria	NOUN
ajlm-435	23	7	and	and	CCONJ
ajlm-435	23	8	viruses	virus	NOUN
ajlm-435	23	9	,	,	PUNCT
ajlm-435	23	10	the	the	DET
ajlm-435	23	11	lung	lung	NOUN
ajlm-435	23	12	tissue	tissue	NOUN
ajlm-435	23	13	becomes	become	VERB
ajlm-435	23	14	inflamed	inflame	VERB
ajlm-435	23	15	,	,	PUNCT
ajlm-435	23	16	deflated	deflate	VERB
ajlm-435	23	17	and	and	CCONJ
ajlm-435	23	18	occupied	occupy	VERB
ajlm-435	23	19	by	by	ADP
ajlm-435	23	20	pus	pus	NOUN
ajlm-435	23	21	and	and	CCONJ
ajlm-435	23	22	mucus	mucus	NOUN
ajlm-435	23	23	,	,	PUNCT
ajlm-435	23	24	and	and	CCONJ
ajlm-435	23	25	the	the	DET
ajlm-435	23	26	bronchial	bronchial	ADJ
ajlm-435	23	27	walls	wall	NOUN
ajlm-435	23	28	thicken	thicken	VERB
ajlm-435	23	29	due	due	ADP
ajlm-435	23	30	to	to	ADP
ajlm-435	23	31	accumulation	accumulation	NOUN
ajlm-435	23	32	of	of	ADP
ajlm-435	23	33	lymphocytes.1	lymphocytes.1	PROPN
ajlm-435	23	34	streptococcus	streptococcus	NOUN
ajlm-435	23	35	pneumoniae	pneumoniae	ADJ
ajlm-435	23	36	,	,	PUNCT
ajlm-435	23	37	haemophilus	haemophilus	ADJ
ajlm-435	23	38	influenzae	influenzae	X
ajlm-435	23	39	,	,	PUNCT
ajlm-435	23	40	mycoplasma	mycoplasma	VERB
ajlm-435	23	41	pneumoniae	pneumoniae	ADJ
ajlm-435	23	42	and	and	CCONJ
ajlm-435	23	43	staphylococcus	staphylococcus	NOUN
ajlm-435	23	44	aureus	aureus	NOUN
ajlm-435	23	45	all	all	PRON
ajlm-435	23	46	cause	cause	VERB
ajlm-435	23	47	pneumonia.2	pneumonia.2	PROPN
ajlm-435	23	48	s.	s.	PROPN
ajlm-435	23	49	aureus	aureus	PROPN
ajlm-435	23	50	pneumonia	pneumonia	NOUN
ajlm-435	23	51	is	be	AUX
ajlm-435	23	52	usually	usually	ADV
ajlm-435	23	53	associated	associate	VERB
ajlm-435	23	54	with	with	ADP
ajlm-435	23	55	nosocomial	nosocomial	ADJ
ajlm-435	23	56	infections	infection	NOUN
ajlm-435	23	57	common	common	ADJ
ajlm-435	23	58	with	with	ADP
ajlm-435	23	59	patients	patient	NOUN
ajlm-435	23	60	in	in	ADP
ajlm-435	23	61	intensive	intensive	ADJ
ajlm-435	23	62	care	care	NOUN
ajlm-435	23	63	units.3	units.3	PROPN
ajlm-435	23	64	community	community	NOUN
ajlm-435	23	65	-	-	PUNCT
ajlm-435	23	66	acquired	acquire	VERB
ajlm-435	23	67	pneumonia	pneumonia	NOUN
ajlm-435	23	68	,	,	PUNCT
ajlm-435	23	69	especially	especially	ADV
ajlm-435	23	70	haematogenous	haematogenous	ADJ
ajlm-435	23	71	(	(	PUNCT
ajlm-435	23	72	blood	blood	NOUN
ajlm-435	23	73	-	-	PUNCT
ajlm-435	23	74	borne	borne	NOUN
ajlm-435	23	75	)	)	PUNCT
ajlm-435	23	76	s.	s.	PROPN
ajlm-435	23	77	aureus	aureus	PROPN
ajlm-435	23	78	pneumonia	pneumonia	NOUN
ajlm-435	23	79	is	be	AUX
ajlm-435	23	80	rare	rare	ADJ
ajlm-435	23	81	;	;	PUNCT
ajlm-435	23	82	however	however	ADV
ajlm-435	23	83	,	,	PUNCT
ajlm-435	23	84	it	it	PRON
ajlm-435	23	85	has	have	AUX
ajlm-435	23	86	been	be	AUX
ajlm-435	23	87	documented	document	VERB
ajlm-435	23	88	to	to	PART
ajlm-435	23	89	have	have	VERB
ajlm-435	23	90	high	high	ADJ
ajlm-435	23	91	morbidity	morbidity	NOUN
ajlm-435	23	92	and	and	CCONJ
ajlm-435	23	93	mortality	mortality	NOUN
ajlm-435	23	94	rates	rate	NOUN
ajlm-435	23	95	world	world	NOUN
ajlm-435	23	96	-	-	PUNCT
ajlm-435	23	97	wide.4	wide.4	ADV
ajlm-435	23	98	haematogenous	haematogenous	ADJ
ajlm-435	23	99	pneumonia	pneumonia	NOUN
ajlm-435	23	100	is	be	AUX
ajlm-435	23	101	common	common	ADJ
ajlm-435	23	102	in	in	ADP
ajlm-435	23	103	children	child	NOUN
ajlm-435	23	104	,	,	PUNCT
ajlm-435	23	105	immunocompromised	immunocompromise	VERB
ajlm-435	23	106	persons	person	NOUN
ajlm-435	23	107	and	and	CCONJ
ajlm-435	23	108	the	the	DET
ajlm-435	23	109	elderly	elderly	ADJ
ajlm-435	23	110	who	who	PRON
ajlm-435	23	111	have	have	VERB
ajlm-435	23	112	chronic	chronic	ADJ
ajlm-435	23	113	skin	skin	NOUN
ajlm-435	23	114	and	and	CCONJ
ajlm-435	23	115	soft	soft	ADJ
ajlm-435	23	116	tissue	tissue	NOUN
ajlm-435	23	117	infections.5	infections.5	NOUN
ajlm-435	23	118	globally	globally	ADV
ajlm-435	23	119	,	,	PUNCT
ajlm-435	23	120	there	there	PRON
ajlm-435	23	121	has	have	AUX
ajlm-435	23	122	been	be	AUX
ajlm-435	23	123	an	an	DET
ajlm-435	23	124	emergence	emergence	NOUN
ajlm-435	23	125	of	of	ADP
ajlm-435	23	126	multidrug	multidrug	NOUN
ajlm-435	23	127	-	-	PUNCT
ajlm-435	23	128	resistant	resistant	ADJ
ajlm-435	23	129	bacteria	bacteria	NOUN
ajlm-435	23	130	,	,	PUNCT
ajlm-435	23	131	including	include	VERB
ajlm-435	23	132	methicillin	methicillin	NOUN
ajlm-435	23	133	resistant	resistant	ADJ
ajlm-435	23	134	s.	s.	PROPN
ajlm-435	23	135	aureus	aureus	PROPN
ajlm-435	23	136	and	and	CCONJ
ajlm-435	23	137	multidrug	multidrug	NOUN
ajlm-435	23	138	-	-	PUNCT
ajlm-435	23	139	resistant	resistant	ADJ
ajlm-435	23	140	s.	s.	PROPN
ajlm-435	23	141	aureus	aureus	PROPN
ajlm-435	23	142	(	(	PUNCT
ajlm-435	23	143	mdrsa	mdrsa	PROPN
ajlm-435	23	144	)	)	PUNCT
ajlm-435	23	145	,	,	PUNCT
ajlm-435	23	146	which	which	PRON
ajlm-435	23	147	are	be	AUX
ajlm-435	23	148	difficult	difficult	ADJ
ajlm-435	23	149	to	to	PART
ajlm-435	23	150	treat	treat	VERB
ajlm-435	23	151	with	with	ADP
ajlm-435	23	152	currently	currently	ADV
ajlm-435	23	153	available	available	ADJ
ajlm-435	23	154	antibiotics.6,7	antibiotics.6,7	PROPN
ajlm-435	23	155	these	these	DET
ajlm-435	23	156	‘	'	PUNCT
ajlm-435	23	157	super	super	ADJ
ajlm-435	23	158	bugs	bug	NOUN
ajlm-435	23	159	’	'	PUNCT
ajlm-435	23	160	have	have	AUX
ajlm-435	23	161	made	make	VERB
ajlm-435	23	162	the	the	DET
ajlm-435	23	163	treatment	treatment	NOUN
ajlm-435	23	164	of	of	ADP
ajlm-435	23	165	haematogenous	haematogenous	ADJ
ajlm-435	23	166	pneumonia	pneumonia	NOUN
ajlm-435	23	167	and	and	CCONJ
ajlm-435	23	168	other	other	ADJ
ajlm-435	23	169	associated	associated	ADJ
ajlm-435	23	170	infections	infection	NOUN
ajlm-435	23	171	difficult.8,9,10,11	difficult.8,9,10,11	PUNCT
ajlm-435	24	1	thus	thus	ADV
ajlm-435	24	2	,	,	PUNCT
ajlm-435	24	3	there	there	PRON
ajlm-435	24	4	is	be	VERB
ajlm-435	24	5	need	need	NOUN
ajlm-435	24	6	for	for	ADP
ajlm-435	24	7	an	an	DET
ajlm-435	24	8	alternative	alternative	ADJ
ajlm-435	24	9	therapeutic	therapeutic	ADJ
ajlm-435	24	10	measure	measure	NOUN
ajlm-435	24	11	,	,	PUNCT
ajlm-435	24	12	such	such	ADJ
ajlm-435	24	13	as	as	ADP
ajlm-435	24	14	phage	phage	NOUN
ajlm-435	24	15	therapy	therapy	NOUN
ajlm-435	24	16	,	,	PUNCT
ajlm-435	24	17	to	to	PART
ajlm-435	24	18	combat	combat	VERB
ajlm-435	24	19	super	super	ADJ
ajlm-435	24	20	bugs	bug	NOUN
ajlm-435	24	21	.	.	PUNCT
ajlm-435	25	1	phage	phage	NOUN
ajlm-435	25	2	therapy	therapy	NOUN
ajlm-435	25	3	refers	refer	VERB
ajlm-435	25	4	to	to	ADP
ajlm-435	25	5	the	the	DET
ajlm-435	25	6	use	use	NOUN
ajlm-435	25	7	of	of	ADP
ajlm-435	25	8	bacteriophages	bacteriophage	NOUN
ajlm-435	25	9	(	(	PUNCT
ajlm-435	25	10	or	or	CCONJ
ajlm-435	25	11	phages	phage	NOUN
ajlm-435	25	12	)	)	PUNCT
ajlm-435	25	13	as	as	ADP
ajlm-435	25	14	antibacterial	antibacterial	ADJ
ajlm-435	25	15	agents	agent	NOUN
ajlm-435	25	16	against	against	ADP
ajlm-435	25	17	bacterial	bacterial	ADJ
ajlm-435	25	18	pathogens.12	pathogens.12	NOUN
ajlm-435	25	19	currently	currently	ADV
ajlm-435	25	20	,	,	PUNCT
ajlm-435	25	21	the	the	DET
ajlm-435	25	22	use	use	NOUN
ajlm-435	25	23	of	of	ADP
ajlm-435	25	24	phage	phage	NOUN
ajlm-435	25	25	therapy	therapy	NOUN
ajlm-435	25	26	is	be	AUX
ajlm-435	25	27	common	common	ADJ
ajlm-435	25	28	primarily	primarily	ADV
ajlm-435	25	29	in	in	ADP
ajlm-435	25	30	georgia	georgia	PROPN
ajlm-435	25	31	and	and	CCONJ
ajlm-435	25	32	russia	russia	PROPN
ajlm-435	25	33	,	,	PUNCT
ajlm-435	25	34	despite	despite	SCONJ
ajlm-435	25	35	once	once	ADV
ajlm-435	25	36	being	be	AUX
ajlm-435	25	37	practised	practise	VERB
ajlm-435	25	38	globally	globally	ADV
ajlm-435	25	39	before	before	ADP
ajlm-435	25	40	the	the	DET
ajlm-435	25	41	advent	advent	NOUN
ajlm-435	25	42	of	of	ADP
ajlm-435	25	43	antibiotics.13,14,15	antibiotics.13,14,15	NOUN
ajlm-435	25	44	its	its	PRON
ajlm-435	25	45	use	use	NOUN
ajlm-435	25	46	ceased	cease	VERB
ajlm-435	25	47	in	in	ADP
ajlm-435	25	48	western	western	PROPN
ajlm-435	25	49	europe	europe	PROPN
ajlm-435	25	50	,	,	PUNCT
ajlm-435	25	51	the	the	DET
ajlm-435	25	52	united	united	PROPN
ajlm-435	25	53	states	states	PROPN
ajlm-435	25	54	and	and	CCONJ
ajlm-435	25	55	canada	canada	PROPN
ajlm-435	25	56	in	in	ADP
ajlm-435	25	57	the	the	DET
ajlm-435	25	58	1940s	1940	NOUN
ajlm-435	25	59	due	due	ADJ
ajlm-435	25	60	to	to	ADP
ajlm-435	25	61	poor	poor	ADJ
ajlm-435	25	62	understanding	understanding	NOUN
ajlm-435	25	63	of	of	ADP
ajlm-435	25	64	the	the	DET
ajlm-435	25	65	nature	nature	NOUN
ajlm-435	25	66	,	,	PUNCT
ajlm-435	25	67	safety	safety	NOUN
ajlm-435	25	68	,	,	PUNCT
ajlm-435	25	69	therapeutics	therapeutic	NOUN
ajlm-435	25	70	and	and	CCONJ
ajlm-435	25	71	pharmacology	pharmacology	NOUN
ajlm-435	25	72	of	of	ADP
ajlm-435	25	73	phages.16	phages.16	PROPN
ajlm-435	25	74	phage	phage	NOUN
ajlm-435	25	75	therapy	therapy	NOUN
ajlm-435	25	76	is	be	AUX
ajlm-435	25	77	cheap	cheap	ADJ
ajlm-435	25	78	in	in	ADP
ajlm-435	25	79	terms	term	NOUN
ajlm-435	25	80	of	of	ADP
ajlm-435	25	81	development	development	NOUN
ajlm-435	25	82	and	and	CCONJ
ajlm-435	25	83	use	use	NOUN
ajlm-435	25	84	as	as	ADP
ajlm-435	25	85	a	a	DET
ajlm-435	25	86	therapeutic	therapeutic	ADJ
ajlm-435	25	87	agent	agent	NOUN
ajlm-435	25	88	.	.	PUNCT
ajlm-435	26	1	phages	phage	NOUN
ajlm-435	26	2	are	be	AUX
ajlm-435	26	3	abundant	abundant	ADJ
ajlm-435	26	4	in	in	ADP
ajlm-435	26	5	nature	nature	NOUN
ajlm-435	26	6	and	and	CCONJ
ajlm-435	26	7	are	be	AUX
ajlm-435	26	8	capable	capable	ADJ
ajlm-435	26	9	of	of	ADP
ajlm-435	26	10	in	in	ADP
ajlm-435	26	11	vivo	vivo	ADJ
ajlm-435	26	12	auto	auto	NOUN
ajlm-435	26	13	-	-	PUNCT
ajlm-435	26	14	dosing	dosing	NOUN
ajlm-435	26	15	,	,	PUNCT
ajlm-435	26	16	that	that	PRON
ajlm-435	26	17	is	be	AUX
ajlm-435	26	18	to	to	PART
ajlm-435	26	19	say	say	VERB
ajlm-435	26	20	,	,	PUNCT
ajlm-435	26	21	they	they	PRON
ajlm-435	26	22	are	be	AUX
ajlm-435	26	23	capable	capable	ADJ
ajlm-435	26	24	of	of	ADP
ajlm-435	26	25	multiplying	multiply	VERB
ajlm-435	26	26	into	into	ADP
ajlm-435	26	27	several	several	ADJ
ajlm-435	26	28	copies	copy	NOUN
ajlm-435	26	29	at	at	ADP
ajlm-435	26	30	the	the	DET
ajlm-435	26	31	infection	infection	NOUN
ajlm-435	26	32	site	site	NOUN
ajlm-435	26	33	;	;	PUNCT
ajlm-435	26	34	hence	hence	ADV
ajlm-435	26	35	,	,	PUNCT
ajlm-435	26	36	only	only	ADV
ajlm-435	26	37	a	a	DET
ajlm-435	26	38	small	small	ADJ
ajlm-435	26	39	dose	dose	NOUN
ajlm-435	26	40	is	be	AUX
ajlm-435	26	41	required	require	VERB
ajlm-435	26	42	for	for	ADP
ajlm-435	26	43	treatment.17	treatment.17	PROPN
ajlm-435	26	44	in	in	ADP
ajlm-435	26	45	kenya	kenya	PROPN
ajlm-435	26	46	,	,	PUNCT
ajlm-435	26	47	community	community	NOUN
ajlm-435	26	48	-	-	PUNCT
ajlm-435	26	49	acquired	acquire	VERB
ajlm-435	26	50	mdrsa	mdrsa	NOUN
ajlm-435	26	51	infections	infection	NOUN
ajlm-435	26	52	are	be	AUX
ajlm-435	26	53	commonly	commonly	ADV
ajlm-435	26	54	reported	report	VERB
ajlm-435	26	55	among	among	ADP
ajlm-435	26	56	hiv	hiv	PROPN
ajlm-435	26	57	patients	patient	NOUN
ajlm-435	26	58	and	and	CCONJ
ajlm-435	26	59	at	at	ADP
ajlm-435	26	60	public	public	ADJ
ajlm-435	26	61	hospitals	hospital	NOUN
ajlm-435	26	62	that	that	PRON
ajlm-435	26	63	are	be	AUX
ajlm-435	26	64	located	locate	VERB
ajlm-435	26	65	in	in	ADP
ajlm-435	26	66	informal	informal	ADJ
ajlm-435	26	67	settlements	settlement	NOUN
ajlm-435	26	68	or	or	CCONJ
ajlm-435	26	69	slums.18	slums.18	NOUN
ajlm-435	26	70	thus	thus	ADV
ajlm-435	26	71	,	,	PUNCT
ajlm-435	26	72	there	there	PRON
ajlm-435	26	73	is	be	VERB
ajlm-435	26	74	a	a	DET
ajlm-435	26	75	need	need	NOUN
ajlm-435	26	76	to	to	PART
ajlm-435	26	77	characterise	characterise	VERB
ajlm-435	26	78	the	the	DET
ajlm-435	26	79	profile	profile	NOUN
ajlm-435	26	80	of	of	ADP
ajlm-435	26	81	bacterial	bacterial	ADJ
ajlm-435	26	82	strains	strain	NOUN
ajlm-435	26	83	that	that	PRON
ajlm-435	26	84	are	be	AUX
ajlm-435	26	85	currently	currently	ADV
ajlm-435	26	86	circulating	circulate	VERB
ajlm-435	26	87	in	in	ADP
ajlm-435	26	88	environmental	environmental	ADJ
ajlm-435	26	89	sources	source	NOUN
ajlm-435	26	90	.	.	PUNCT
ajlm-435	27	1	this	this	PRON
ajlm-435	27	2	will	will	AUX
ajlm-435	27	3	provide	provide	VERB
ajlm-435	27	4	necessary	necessary	ADJ
ajlm-435	27	5	information	information	NOUN
ajlm-435	27	6	that	that	PRON
ajlm-435	27	7	can	can	AUX
ajlm-435	27	8	be	be	AUX
ajlm-435	27	9	used	use	VERB
ajlm-435	27	10	in	in	ADP
ajlm-435	27	11	management	management	NOUN
ajlm-435	27	12	of	of	ADP
ajlm-435	27	13	infections	infection	NOUN
ajlm-435	27	14	caused	cause	VERB
ajlm-435	27	15	by	by	ADP
ajlm-435	27	16	mdrsa	mdrsa	PROPN
ajlm-435	27	17	bacteria	bacteria	NOUN
ajlm-435	27	18	.	.	PUNCT
ajlm-435	28	1	this	this	DET
ajlm-435	28	2	study	study	NOUN
ajlm-435	28	3	sought	seek	VERB
ajlm-435	28	4	to	to	PART
ajlm-435	28	5	determine	determine	VERB
ajlm-435	28	6	the	the	DET
ajlm-435	28	7	therapeutic	therapeutic	ADJ
ajlm-435	28	8	potential	potential	NOUN
ajlm-435	28	9	of	of	ADP
ajlm-435	28	10	environmentally	environmentally	ADV
ajlm-435	28	11	-	-	PUNCT
ajlm-435	28	12	obtained	obtain	VERB
ajlm-435	28	13	lytic	lytic	ADJ
ajlm-435	28	14	phages	phage	NOUN
ajlm-435	28	15	in	in	ADP
ajlm-435	28	16	nairobi	nairobi	PROPN
ajlm-435	28	17	,	,	PUNCT
ajlm-435	28	18	kenya	kenya	PROPN
ajlm-435	28	19	,	,	PUNCT
ajlm-435	28	20	against	against	ADP
ajlm-435	28	21	haematogenous	haematogenous	ADJ
ajlm-435	28	22	mdrsa	mdrsa	PROPN
ajlm-435	28	23	pneumonia	pneumonia	NOUN
ajlm-435	28	24	in	in	ADP
ajlm-435	28	25	balb	balb	ADJ
ajlm-435	28	26	/	/	SYM
ajlm-435	28	27	c	c	NOUN
ajlm-435	28	28	mice	mouse	NOUN
ajlm-435	28	29	.	.	PUNCT
ajlm-435	29	1	research	research	NOUN
ajlm-435	29	2	method	method	NOUN
ajlm-435	29	3	and	and	CCONJ
ajlm-435	29	4	design	design	VERB
ajlm-435	29	5	ethical	ethical	ADJ
ajlm-435	29	6	considerations	consideration	NOUN
ajlm-435	29	7	all	all	DET
ajlm-435	29	8	experimental	experimental	ADJ
ajlm-435	29	9	protocols	protocol	NOUN
ajlm-435	29	10	and	and	CCONJ
ajlm-435	29	11	procedures	procedure	NOUN
ajlm-435	29	12	of	of	ADP
ajlm-435	29	13	the	the	DET
ajlm-435	29	14	study	study	NOUN
ajlm-435	29	15	were	be	AUX
ajlm-435	29	16	reviewed	review	VERB
ajlm-435	29	17	and	and	CCONJ
ajlm-435	29	18	approved	approve	VERB
ajlm-435	29	19	by	by	ADP
ajlm-435	29	20	the	the	DET
ajlm-435	29	21	institutional	institutional	PROPN
ajlm-435	29	22	review	review	PROPN
ajlm-435	29	23	committee	committee	NOUN
ajlm-435	29	24	on	on	ADP
ajlm-435	29	25	animals	animal	NOUN
ajlm-435	29	26	ethics	ethic	NOUN
ajlm-435	29	27	of	of	ADP
ajlm-435	29	28	the	the	DET
ajlm-435	29	29	institute	institute	PROPN
ajlm-435	29	30	of	of	ADP
ajlm-435	29	31	primate	primate	PROPN
ajlm-435	29	32	research	research	NOUN
ajlm-435	29	33	(	(	PUNCT
ajlm-435	29	34	ref	ref	NOUN
ajlm-435	29	35	no	no	INTJ
ajlm-435	29	36	:	:	PUNCT
ajlm-435	29	37	irc/02/14	irc/02/14	NUM
ajlm-435	29	38	)	)	PUNCT
ajlm-435	29	39	ethical	ethical	ADJ
ajlm-435	29	40	committee	committee	NOUN
ajlm-435	29	41	on	on	ADP
ajlm-435	29	42	the	the	DET
ajlm-435	29	43	use	use	NOUN
ajlm-435	29	44	of	of	ADP
ajlm-435	29	45	laboratory	laboratory	NOUN
ajlm-435	29	46	animals	animal	NOUN
ajlm-435	29	47	for	for	ADP
ajlm-435	29	48	biomedical	biomedical	ADJ
ajlm-435	29	49	science	science	NOUN
ajlm-435	29	50	in	in	ADP
ajlm-435	29	51	accordance	accordance	NOUN
ajlm-435	29	52	with	with	ADP
ajlm-435	29	53	the	the	DET
ajlm-435	29	54	international	international	ADJ
ajlm-435	29	55	guidelines	guideline	NOUN
ajlm-435	29	56	on	on	ADP
ajlm-435	29	57	animal	animal	NOUN
ajlm-435	29	58	care	care	NOUN
ajlm-435	29	59	,	,	PUNCT
ajlm-435	29	60	handling	handling	NOUN
ajlm-435	29	61	and	and	CCONJ
ajlm-435	29	62	use	use	NOUN
ajlm-435	29	63	for	for	ADP
ajlm-435	29	64	biomedical	biomedical	ADJ
ajlm-435	29	65	research	research	NOUN
ajlm-435	29	66	.	.	PUNCT
ajlm-435	30	1	the	the	DET
ajlm-435	30	2	experiments	experiment	NOUN
ajlm-435	30	3	are	be	AUX
ajlm-435	30	4	reported	report	VERB
ajlm-435	30	5	in	in	ADP
ajlm-435	30	6	accordance	accordance	NOUN
ajlm-435	30	7	with	with	ADP
ajlm-435	30	8	arrive	arrive	ADJ
ajlm-435	30	9	guidelines.19	guidelines.19	NOUN
ajlm-435	30	10	study	study	NOUN
ajlm-435	30	11	animals	animal	NOUN
ajlm-435	30	12	the	the	DET
ajlm-435	30	13	study	study	NOUN
ajlm-435	30	14	included	include	VERB
ajlm-435	30	15	30	30	NUM
ajlm-435	30	16	balb	balb	ADJ
ajlm-435	30	17	/	/	SYM
ajlm-435	30	18	c	c	NOUN
ajlm-435	30	19	mice	mouse	NOUN
ajlm-435	30	20	of	of	ADP
ajlm-435	30	21	mixed	mixed	ADJ
ajlm-435	30	22	sexes	sex	NOUN
ajlm-435	30	23	aged	age	VERB
ajlm-435	30	24	6	6	NUM
ajlm-435	30	25	to	to	PART
ajlm-435	30	26	8	8	NUM
ajlm-435	30	27	weeks	week	NOUN
ajlm-435	30	28	which	which	PRON
ajlm-435	30	29	were	be	AUX
ajlm-435	30	30	sourced	source	VERB
ajlm-435	30	31	from	from	ADP
ajlm-435	30	32	the	the	DET
ajlm-435	30	33	institute	institute	NOUN
ajlm-435	30	34	of	of	ADP
ajlm-435	30	35	primate	primate	PROPN
ajlm-435	30	36	research	research	NOUN
ajlm-435	30	37	rodent	rodent	NOUN
ajlm-435	30	38	house	house	NOUN
ajlm-435	30	39	,	,	PUNCT
ajlm-435	30	40	karen	karen	PROPN
ajlm-435	30	41	-	-	PUNCT
ajlm-435	30	42	nairobi	nairobi	PROPN
ajlm-435	30	43	,	,	PUNCT
ajlm-435	30	44	kenya	kenya	NOUN
ajlm-435	30	45	,	,	PUNCT
ajlm-435	30	46	and	and	CCONJ
ajlm-435	30	47	maintained	maintain	VERB
ajlm-435	30	48	at	at	ADP
ajlm-435	30	49	their	their	PRON
ajlm-435	30	50	rodent	rodent	ADJ
ajlm-435	30	51	facility	facility	NOUN
ajlm-435	30	52	.	.	PUNCT
ajlm-435	31	1	the	the	DET
ajlm-435	31	2	mice	mouse	NOUN
ajlm-435	31	3	were	be	AUX
ajlm-435	31	4	fed	feed	VERB
ajlm-435	31	5	on	on	ADP
ajlm-435	31	6	antibiotic	antibiotic	ADJ
ajlm-435	31	7	-	-	PUNCT
ajlm-435	31	8	free	free	ADJ
ajlm-435	31	9	food	food	NOUN
ajlm-435	31	10	rations	ration	NOUN
ajlm-435	31	11	(	(	PUNCT
ajlm-435	31	12	obtained	obtain	VERB
ajlm-435	31	13	from	from	ADP
ajlm-435	31	14	unga	unga	PROPN
ajlm-435	31	15	feeds	feed	NOUN
ajlm-435	31	16	,	,	PUNCT
ajlm-435	31	17	nairobi	nairobi	PROPN
ajlm-435	31	18	,	,	PUNCT
ajlm-435	31	19	kenya	kenya	PROPN
ajlm-435	31	20	)	)	PUNCT
ajlm-435	31	21	and	and	CCONJ
ajlm-435	31	22	water	water	NOUN
ajlm-435	31	23	was	be	AUX
ajlm-435	31	24	provided	provide	VERB
ajlm-435	31	25	ad	ad	NOUN
ajlm-435	31	26	libitum	libitum	NOUN
ajlm-435	31	27	.	.	PUNCT
ajlm-435	32	1	isolation	isolation	NOUN
ajlm-435	32	2	of	of	ADP
ajlm-435	32	3	mdrsa	mdrsa	PROPN
ajlm-435	32	4	s.	s.	PROPN
ajlm-435	32	5	aureus	aureus	PROPN
ajlm-435	32	6	bacterial	bacterial	ADJ
ajlm-435	32	7	strains	strain	NOUN
ajlm-435	32	8	were	be	AUX
ajlm-435	32	9	isolated	isolate	VERB
ajlm-435	32	10	from	from	ADP
ajlm-435	32	11	20	20	NUM
ajlm-435	32	12	sewage	sewage	NOUN
ajlm-435	32	13	samples	sample	NOUN
ajlm-435	32	14	collected	collect	VERB
ajlm-435	32	15	from	from	ADP
ajlm-435	32	16	informal	informal	ADJ
ajlm-435	32	17	settlements	settlement	NOUN
ajlm-435	32	18	,	,	PUNCT
ajlm-435	32	19	sewage	sewage	NOUN
ajlm-435	32	20	treatment	treatment	NOUN
ajlm-435	32	21	plants	plant	NOUN
ajlm-435	32	22	and	and	CCONJ
ajlm-435	32	23	abattoirs	abattoir	NOUN
ajlm-435	32	24	within	within	ADP
ajlm-435	32	25	nairobi	nairobi	PROPN
ajlm-435	32	26	county	county	PROPN
ajlm-435	32	27	,	,	PUNCT
ajlm-435	32	28	kenya	kenya	PROPN
ajlm-435	32	29	.	.	PUNCT
ajlm-435	33	1	specimens	specimen	NOUN
ajlm-435	33	2	from	from	ADP
ajlm-435	33	3	all	all	DET
ajlm-435	33	4	the	the	DET
ajlm-435	33	5	samples	sample	NOUN
ajlm-435	33	6	were	be	AUX
ajlm-435	33	7	streaked	streak	VERB
ajlm-435	33	8	on	on	ADP
ajlm-435	33	9	selective	selective	ADJ
ajlm-435	33	10	mannitol	mannitol	NOUN
ajlm-435	33	11	salt	salt	NOUN
ajlm-435	33	12	agar	agar	NOUN
ajlm-435	33	13	(	(	PUNCT
ajlm-435	33	14	liofilchem	liofilchem	PROPN
ajlm-435	33	15	®	®	NOUN
ajlm-435	33	16	,	,	PUNCT
ajlm-435	33	17	roseto	roseto	NOUN
ajlm-435	33	18	degli	degli	NOUN
ajlm-435	33	19	abruzzi	abruzzi	NOUN
ajlm-435	33	20	,	,	PUNCT
ajlm-435	33	21	italy	italy	PROPN
ajlm-435	33	22	)	)	PUNCT
ajlm-435	33	23	supplemented	supplement	VERB
ajlm-435	33	24	with	with	ADP
ajlm-435	33	25	4	4	NUM
ajlm-435	33	26	µg	µg	NOUN
ajlm-435	33	27	of	of	ADP
ajlm-435	33	28	ciprofloxacin	ciprofloxacin	PRON
ajlm-435	33	29	[	[	X
ajlm-435	33	30	liofilchem	liofilchem	NOUN
ajlm-435	33	31	®	®	NOUN
ajlm-435	33	32	,	,	PUNCT
ajlm-435	33	33	roseto	roseto	NOUN
ajlm-435	33	34	degli	degli	NOUN
ajlm-435	33	35	abruzzi	abruzzi	NOUN
ajlm-435	33	36	,	,	PUNCT
ajlm-435	33	37	italy	italy	PROPN
ajlm-435	33	38	]	]	PUNCT
ajlm-435	33	39	.	.	PUNCT
ajlm-435	34	1	single	single	ADJ
ajlm-435	34	2	colonies	colony	NOUN
ajlm-435	34	3	were	be	AUX
ajlm-435	34	4	amplified	amplify	VERB
ajlm-435	34	5	in	in	ADP
ajlm-435	34	6	nutrient	nutrient	NOUN
ajlm-435	34	7	agar	agar	NOUN
ajlm-435	34	8	(	(	PUNCT
ajlm-435	34	9	himedia	himedia	NOUN
ajlm-435	34	10	,	,	PUNCT
ajlm-435	34	11	mumbai	mumbai	PROPN
ajlm-435	34	12	,	,	PUNCT
ajlm-435	34	13	india	india	PROPN
ajlm-435	34	14	)	)	PUNCT
ajlm-435	34	15	.	.	PUNCT
ajlm-435	35	1	staphylococcus	staphylococcus	NOUN
ajlm-435	35	2	strains	strain	NOUN
ajlm-435	35	3	were	be	AUX
ajlm-435	35	4	identified	identify	VERB
ajlm-435	35	5	using	use	VERB
ajlm-435	35	6	microscopy	microscopy	NOUN
ajlm-435	35	7	,	,	PUNCT
ajlm-435	35	8	physiological	physiological	ADJ
ajlm-435	35	9	tests	test	NOUN
ajlm-435	35	10	and	and	CCONJ
ajlm-435	35	11	an	an	DET
ajlm-435	35	12	analytical	analytical	ADJ
ajlm-435	35	13	profile	profile	NOUN
ajlm-435	35	14	index	index	NOUN
ajlm-435	35	15	of	of	ADP
ajlm-435	35	16	staphylococcus	staphylococcus	NOUN
ajlm-435	35	17	system	system	NOUN
ajlm-435	35	18	[	[	X
ajlm-435	35	19	biomérieux	biomérieux	PROPN
ajlm-435	35	20	,	,	PUNCT
ajlm-435	35	21	marcy	marcy	PROPN
ajlm-435	35	22	l’etoile	l’etoile	PROPN
ajlm-435	35	23	,	,	PUNCT
ajlm-435	35	24	france	france	PROPN
ajlm-435	35	25	]	]	PUNCT
ajlm-435	35	26	.	.	PUNCT
ajlm-435	36	1	we	we	PRON
ajlm-435	36	2	screened	screen	VERB
ajlm-435	36	3	isolated	isolated	ADJ
ajlm-435	36	4	s.	s.	PROPN
ajlm-435	36	5	aureus	aureus	PROPN
ajlm-435	36	6	bacteria	bacteria	NOUN
ajlm-435	36	7	for	for	ADP
ajlm-435	36	8	antimicrobial	antimicrobial	ADJ
ajlm-435	36	9	resistance	resistance	NOUN
ajlm-435	36	10	to	to	ADP
ajlm-435	36	11	the	the	DET
ajlm-435	36	12	following	follow	VERB
ajlm-435	36	13	drugs	drug	NOUN
ajlm-435	36	14	:	:	PUNCT
ajlm-435	36	15	ceftazidime	ceftazidime	NOUN
ajlm-435	36	16	30	30	NUM
ajlm-435	36	17	µg	µg	NOUN
ajlm-435	36	18	,	,	PUNCT
ajlm-435	36	19	oxacillin	oxacillin	NOUN
ajlm-435	36	20	1	1	NUM
ajlm-435	36	21	µg	µg	ADV
ajlm-435	36	22	,	,	PUNCT
ajlm-435	36	23	vancomycin	vancomycin	PROPN
ajlm-435	36	24	30	30	NUM
ajlm-435	36	25	µg	µg	NOUN
ajlm-435	36	26	,	,	PUNCT
ajlm-435	36	27	netilmicin	netilmicin	PROPN
ajlm-435	36	28	30	30	NUM
ajlm-435	36	29	µg	µg	NOUN
ajlm-435	36	30	,	,	PUNCT
ajlm-435	36	31	gentamicin	gentamicin	NOUN
ajlm-435	36	32	10	10	NUM
ajlm-435	36	33	µg	µg	NOUN
ajlm-435	36	34	,	,	PUNCT
ajlm-435	36	35	erythromycin	erythromycin	VERB
ajlm-435	36	36	15	15	NUM
ajlm-435	36	37	µg	µg	ADJ
ajlm-435	36	38	,	,	PUNCT
ajlm-435	36	39	trimethroprim	trimethroprim	NOUN
ajlm-435	36	40	-	-	PUNCT
ajlm-435	36	41	sulfamethoxazole	sulfamethoxazole	NOUN
ajlm-435	36	42	25	25	NUM
ajlm-435	36	43	µg	µg	ADV
ajlm-435	36	44	and	and	CCONJ
ajlm-435	36	45	cefuroxime	cefuroxime	ADJ
ajlm-435	36	46	30	30	NUM
ajlm-435	36	47	µg	µg	ADV
ajlm-435	36	48	(	(	PUNCT
ajlm-435	36	49	liofilchem	liofilchem	PROPN
ajlm-435	36	50	®	®	NOUN
ajlm-435	36	51	,	,	PUNCT
ajlm-435	36	52	roseto	roseto	NOUN
ajlm-435	36	53	degli	degli	NOUN
ajlm-435	36	54	abruzzi	abruzzi	NOUN
ajlm-435	36	55	,	,	PUNCT
ajlm-435	36	56	italy	italy	PROPN
ajlm-435	36	57	)	)	PUNCT
ajlm-435	36	58	,	,	PUNCT
ajlm-435	36	59	according	accord	VERB
ajlm-435	36	60	to	to	ADP
ajlm-435	36	61	the	the	DET
ajlm-435	36	62	clinical	clinical	ADJ
ajlm-435	36	63	laboratory	laboratory	PROPN
ajlm-435	36	64	standard	standard	PROPN
ajlm-435	36	65	institute	institute	PROPN
ajlm-435	36	66	protocol.20	protocol.20	PROPN
ajlm-435	36	67	isolates	isolate	NOUN
ajlm-435	36	68	were	be	AUX
ajlm-435	36	69	considered	consider	VERB
ajlm-435	36	70	to	to	PART
ajlm-435	36	71	be	be	AUX
ajlm-435	36	72	mdrsa	mdrsa	NOUN
ajlm-435	36	73	,	,	PUNCT
ajlm-435	36	74	if	if	SCONJ
ajlm-435	36	75	they	they	PRON
ajlm-435	36	76	were	be	AUX
ajlm-435	36	77	non	non	ADJ
ajlm-435	36	78	-	-	ADJ
ajlm-435	36	79	susceptible	susceptible	ADJ
ajlm-435	36	80	to	to	ADP
ajlm-435	36	81	more	more	ADJ
ajlm-435	36	82	than	than	ADP
ajlm-435	36	83	one	one	NUM
ajlm-435	36	84	class	class	NOUN
ajlm-435	36	85	of	of	ADP
ajlm-435	36	86	antibiotics	antibiotic	NOUN
ajlm-435	36	87	.	.	PUNCT
ajlm-435	37	1	colonies	colony	NOUN
ajlm-435	37	2	identified	identify	VERB
ajlm-435	37	3	as	as	ADP
ajlm-435	37	4	mdrsa	mdrsa	PROPN
ajlm-435	37	5	were	be	AUX
ajlm-435	37	6	re	re	VERB
ajlm-435	37	7	-	-	VERB
ajlm-435	37	8	suspended	suspend	VERB
ajlm-435	37	9	in	in	ADP
ajlm-435	37	10	50	50	NUM
ajlm-435	37	11	%	%	NOUN
ajlm-435	37	12	glycerol	glycerol	NOUN
ajlm-435	37	13	-	-	PUNCT
ajlm-435	37	14	nutrient	nutrient	NOUN
ajlm-435	37	15	broth	broth	NOUN
ajlm-435	37	16	and	and	CCONJ
ajlm-435	37	17	stored	store	VERB
ajlm-435	37	18	at	at	ADP
ajlm-435	37	19	-20	-20	NUM
ajlm-435	37	20	°	°	ADP
ajlm-435	37	21	c	c	NOUN
ajlm-435	37	22	until	until	ADP
ajlm-435	37	23	use	use	NOUN
ajlm-435	37	24	.	.	PUNCT
ajlm-435	38	1	phage	phage	NOUN
ajlm-435	38	2	isolation	isolation	NOUN
ajlm-435	38	3	we	we	PRON
ajlm-435	38	4	analysed	analyse	VERB
ajlm-435	38	5	half	half	DET
ajlm-435	38	6	a	a	DET
ajlm-435	38	7	litre	litre	NOUN
ajlm-435	38	8	of	of	ADP
ajlm-435	38	9	sewage	sewage	NOUN
ajlm-435	38	10	samples	sample	NOUN
ajlm-435	38	11	collected	collect	VERB
ajlm-435	38	12	from	from	ADP
ajlm-435	38	13	10	10	NUM
ajlm-435	38	14	sites	site	NOUN
ajlm-435	38	15	(	(	PUNCT
ajlm-435	38	16	nairobi	nairobi	PROPN
ajlm-435	38	17	city	city	PROPN
ajlm-435	38	18	sewage	sewage	NOUN
ajlm-435	38	19	treatment	treatment	NOUN
ajlm-435	38	20	plant	plant	NOUN
ajlm-435	38	21	,	,	PUNCT
ajlm-435	38	22	informal	informal	ADJ
ajlm-435	38	23	settlements	settlement	NOUN
ajlm-435	38	24	and	and	CCONJ
ajlm-435	38	25	an	an	DET
ajlm-435	38	26	abattoir	abattoir	NOUN
ajlm-435	38	27	)	)	PUNCT
ajlm-435	38	28	within	within	ADP
ajlm-435	38	29	nairobi	nairobi	PROPN
ajlm-435	38	30	county	county	PROPN
ajlm-435	38	31	,	,	PUNCT
ajlm-435	38	32	kenya	kenya	PROPN
ajlm-435	38	33	.	.	PUNCT
ajlm-435	39	1	twenty	twenty	NUM
ajlm-435	39	2	specific	specific	ADJ
ajlm-435	39	3	s.	s.	PROPN
ajlm-435	39	4	aureus	aureus	PROPN
ajlm-435	39	5	lytic	lytic	ADJ
ajlm-435	39	6	phages	phage	NOUN
ajlm-435	39	7	were	be	AUX
ajlm-435	39	8	isolated	isolate	VERB
ajlm-435	39	9	from	from	ADP
ajlm-435	39	10	these	these	DET
ajlm-435	39	11	samples	sample	NOUN
ajlm-435	39	12	using	use	VERB
ajlm-435	39	13	the	the	DET
ajlm-435	39	14	modified	modify	VERB
ajlm-435	39	15	method	method	NOUN
ajlm-435	39	16	of	of	ADP
ajlm-435	39	17	anany	anany	ADJ
ajlm-435	39	18	et	et	NOUN
ajlm-435	39	19	al.21	al.21	PROPN
ajlm-435	39	20	briefly	briefly	ADV
ajlm-435	39	21	,	,	PUNCT
ajlm-435	39	22	equal	equal	ADJ
ajlm-435	39	23	volumes	volume	NOUN
ajlm-435	39	24	of	of	ADP
ajlm-435	39	25	ultra	ultra	ADJ
ajlm-435	39	26	-	-	ADJ
ajlm-435	39	27	filtered	filter	VERB
ajlm-435	39	28	sewage	sewage	NOUN
ajlm-435	39	29	samples	sample	NOUN
ajlm-435	39	30	and	and	CCONJ
ajlm-435	39	31	nutrient	nutrient	ADJ
ajlm-435	39	32	broth	broth	NOUN
ajlm-435	39	33	,	,	PUNCT
ajlm-435	39	34	plus	plus	CCONJ
ajlm-435	39	35	1	1	NUM
ajlm-435	39	36	ml	ml	NOUN
ajlm-435	39	37	of	of	ADP
ajlm-435	39	38	18	18	NUM
ajlm-435	39	39	-	-	PUNCT
ajlm-435	39	40	hour	hour	NOUN
ajlm-435	39	41	-	-	PUNCT
ajlm-435	39	42	old	old	ADJ
ajlm-435	39	43	mdrsa	mdrsa	NOUN
ajlm-435	39	44	culture	culture	NOUN
ajlm-435	39	45	were	be	AUX
ajlm-435	39	46	mixed	mixed	ADJ
ajlm-435	39	47	and	and	CCONJ
ajlm-435	39	48	incubated	incubate	VERB
ajlm-435	39	49	overnight	overnight	ADV
ajlm-435	39	50	at	at	ADP
ajlm-435	39	51	37	37	NUM
ajlm-435	39	52	°	°	NOUN
ajlm-435	39	53	c	c	NOUN
ajlm-435	39	54	while	while	SCONJ
ajlm-435	39	55	shaking	shake	VERB
ajlm-435	39	56	at	at	ADP
ajlm-435	39	57	120	120	NUM
ajlm-435	39	58	rpm	rpm	NOUN
ajlm-435	39	59	(	(	PUNCT
ajlm-435	39	60	lab	lab	NOUN
ajlm-435	39	61	-	-	PUNCT
ajlm-435	39	62	line	line	NOUN
ajlm-435	39	63	®	®	NOUN
ajlm-435	39	64	incubator	incubator	NOUN
ajlm-435	39	65	-	-	PUNCT
ajlm-435	39	66	shaker	shaker	NOUN
ajlm-435	39	67	,	,	PUNCT
ajlm-435	39	68	waltham	waltham	PROPN
ajlm-435	39	69	,	,	PUNCT
ajlm-435	39	70	massachusetts	massachusetts	PROPN
ajlm-435	39	71	,	,	PUNCT
ajlm-435	39	72	united	united	PROPN
ajlm-435	39	73	states	states	PROPN
ajlm-435	39	74	)	)	PUNCT
ajlm-435	39	75	.	.	PUNCT
ajlm-435	40	1	the	the	DET
ajlm-435	40	2	following	following	ADJ
ajlm-435	40	3	day	day	NOUN
ajlm-435	40	4	,	,	PUNCT
ajlm-435	40	5	the	the	DET
ajlm-435	40	6	culture	culture	NOUN
ajlm-435	40	7	was	be	AUX
ajlm-435	40	8	centrifuged	centrifuge	VERB
ajlm-435	40	9	at	at	ADP
ajlm-435	40	10	10	10	NUM
ajlm-435	40	11	000	000	NUM
ajlm-435	40	12	g	g	NOUN
ajlm-435	40	13	for	for	ADP
ajlm-435	40	14	10	10	NUM
ajlm-435	40	15	minutes	minute	NOUN
ajlm-435	40	16	(	(	PUNCT
ajlm-435	40	17	fisher	fisher	PROPN
ajlm-435	40	18	centrific	centrific	PROPN
ajlm-435	40	19	®	®	NOUN
ajlm-435	40	20	centrifuge	centrifuge	NOUN
ajlm-435	40	21	,	,	PUNCT
ajlm-435	40	22	waltham	waltham	PROPN
ajlm-435	40	23	,	,	PUNCT
ajlm-435	40	24	massachusetts	massachusetts	PROPN
ajlm-435	40	25	,	,	PUNCT
ajlm-435	40	26	united	united	PROPN
ajlm-435	40	27	states	states	PROPN
ajlm-435	40	28	)	)	PUNCT
ajlm-435	40	29	,	,	PUNCT
ajlm-435	40	30	and	and	CCONJ
ajlm-435	40	31	the	the	DET
ajlm-435	40	32	supernatant	supernatant	NOUN
ajlm-435	40	33	was	be	AUX
ajlm-435	40	34	filtered	filter	VERB
ajlm-435	40	35	through	through	ADP
ajlm-435	40	36	a	a	DET
ajlm-435	40	37	0.22	0.22	NUM
ajlm-435	40	38	µm	µm	NOUN
ajlm-435	40	39	filtration	filtration	NOUN
ajlm-435	40	40	unit	unit	NOUN
ajlm-435	40	41	(	(	PUNCT
ajlm-435	40	42	cambridge	cambridge	PROPN
ajlm-435	40	43	,	,	PUNCT
ajlm-435	40	44	massachusetts	massachusetts	PROPN
ajlm-435	40	45	,	,	PUNCT
ajlm-435	40	46	united	united	PROPN
ajlm-435	40	47	states	states	PROPN
ajlm-435	40	48	)	)	PUNCT
ajlm-435	40	49	,	,	PUNCT
ajlm-435	40	50	then	then	ADV
ajlm-435	40	51	screened	screen	VERB
ajlm-435	40	52	for	for	ADP
ajlm-435	40	53	the	the	DET
ajlm-435	40	54	presence	presence	NOUN
ajlm-435	40	55	of	of	ADP
ajlm-435	40	56	phages	phage	NOUN
ajlm-435	40	57	using	use	VERB
ajlm-435	40	58	a	a	DET
ajlm-435	40	59	double	double	ADJ
ajlm-435	40	60	-	-	PUNCT
ajlm-435	40	61	layer	layer	NOUN
ajlm-435	40	62	plaque	plaque	NOUN
ajlm-435	40	63	assay	assay	NOUN
ajlm-435	40	64	.	.	PUNCT
ajlm-435	41	1	individual	individual	ADJ
ajlm-435	41	2	plaques	plaque	NOUN
ajlm-435	41	3	were	be	AUX
ajlm-435	41	4	selected	select	VERB
ajlm-435	41	5	and	and	CCONJ
ajlm-435	41	6	sub	sub	ADJ
ajlm-435	41	7	-	-	ADJ
ajlm-435	41	8	cultured	cultured	ADJ
ajlm-435	41	9	in	in	ADP
ajlm-435	41	10	2	2	NUM
ajlm-435	41	11	ml	ml	NOUN
ajlm-435	41	12	of	of	ADP
ajlm-435	41	13	nutrient	nutrient	ADJ
ajlm-435	41	14	broth	broth	NOUN
ajlm-435	41	15	containing	contain	VERB
ajlm-435	41	16	a	a	DET
ajlm-435	41	17	sensitive	sensitive	ADJ
ajlm-435	41	18	bacterial	bacterial	ADJ
ajlm-435	41	19	host	host	NOUN
ajlm-435	41	20	(	(	PUNCT
ajlm-435	41	21	106	106	NUM
ajlm-435	41	22	cfu	cfu	NOUN
ajlm-435	41	23	/	/	SYM
ajlm-435	41	24	ml	ml	NOUN
ajlm-435	41	25	)	)	PUNCT
ajlm-435	41	26	.	.	PUNCT
ajlm-435	42	1	the	the	DET
ajlm-435	42	2	isolated	isolated	ADJ
ajlm-435	42	3	phages	phage	NOUN
ajlm-435	42	4	were	be	AUX
ajlm-435	42	5	then	then	ADV
ajlm-435	42	6	tested	test	VERB
ajlm-435	42	7	against	against	ADP
ajlm-435	42	8	the	the	DET
ajlm-435	42	9	previously	previously	ADV
ajlm-435	42	10	-	-	PUNCT
ajlm-435	42	11	isolated	isolate	VERB
ajlm-435	42	12	mdrsa	mdrsa	NOUN
ajlm-435	42	13	by	by	ADP
ajlm-435	42	14	spot	spot	NOUN
ajlm-435	42	15	assay	assay	PROPN
ajlm-435	42	16	.	.	PUNCT
ajlm-435	43	1	the	the	DET
ajlm-435	43	2	virulence	virulence	NOUN
ajlm-435	43	3	of	of	ADP
ajlm-435	43	4	the	the	DET
ajlm-435	43	5	phages	phage	NOUN
ajlm-435	43	6	was	be	AUX
ajlm-435	43	7	determined	determine	VERB
ajlm-435	43	8	by	by	ADP
ajlm-435	43	9	using	use	VERB
ajlm-435	43	10	an	an	DET
ajlm-435	43	11	efficiency	efficiency	NOUN
ajlm-435	43	12	of	of	ADP
ajlm-435	43	13	plating	plating	NOUN
ajlm-435	43	14	analysis,22	analysis,22	NOUN
ajlm-435	43	15	whereby	whereby	SCONJ
ajlm-435	43	16	the	the	DET
ajlm-435	43	17	strain	strain	NOUN
ajlm-435	43	18	with	with	ADP
ajlm-435	43	19	numerous	numerous	ADJ
ajlm-435	43	20	plaques	plaque	NOUN
ajlm-435	43	21	on	on	ADP
ajlm-435	43	22	mdrsa	mdrsa	PROPN
ajlm-435	43	23	lawn	lawn	NOUN
ajlm-435	43	24	was	be	AUX
ajlm-435	43	25	considered	consider	VERB
ajlm-435	43	26	the	the	DET
ajlm-435	43	27	most	most	ADV
ajlm-435	43	28	virulent	virulent	NOUN
ajlm-435	43	29	.	.	PUNCT
ajlm-435	44	1	the	the	DET
ajlm-435	44	2	virulent	virulent	ADJ
ajlm-435	44	3	phage	phage	NOUN
ajlm-435	44	4	was	be	AUX
ajlm-435	44	5	selected	select	VERB
ajlm-435	44	6	and	and	CCONJ
ajlm-435	44	7	used	use	VERB
ajlm-435	44	8	as	as	ADP
ajlm-435	44	9	a	a	DET
ajlm-435	44	10	therapeutic	therapeutic	ADJ
ajlm-435	44	11	agent	agent	NOUN
ajlm-435	44	12	against	against	ADP
ajlm-435	44	13	mdrsa	mdrsa	NOUN
ajlm-435	44	14	in	in	ADP
ajlm-435	44	15	mice	mouse	NOUN
ajlm-435	44	16	.	.	PUNCT
ajlm-435	45	1	experimental	experimental	ADJ
ajlm-435	45	2	design	design	NOUN
ajlm-435	45	3	thirty	thirty	NUM
ajlm-435	45	4	mice	mouse	NOUN
ajlm-435	45	5	were	be	AUX
ajlm-435	45	6	randomly	randomly	ADV
ajlm-435	45	7	assigned	assign	VERB
ajlm-435	45	8	to	to	ADP
ajlm-435	45	9	one	one	NUM
ajlm-435	45	10	of	of	ADP
ajlm-435	45	11	three	three	NUM
ajlm-435	45	12	groups	group	NOUN
ajlm-435	45	13	:	:	PUNCT
ajlm-435	45	14	the	the	DET
ajlm-435	45	15	mdrsa	mdrsa	PROPN
ajlm-435	45	16	infection	infection	NOUN
ajlm-435	45	17	group	group	NOUN
ajlm-435	45	18	(	(	PUNCT
ajlm-435	45	19	n	n	NOUN
ajlm-435	45	20	=	=	NUM
ajlm-435	45	21	20	20	NUM
ajlm-435	45	22	)	)	PUNCT
ajlm-435	45	23	,	,	PUNCT
ajlm-435	45	24	the	the	DET
ajlm-435	45	25	non	non	ADJ
ajlm-435	45	26	-	-	ADJ
ajlm-435	45	27	infection	infection	ADJ
ajlm-435	45	28	group	group	NOUN
ajlm-435	45	29	(	(	PUNCT
ajlm-435	45	30	n	n	NOUN
ajlm-435	45	31	=	=	SYM
ajlm-435	45	32	5	5	NUM
ajlm-435	45	33	)	)	PUNCT
ajlm-435	45	34	and	and	CCONJ
ajlm-435	45	35	the	the	DET
ajlm-435	45	36	phage	phage	NOUN
ajlm-435	45	37	infection	infection	NOUN
ajlm-435	45	38	group	group	NOUN
ajlm-435	45	39	(	(	PUNCT
ajlm-435	45	40	n	n	NOUN
ajlm-435	45	41	=	=	SYM
ajlm-435	45	42	5	5	NUM
ajlm-435	45	43	)	)	PUNCT
ajlm-435	45	44	.	.	PUNCT
ajlm-435	46	1	twenty	twenty	NUM
ajlm-435	46	2	mice	mouse	NOUN
ajlm-435	46	3	were	be	AUX
ajlm-435	46	4	infected	infect	VERB
ajlm-435	46	5	with	with	ADP
ajlm-435	46	6	108	108	NUM
ajlm-435	46	7	cfu	cfu	NOUN
ajlm-435	46	8	/	/	SYM
ajlm-435	46	9	ml	ml	NOUN
ajlm-435	46	10	of	of	ADP
ajlm-435	46	11	mdrsa	mdrsa	PROPN
ajlm-435	46	12	isolate	isolate	VERB
ajlm-435	46	13	intravenously	intravenously	ADV
ajlm-435	46	14	by	by	ADP
ajlm-435	46	15	means	mean	NOUN
ajlm-435	46	16	of	of	ADP
ajlm-435	46	17	the	the	DET
ajlm-435	46	18	tail	tail	NOUN
ajlm-435	46	19	vein	vein	NOUN
ajlm-435	46	20	and	and	CCONJ
ajlm-435	46	21	then	then	ADV
ajlm-435	46	22	sub	sub	ADJ
ajlm-435	46	23	-	-	ADJ
ajlm-435	46	24	divided	divided	ADJ
ajlm-435	46	25	into	into	ADP
ajlm-435	46	26	four	four	NUM
ajlm-435	46	27	sub	sub	NOUN
ajlm-435	46	28	-	-	NOUN
ajlm-435	46	29	groups	group	NOUN
ajlm-435	46	30	:	:	PUNCT
ajlm-435	46	31	mdrsa	mdrsa	NOUN
ajlm-435	46	32	with	with	ADP
ajlm-435	46	33	clindamycin	clindamycin	NOUN
ajlm-435	46	34	(	(	PUNCT
ajlm-435	46	35	clindar	clindar	NOUN
ajlm-435	46	36	,	,	PUNCT
ajlm-435	46	37	indi	indi	PROPN
ajlm-435	46	38	pharma	pharma	PROPN
ajlm-435	46	39	,	,	PUNCT
ajlm-435	46	40	mumbai	mumbai	PROPN
ajlm-435	46	41	,	,	PUNCT
ajlm-435	46	42	india	india	PROPN
ajlm-435	46	43	)	)	PUNCT
ajlm-435	46	44	(	(	PUNCT
ajlm-435	46	45	8	8	NUM
ajlm-435	46	46	mg	mg	NUM
ajlm-435	46	47	/	/	SYM
ajlm-435	46	48	kg	kg	PROPN
ajlm-435	46	49	body	body	NOUN
ajlm-435	46	50	weight	weight	NOUN
ajlm-435	46	51	)	)	PUNCT
ajlm-435	46	52	treatment	treatment	NOUN
ajlm-435	46	53	(	(	PUNCT
ajlm-435	46	54	n	n	NOUN
ajlm-435	46	55	=	=	SYM
ajlm-435	46	56	5	5	NUM
ajlm-435	46	57	)	)	PUNCT
ajlm-435	46	58	;	;	PUNCT
ajlm-435	46	59	mdrsa	mdrsa	NOUN
ajlm-435	46	60	with	with	ADP
ajlm-435	46	61	phage	phage	NOUN
ajlm-435	46	62	(	(	PUNCT
ajlm-435	46	63	108	108	NUM
ajlm-435	46	64	pfu	pfu	NOUN
ajlm-435	46	65	/	/	SYM
ajlm-435	46	66	ml	ml	NOUN
ajlm-435	46	67	)	)	PUNCT
ajlm-435	46	68	treatment	treatment	NOUN
ajlm-435	46	69	(	(	PUNCT
ajlm-435	46	70	n	n	NOUN
ajlm-435	46	71	=	=	SYM
ajlm-435	46	72	5	5	NUM
ajlm-435	46	73	)	)	PUNCT
ajlm-435	46	74	;	;	PUNCT
ajlm-435	46	75	mdrsa	mdrsa	NOUN
ajlm-435	46	76	with	with	ADP
ajlm-435	46	77	combination	combination	NOUN
ajlm-435	46	78	treatment	treatment	NOUN
ajlm-435	46	79	(	(	PUNCT
ajlm-435	46	80	clindamycin	clindamycin	NOUN
ajlm-435	46	81	[	[	X
ajlm-435	46	82	8	8	NUM
ajlm-435	46	83	mg	mg	NUM
ajlm-435	46	84	/	/	SYM
ajlm-435	46	85	kg	kg	PROPN
ajlm-435	46	86	body	body	NOUN
ajlm-435	46	87	weight	weight	NOUN
ajlm-435	46	88	]	]	PUNCT
ajlm-435	46	89	and	and	CCONJ
ajlm-435	46	90	phage	phage	NOUN
ajlm-435	47	1	[	[	PUNCT
ajlm-435	47	2	108	108	NUM
ajlm-435	47	3	pfu	pfu	NOUN
ajlm-435	47	4	/	/	SYM
ajlm-435	47	5	ml	ml	NOUN
ajlm-435	47	6	]	]	PUNCT
ajlm-435	47	7	)	)	PUNCT
ajlm-435	47	8	(	(	PUNCT
ajlm-435	47	9	n	n	NOUN
ajlm-435	47	10	=	=	SYM
ajlm-435	47	11	5	5	NUM
ajlm-435	47	12	)	)	PUNCT
ajlm-435	47	13	;	;	PUNCT
ajlm-435	47	14	and	and	CCONJ
ajlm-435	47	15	mdrsa	mdrsa	NOUN
ajlm-435	47	16	with	with	ADP
ajlm-435	47	17	no	no	DET
ajlm-435	47	18	treatment	treatment	NOUN
ajlm-435	47	19	as	as	ADP
ajlm-435	47	20	the	the	DET
ajlm-435	47	21	control	control	NOUN
ajlm-435	47	22	(	(	PUNCT
ajlm-435	47	23	n	n	NOUN
ajlm-435	47	24	=	=	SYM
ajlm-435	47	25	5	5	NUM
ajlm-435	47	26	)	)	PUNCT
ajlm-435	47	27	(	(	PUNCT
ajlm-435	47	28	figure	figure	NOUN
ajlm-435	47	29	1	1	NUM
ajlm-435	47	30	)	)	PUNCT
ajlm-435	47	31	.	.	PUNCT
ajlm-435	48	1	presence	presence	NOUN
ajlm-435	48	2	of	of	ADP
ajlm-435	48	3	infection	infection	NOUN
ajlm-435	48	4	was	be	AUX
ajlm-435	48	5	determined	determine	VERB
ajlm-435	48	6	by	by	ADP
ajlm-435	48	7	observing	observe	VERB
ajlm-435	48	8	the	the	DET
ajlm-435	48	9	physical	physical	ADJ
ajlm-435	48	10	appearance	appearance	NOUN
ajlm-435	48	11	of	of	ADP
ajlm-435	48	12	the	the	DET
ajlm-435	48	13	mice	mouse	NOUN
ajlm-435	48	14	and	and	CCONJ
ajlm-435	48	15	assessing	assess	VERB
ajlm-435	48	16	the	the	DET
ajlm-435	48	17	bacteraemia	bacteraemia	NOUN
ajlm-435	48	18	level	level	NOUN
ajlm-435	48	19	.	.	PUNCT
ajlm-435	49	1	the	the	DET
ajlm-435	49	2	bacteraemia	bacteraemia	NOUN
ajlm-435	49	3	count	count	NOUN
ajlm-435	49	4	was	be	AUX
ajlm-435	49	5	assessed	assess	VERB
ajlm-435	49	6	by	by	ADP
ajlm-435	49	7	culturing	culture	VERB
ajlm-435	49	8	blood	blood	NOUN
ajlm-435	49	9	samples	sample	NOUN
ajlm-435	49	10	from	from	ADP
ajlm-435	49	11	each	each	DET
ajlm-435	49	12	mouse	mouse	NOUN
ajlm-435	49	13	by	by	ADP
ajlm-435	49	14	using	use	VERB
ajlm-435	49	15	the	the	DET
ajlm-435	49	16	pour	pour	ADJ
ajlm-435	49	17	plate	plate	NOUN
ajlm-435	49	18	method	method	NOUN
ajlm-435	49	19	.	.	PUNCT
ajlm-435	50	1	fifty	fifty	NUM
ajlm-435	50	2	microlitres	microlitre	NOUN
ajlm-435	50	3	(	(	PUNCT
ajlm-435	50	4	50	50	NUM
ajlm-435	50	5	µl	µl	NOUN
ajlm-435	50	6	)	)	PUNCT
ajlm-435	50	7	of	of	ADP
ajlm-435	50	8	blood	blood	NOUN
ajlm-435	50	9	was	be	AUX
ajlm-435	50	10	obtained	obtain	VERB
ajlm-435	50	11	from	from	ADP
ajlm-435	50	12	each	each	DET
ajlm-435	50	13	mouse	mouse	NOUN
ajlm-435	50	14	from	from	ADP
ajlm-435	50	15	the	the	DET
ajlm-435	50	16	tail	tail	NOUN
ajlm-435	50	17	vein	vein	NOUN
ajlm-435	50	18	and	and	CCONJ
ajlm-435	50	19	mixed	mix	VERB
ajlm-435	50	20	with	with	ADP
ajlm-435	50	21	950	950	NUM
ajlm-435	50	22	µl	µl	ADP
ajlm-435	50	23	sterile	sterile	ADJ
ajlm-435	50	24	normal	normal	ADJ
ajlm-435	50	25	saline	saline	NOUN
ajlm-435	50	26	.	.	PUNCT
ajlm-435	51	1	this	this	DET
ajlm-435	51	2	mixture	mixture	NOUN
ajlm-435	51	3	(	(	PUNCT
ajlm-435	51	4	blood	blood	NOUN
ajlm-435	51	5	-	-	PUNCT
ajlm-435	51	6	normal	normal	ADJ
ajlm-435	51	7	saline	saline	NOUN
ajlm-435	51	8	)	)	PUNCT
ajlm-435	51	9	was	be	AUX
ajlm-435	51	10	added	add	VERB
ajlm-435	51	11	to	to	ADP
ajlm-435	51	12	molten	molten	ADJ
ajlm-435	51	13	nutrient	nutrient	NOUN
ajlm-435	51	14	broth	broth	NOUN
ajlm-435	51	15	,	,	PUNCT
ajlm-435	51	16	allowed	allow	VERB
ajlm-435	51	17	to	to	PART
ajlm-435	51	18	cool	cool	VERB
ajlm-435	51	19	,	,	PUNCT
ajlm-435	51	20	then	then	ADV
ajlm-435	51	21	incubated	incubate	VERB
ajlm-435	51	22	overnight	overnight	ADV
ajlm-435	51	23	at	at	ADP
ajlm-435	51	24	37	37	NUM
ajlm-435	51	25	°	°	NOUN
ajlm-435	51	26	c	c	NOUN
ajlm-435	51	27	.	.	PUNCT
ajlm-435	52	1	the	the	DET
ajlm-435	52	2	bacterial	bacterial	ADJ
ajlm-435	52	3	colony	colony	NOUN
ajlm-435	52	4	count	count	NOUN
ajlm-435	52	5	was	be	AUX
ajlm-435	52	6	recorded	record	VERB
ajlm-435	52	7	per	per	ADP
ajlm-435	52	8	millilitre	millilitre	NOUN
ajlm-435	52	9	for	for	ADP
ajlm-435	52	10	each	each	DET
ajlm-435	52	11	mouse	mouse	NOUN
ajlm-435	52	12	.	.	PUNCT
ajlm-435	53	1	a	a	DET
ajlm-435	53	2	similar	similar	ADJ
ajlm-435	53	3	procedure	procedure	NOUN
ajlm-435	53	4	was	be	AUX
ajlm-435	53	5	used	use	VERB
ajlm-435	53	6	to	to	PART
ajlm-435	53	7	determine	determine	VERB
ajlm-435	53	8	the	the	DET
ajlm-435	53	9	bacteraemia	bacteraemia	NOUN
ajlm-435	53	10	for	for	ADP
ajlm-435	53	11	each	each	DET
ajlm-435	53	12	mouse	mouse	NOUN
ajlm-435	53	13	after	after	SCONJ
ajlm-435	53	14	treatment	treatment	NOUN
ajlm-435	53	15	was	be	AUX
ajlm-435	53	16	initiated	initiate	VERB
ajlm-435	53	17	.	.	PUNCT
ajlm-435	54	1	treatment	treatment	NOUN
ajlm-435	54	2	with	with	ADP
ajlm-435	54	3	clindamycin	clindamycin	NOUN
ajlm-435	54	4	,	,	PUNCT
ajlm-435	54	5	phage	phage	NOUN
ajlm-435	54	6	or	or	CCONJ
ajlm-435	54	7	combination	combination	NOUN
ajlm-435	54	8	was	be	AUX
ajlm-435	54	9	administered	administer	VERB
ajlm-435	54	10	at	at	ADP
ajlm-435	54	11	72	72	NUM
ajlm-435	54	12	hours	hour	NOUN
ajlm-435	54	13	post	post	ADJ
ajlm-435	54	14	-	-	ADJ
ajlm-435	54	15	mdrsa	mdrsa	ADJ
ajlm-435	54	16	infection	infection	NOUN
ajlm-435	54	17	when	when	SCONJ
ajlm-435	54	18	the	the	DET
ajlm-435	54	19	bacterial	bacterial	ADJ
ajlm-435	54	20	levels	level	NOUN
ajlm-435	54	21	in	in	ADP
ajlm-435	54	22	the	the	DET
ajlm-435	54	23	blood	blood	NOUN
ajlm-435	54	24	began	begin	VERB
ajlm-435	54	25	to	to	PART
ajlm-435	54	26	rise	rise	VERB
ajlm-435	54	27	.	.	PUNCT
ajlm-435	55	1	each	each	DET
ajlm-435	55	2	mouse	mouse	NOUN
ajlm-435	55	3	in	in	ADP
ajlm-435	55	4	the	the	DET
ajlm-435	55	5	treatment	treatment	NOUN
ajlm-435	55	6	groups	group	NOUN
ajlm-435	55	7	received	receive	VERB
ajlm-435	55	8	a	a	DET
ajlm-435	55	9	single	single	ADJ
ajlm-435	55	10	dose	dose	NOUN
ajlm-435	55	11	of	of	ADP
ajlm-435	55	12	the	the	DET
ajlm-435	55	13	mentioned	mention	VERB
ajlm-435	55	14	therapeutic	therapeutic	ADJ
ajlm-435	55	15	agents	agent	NOUN
ajlm-435	55	16	.	.	PUNCT
ajlm-435	56	1	the	the	DET
ajlm-435	56	2	experiments	experiment	NOUN
ajlm-435	56	3	were	be	AUX
ajlm-435	56	4	repeated	repeat	VERB
ajlm-435	56	5	three	three	NUM
ajlm-435	56	6	times	time	NOUN
ajlm-435	56	7	;	;	PUNCT
ajlm-435	56	8	thus	thus	ADV
ajlm-435	56	9	,	,	PUNCT
ajlm-435	56	10	the	the	DET
ajlm-435	56	11	total	total	ADJ
ajlm-435	56	12	number	number	NOUN
ajlm-435	56	13	of	of	ADP
ajlm-435	56	14	mice	mouse	NOUN
ajlm-435	56	15	used	use	VERB
ajlm-435	56	16	in	in	ADP
ajlm-435	56	17	the	the	DET
ajlm-435	56	18	study	study	NOUN
ajlm-435	56	19	was	be	AUX
ajlm-435	56	20	90	90	NUM
ajlm-435	56	21	.	.	PUNCT
ajlm-435	56	22	figure	figure	NOUN
ajlm-435	56	23	1	1	NUM
ajlm-435	56	24	:	:	PUNCT
ajlm-435	56	25	design	design	NOUN
ajlm-435	56	26	of	of	ADP
ajlm-435	56	27	the	the	DET
ajlm-435	56	28	in	in	ADP
ajlm-435	56	29	vivo	vivo	ADJ
ajlm-435	56	30	experimental	experimental	ADJ
ajlm-435	56	31	study	study	NOUN
ajlm-435	56	32	.	.	PUNCT
ajlm-435	57	1	the	the	DET
ajlm-435	57	2	study	study	NOUN
ajlm-435	57	3	was	be	AUX
ajlm-435	57	4	repeated	repeat	VERB
ajlm-435	57	5	three	three	NUM
ajlm-435	57	6	times	time	NOUN
ajlm-435	57	7	and	and	CCONJ
ajlm-435	57	8	a	a	DET
ajlm-435	57	9	total	total	ADJ
ajlm-435	57	10	number	number	NOUN
ajlm-435	57	11	of	of	ADP
ajlm-435	57	12	90	90	NUM
ajlm-435	57	13	mice	mouse	NOUN
ajlm-435	57	14	were	be	AUX
ajlm-435	57	15	used	use	VERB
ajlm-435	57	16	.	.	PUNCT
ajlm-435	58	1	viable	viable	ADJ
ajlm-435	58	2	bacteria	bacteria	NOUN
ajlm-435	58	3	levels	level	NOUN
ajlm-435	58	4	in	in	ADP
ajlm-435	58	5	mouse	mouse	NOUN
ajlm-435	58	6	lung	lung	NOUN
ajlm-435	58	7	homogenates	homogenate	NOUN
ajlm-435	58	8	upon	upon	SCONJ
ajlm-435	58	9	necropsy	necropsy	NOUN
ajlm-435	58	10	,	,	PUNCT
ajlm-435	58	11	lungs	lung	NOUN
ajlm-435	58	12	were	be	AUX
ajlm-435	58	13	obtained	obtain	VERB
ajlm-435	58	14	aseptically	aseptically	ADV
ajlm-435	58	15	and	and	CCONJ
ajlm-435	58	16	homogenised	homogenise	VERB
ajlm-435	58	17	for	for	ADP
ajlm-435	58	18	bacterial	bacterial	ADJ
ajlm-435	58	19	culture	culture	NOUN
ajlm-435	58	20	as	as	SCONJ
ajlm-435	58	21	follows	follow	VERB
ajlm-435	58	22	:	:	PUNCT
ajlm-435	58	23	500	500	NUM
ajlm-435	58	24	µl	µl	NOUN
ajlm-435	58	25	of	of	ADP
ajlm-435	58	26	homogenised	homogenised	ADJ
ajlm-435	58	27	tissue	tissue	NOUN
ajlm-435	58	28	was	be	AUX
ajlm-435	58	29	diluted	dilute	VERB
ajlm-435	58	30	with	with	ADP
ajlm-435	58	31	normal	normal	ADJ
ajlm-435	58	32	saline	saline	NOUN
ajlm-435	58	33	at	at	ADP
ajlm-435	58	34	a	a	DET
ajlm-435	58	35	ratio	ratio	NOUN
ajlm-435	58	36	of	of	ADP
ajlm-435	58	37	1:20	1:20	NUM
ajlm-435	58	38	(	(	PUNCT
ajlm-435	58	39	homogenised	homogenise	VERB
ajlm-435	58	40	lung	lung	NOUN
ajlm-435	58	41	tissue	tissue	NOUN
ajlm-435	58	42	to	to	PART
ajlm-435	58	43	saline	saline	VERB
ajlm-435	58	44	)	)	PUNCT
ajlm-435	58	45	.	.	PUNCT
ajlm-435	59	1	the	the	DET
ajlm-435	59	2	diluted	diluted	ADJ
ajlm-435	59	3	,	,	PUNCT
ajlm-435	59	4	homogenised	homogenise	VERB
ajlm-435	59	5	tissue	tissue	NOUN
ajlm-435	59	6	was	be	AUX
ajlm-435	59	7	then	then	ADV
ajlm-435	59	8	plated	plate	VERB
ajlm-435	59	9	on	on	ADP
ajlm-435	59	10	7.5	7.5	NUM
ajlm-435	59	11	%	%	NOUN
ajlm-435	59	12	sodium	sodium	NOUN
ajlm-435	59	13	chloride	chloride	NOUN
ajlm-435	59	14	nutrient	nutrient	NOUN
ajlm-435	59	15	agar	agar	NOUN
ajlm-435	59	16	to	to	PART
ajlm-435	59	17	select	select	VERB
ajlm-435	59	18	for	for	ADP
ajlm-435	59	19	mdrsa	mdrsa	NOUN
ajlm-435	59	20	and	and	CCONJ
ajlm-435	59	21	incubated	incubate	VERB
ajlm-435	59	22	at	at	ADP
ajlm-435	59	23	37	37	NUM
ajlm-435	59	24	°	°	ADP
ajlm-435	59	25	c	c	NOUN
ajlm-435	59	26	for	for	ADP
ajlm-435	59	27	18–20	18–20	NUM
ajlm-435	59	28	hours	hour	NOUN
ajlm-435	59	29	.	.	PUNCT
ajlm-435	60	1	histopathology	histopathology	NOUN
ajlm-435	60	2	phage	phage	NOUN
ajlm-435	60	3	safety	safety	NOUN
ajlm-435	60	4	and	and	CCONJ
ajlm-435	60	5	mdrsa	mdrsa	NOUN
ajlm-435	60	6	pathogenicity	pathogenicity	NOUN
ajlm-435	60	7	were	be	AUX
ajlm-435	60	8	determined	determine	VERB
ajlm-435	60	9	by	by	ADP
ajlm-435	60	10	euthanising	euthanise	VERB
ajlm-435	60	11	the	the	DET
ajlm-435	60	12	mice	mice	NOUN
ajlm-435	60	13	when	when	SCONJ
ajlm-435	60	14	they	they	PRON
ajlm-435	60	15	exhibited	exhibit	VERB
ajlm-435	60	16	poor	poor	ADJ
ajlm-435	60	17	physical	physical	ADJ
ajlm-435	60	18	appearance	appearance	NOUN
ajlm-435	60	19	and	and	CCONJ
ajlm-435	60	20	breathing	breathing	NOUN
ajlm-435	60	21	difficulties	difficulty	NOUN
ajlm-435	60	22	in	in	ADP
ajlm-435	60	23	order	order	NOUN
ajlm-435	60	24	to	to	PART
ajlm-435	60	25	alleviate	alleviate	VERB
ajlm-435	60	26	pain	pain	NOUN
ajlm-435	60	27	and	and	CCONJ
ajlm-435	60	28	suffering	suffering	NOUN
ajlm-435	60	29	.	.	PUNCT
ajlm-435	61	1	surviving	survive	VERB
ajlm-435	61	2	mice	mouse	NOUN
ajlm-435	61	3	were	be	AUX
ajlm-435	61	4	euthanised	euthanise	VERB
ajlm-435	61	5	at	at	ADP
ajlm-435	61	6	10	10	NUM
ajlm-435	61	7	days	day	NOUN
ajlm-435	61	8	post	post	ADJ
ajlm-435	61	9	-	-	NOUN
ajlm-435	61	10	infection	infection	NOUN
ajlm-435	61	11	.	.	PUNCT
ajlm-435	62	1	lung	lung	NOUN
ajlm-435	62	2	samples	sample	NOUN
ajlm-435	62	3	were	be	AUX
ajlm-435	62	4	collected	collect	VERB
ajlm-435	62	5	in	in	ADP
ajlm-435	62	6	10	10	NUM
ajlm-435	62	7	%	%	NOUN
ajlm-435	62	8	formaldehyde	formaldehyde	NOUN
ajlm-435	62	9	for	for	ADP
ajlm-435	62	10	histological	histological	ADJ
ajlm-435	62	11	analysis	analysis	NOUN
ajlm-435	62	12	.	.	PUNCT
ajlm-435	63	1	levels	level	NOUN
ajlm-435	63	2	of	of	ADP
ajlm-435	63	3	inflammation	inflammation	NOUN
ajlm-435	63	4	were	be	AUX
ajlm-435	63	5	scored	score	VERB
ajlm-435	63	6	using	use	VERB
ajlm-435	63	7	categories	category	NOUN
ajlm-435	63	8	as	as	SCONJ
ajlm-435	63	9	described	describe	VERB
ajlm-435	63	10	by	by	ADP
ajlm-435	63	11	schünemann	schünemann	PROPN
ajlm-435	63	12	et	et	PROPN
ajlm-435	63	13	al.23	al.23	PROPN
ajlm-435	63	14	briefly	briefly	ADV
ajlm-435	63	15	,	,	PUNCT
ajlm-435	63	16	the	the	DET
ajlm-435	63	17	categories	category	NOUN
ajlm-435	63	18	worst	bad	ADJ
ajlm-435	63	19	,	,	PUNCT
ajlm-435	63	20	worse	bad	ADJ
ajlm-435	63	21	,	,	PUNCT
ajlm-435	63	22	bad	bad	ADJ
ajlm-435	63	23	,	,	PUNCT
ajlm-435	63	24	good	good	ADJ
ajlm-435	63	25	,	,	PUNCT
ajlm-435	63	26	better	well	ADJ
ajlm-435	63	27	and	and	CCONJ
ajlm-435	63	28	best	good	ADJ
ajlm-435	63	29	were	be	AUX
ajlm-435	63	30	assigned	assign	VERB
ajlm-435	63	31	based	base	VERB
ajlm-435	63	32	on	on	ADP
ajlm-435	63	33	a	a	DET
ajlm-435	63	34	scale	scale	NOUN
ajlm-435	63	35	of	of	ADP
ajlm-435	63	36	5	5	NUM
ajlm-435	63	37	to	to	PART
ajlm-435	63	38	0	0	NUM
ajlm-435	63	39	.	.	PUNCT
ajlm-435	64	1	the	the	DET
ajlm-435	64	2	‘	'	PUNCT
ajlm-435	64	3	worst	bad	ADJ
ajlm-435	64	4	’	'	PUNCT
ajlm-435	64	5	category	category	NOUN
ajlm-435	64	6	was	be	AUX
ajlm-435	64	7	assigned	assign	VERB
ajlm-435	64	8	for	for	ADP
ajlm-435	64	9	severely	severely	ADV
ajlm-435	64	10	inflammed	inflammed	ADJ
ajlm-435	64	11	septa	septum	NOUN
ajlm-435	64	12	,	,	PUNCT
ajlm-435	64	13	numerous	numerous	ADJ
ajlm-435	64	14	collapsed	collapse	VERB
ajlm-435	64	15	alveoli	alveolus	NOUN
ajlm-435	64	16	,	,	PUNCT
ajlm-435	64	17	large	large	ADJ
ajlm-435	64	18	pockets	pocket	NOUN
ajlm-435	64	19	of	of	ADP
ajlm-435	64	20	pneumonia	pneumonia	NOUN
ajlm-435	64	21	,	,	PUNCT
ajlm-435	64	22	mucus	mucus	NOUN
ajlm-435	64	23	-	-	PUNCT
ajlm-435	64	24	congested	congested	ADJ
ajlm-435	64	25	alveoli	alveoli	NOUN
ajlm-435	64	26	,	,	PUNCT
ajlm-435	64	27	presence	presence	NOUN
ajlm-435	64	28	of	of	ADP
ajlm-435	64	29	perivascular	perivascular	ADJ
ajlm-435	64	30	fibrosis	fibrosis	NOUN
ajlm-435	64	31	blood	blood	NOUN
ajlm-435	64	32	vessels	vessel	NOUN
ajlm-435	64	33	and	and	CCONJ
ajlm-435	64	34	lack	lack	NOUN
ajlm-435	64	35	of	of	ADP
ajlm-435	64	36	ventilation	ventilation	NOUN
ajlm-435	64	37	(	(	PUNCT
ajlm-435	64	38	score	score	NOUN
ajlm-435	64	39	=	=	SYM
ajlm-435	64	40	5	5	NUM
ajlm-435	64	41	)	)	PUNCT
ajlm-435	64	42	.	.	PUNCT
ajlm-435	65	1	the	the	DET
ajlm-435	65	2	‘	'	PUNCT
ajlm-435	65	3	worse	bad	ADJ
ajlm-435	65	4	’	'	PUNCT
ajlm-435	65	5	category	category	NOUN
ajlm-435	65	6	included	include	VERB
ajlm-435	65	7	all	all	DET
ajlm-435	65	8	conditions	condition	NOUN
ajlm-435	65	9	in	in	ADP
ajlm-435	65	10	the	the	DET
ajlm-435	65	11	worst	bad	ADJ
ajlm-435	65	12	category	category	NOUN
ajlm-435	65	13	but	but	CCONJ
ajlm-435	65	14	with	with	ADP
ajlm-435	65	15	poor	poor	ADJ
ajlm-435	65	16	ventilation	ventilation	NOUN
ajlm-435	65	17	(	(	PUNCT
ajlm-435	65	18	score	score	NOUN
ajlm-435	65	19	=	=	NOUN
ajlm-435	65	20	4	4	NUM
ajlm-435	65	21	)	)	PUNCT
ajlm-435	65	22	.	.	PUNCT
ajlm-435	66	1	the	the	DET
ajlm-435	66	2	‘	'	PUNCT
ajlm-435	66	3	bad	bad	ADJ
ajlm-435	66	4	’	'	PUNCT
ajlm-435	66	5	category	category	NOUN
ajlm-435	66	6	was	be	AUX
ajlm-435	66	7	assigned	assign	VERB
ajlm-435	66	8	for	for	ADP
ajlm-435	66	9	minor	minor	ADJ
ajlm-435	66	10	inflammation	inflammation	NOUN
ajlm-435	66	11	of	of	ADP
ajlm-435	66	12	septa	septum	NOUN
ajlm-435	66	13	,	,	PUNCT
ajlm-435	66	14	few	few	ADJ
ajlm-435	66	15	pockets	pocket	NOUN
ajlm-435	66	16	of	of	ADP
ajlm-435	66	17	pneumonia	pneumonia	NOUN
ajlm-435	66	18	and	and	CCONJ
ajlm-435	66	19	moderate	moderate	ADJ
ajlm-435	66	20	ventilation	ventilation	NOUN
ajlm-435	66	21	(	(	PUNCT
ajlm-435	66	22	score	score	NOUN
ajlm-435	66	23	=	=	SYM
ajlm-435	66	24	3	3	NUM
ajlm-435	66	25	)	)	PUNCT
ajlm-435	66	26	.	.	PUNCT
ajlm-435	67	1	the	the	DET
ajlm-435	67	2	‘	'	PUNCT
ajlm-435	67	3	good	good	ADJ
ajlm-435	67	4	’	'	PUNCT
ajlm-435	67	5	category	category	NOUN
ajlm-435	67	6	was	be	AUX
ajlm-435	67	7	assigned	assign	VERB
ajlm-435	67	8	for	for	ADP
ajlm-435	67	9	minor	minor	ADJ
ajlm-435	67	10	inflammation	inflammation	NOUN
ajlm-435	67	11	of	of	ADP
ajlm-435	67	12	septa	septum	NOUN
ajlm-435	67	13	,	,	PUNCT
ajlm-435	67	14	few	few	ADJ
ajlm-435	67	15	pockets	pocket	NOUN
ajlm-435	67	16	of	of	ADP
ajlm-435	67	17	mucus	mucus	NOUN
ajlm-435	67	18	-	-	PUNCT
ajlm-435	67	19	congested	congest	VERB
ajlm-435	67	20	alveoli	alveoli	NOUN
ajlm-435	67	21	and	and	CCONJ
ajlm-435	67	22	good	good	ADJ
ajlm-435	67	23	ventilation	ventilation	NOUN
ajlm-435	67	24	(	(	PUNCT
ajlm-435	67	25	score	score	NOUN
ajlm-435	67	26	=	=	SYM
ajlm-435	67	27	2	2	NUM
ajlm-435	67	28	)	)	PUNCT
ajlm-435	67	29	.	.	PUNCT
ajlm-435	68	1	the	the	DET
ajlm-435	68	2	‘	'	PUNCT
ajlm-435	68	3	better	well	ADJ
ajlm-435	68	4	’	'	PUNCT
ajlm-435	68	5	category	category	NOUN
ajlm-435	68	6	was	be	AUX
ajlm-435	68	7	assigned	assign	VERB
ajlm-435	68	8	for	for	ADP
ajlm-435	68	9	no	no	DET
ajlm-435	68	10	inflammed	inflammed	ADJ
ajlm-435	68	11	septa	septum	NOUN
ajlm-435	68	12	and	and	CCONJ
ajlm-435	68	13	a	a	DET
ajlm-435	68	14	few	few	ADJ
ajlm-435	68	15	pockets	pocket	NOUN
ajlm-435	68	16	of	of	ADP
ajlm-435	68	17	mucus	mucus	NOUN
ajlm-435	68	18	-	-	PUNCT
ajlm-435	68	19	congested	congest	VERB
ajlm-435	68	20	alveoli	alveoli	NOUN
ajlm-435	68	21	(	(	PUNCT
ajlm-435	68	22	score	score	NOUN
ajlm-435	68	23	=	=	NOUN
ajlm-435	68	24	1	1	NUM
ajlm-435	68	25	)	)	PUNCT
ajlm-435	68	26	.	.	PUNCT
ajlm-435	69	1	the	the	DET
ajlm-435	69	2	‘	'	PUNCT
ajlm-435	69	3	best’/normal	best’/normal	ADJ
ajlm-435	69	4	category	category	NOUN
ajlm-435	69	5	was	be	AUX
ajlm-435	69	6	assigned	assign	VERB
ajlm-435	69	7	for	for	ADP
ajlm-435	69	8	no	no	DET
ajlm-435	69	9	inflammation	inflammation	NOUN
ajlm-435	69	10	and	and	CCONJ
ajlm-435	69	11	good	good	ADJ
ajlm-435	69	12	ventilation	ventilation	NOUN
ajlm-435	69	13	(	(	PUNCT
ajlm-435	69	14	score	score	NOUN
ajlm-435	69	15	=	=	NOUN
ajlm-435	69	16	0	0	NUM
ajlm-435	69	17	)	)	PUNCT
ajlm-435	69	18	.	.	PUNCT
ajlm-435	70	1	statistical	statistical	ADJ
ajlm-435	70	2	analysis	analysis	NOUN
ajlm-435	70	3	bacterial	bacterial	ADJ
ajlm-435	70	4	and	and	CCONJ
ajlm-435	70	5	phage	phage	NOUN
ajlm-435	70	6	counts	count	NOUN
ajlm-435	70	7	were	be	AUX
ajlm-435	70	8	represented	represent	VERB
ajlm-435	70	9	as	as	ADP
ajlm-435	70	10	mean	mean	NOUN
ajlm-435	70	11	±	±	NUM
ajlm-435	70	12	standard	standard	ADJ
ajlm-435	70	13	error	error	NOUN
ajlm-435	70	14	of	of	ADP
ajlm-435	70	15	the	the	DET
ajlm-435	70	16	mean	mean	NOUN
ajlm-435	70	17	.	.	PUNCT
ajlm-435	71	1	the	the	DET
ajlm-435	71	2	statistical	statistical	ADJ
ajlm-435	71	3	significance	significance	NOUN
ajlm-435	71	4	of	of	ADP
ajlm-435	71	5	differences	difference	NOUN
ajlm-435	71	6	between	between	ADP
ajlm-435	71	7	groups	group	NOUN
ajlm-435	71	8	was	be	AUX
ajlm-435	71	9	determined	determine	VERB
ajlm-435	71	10	by	by	ADP
ajlm-435	71	11	one	one	NUM
ajlm-435	71	12	-	-	PUNCT
ajlm-435	71	13	way	way	NOUN
ajlm-435	71	14	analysis	analysis	NOUN
ajlm-435	71	15	of	of	ADP
ajlm-435	71	16	variance	variance	NOUN
ajlm-435	71	17	,	,	PUNCT
ajlm-435	71	18	followed	follow	VERB
ajlm-435	71	19	by	by	ADP
ajlm-435	71	20	tukey	tukey	PROPN
ajlm-435	71	21	’s	’s	PART
ajlm-435	71	22	multiple	multiple	ADJ
ajlm-435	71	23	comparison	comparison	NOUN
ajlm-435	71	24	test	test	NOUN
ajlm-435	71	25	,	,	PUNCT
ajlm-435	71	26	using	use	VERB
ajlm-435	71	27	graph	graph	NOUN
ajlm-435	71	28	pad	pad	NOUN
ajlm-435	71	29	prism	prism	NOUN
ajlm-435	71	30	5.0.1	5.0.1	NUM
ajlm-435	71	31	(	(	PUNCT
ajlm-435	71	32	graph	graph	NOUN
ajlm-435	71	33	pad	pad	NOUN
ajlm-435	71	34	software	software	NOUN
ajlm-435	71	35	,	,	PUNCT
ajlm-435	71	36	san	san	PROPN
ajlm-435	71	37	diego	diego	PROPN
ajlm-435	71	38	,	,	PUNCT
ajlm-435	71	39	california	california	PROPN
ajlm-435	71	40	,	,	PUNCT
ajlm-435	71	41	united	united	PROPN
ajlm-435	71	42	states	states	PROPN
ajlm-435	71	43	)	)	PUNCT
ajlm-435	71	44	.	.	PUNCT
ajlm-435	72	1	a	a	DET
ajlm-435	72	2	p	p	NOUN
ajlm-435	72	3	-	-	PUNCT
ajlm-435	72	4	value	value	NOUN
ajlm-435	72	5	of	of	ADP
ajlm-435	72	6	less	less	ADJ
ajlm-435	72	7	than	than	ADP
ajlm-435	72	8	0.05	0.05	NUM
ajlm-435	72	9	was	be	AUX
ajlm-435	72	10	considered	consider	VERB
ajlm-435	72	11	statistically	statistically	ADV
ajlm-435	72	12	significant	significant	ADJ
ajlm-435	72	13	.	.	PUNCT
ajlm-435	73	1	results	result	NOUN
ajlm-435	73	2	multidrug	multidrug	NOUN
ajlm-435	73	3	-	-	PUNCT
ajlm-435	73	4	resistant	resistant	ADJ
ajlm-435	73	5	s.	s.	PROPN
ajlm-435	73	6	aureus	aureus	PROPN
ajlm-435	73	7	isolation	isolation	NOUN
ajlm-435	73	8	the	the	DET
ajlm-435	73	9	environmentally	environmentally	ADV
ajlm-435	73	10	-	-	PUNCT
ajlm-435	73	11	isolated	isolate	VERB
ajlm-435	73	12	s.	s.	PROPN
ajlm-435	73	13	aureus	aureus	PROPN
ajlm-435	73	14	bacterium	bacterium	NOUN
ajlm-435	73	15	was	be	AUX
ajlm-435	73	16	resistant	resistant	ADJ
ajlm-435	73	17	to	to	ADP
ajlm-435	73	18	β	β	NOUN
ajlm-435	73	19	-	-	NOUN
ajlm-435	73	20	lactam	lactam	NOUN
ajlm-435	73	21	antibiotics	antibiotic	NOUN
ajlm-435	73	22	(	(	PUNCT
ajlm-435	73	23	ceftazidime	ceftazidime	NOUN
ajlm-435	73	24	,	,	PUNCT
ajlm-435	73	25	cefuroxime	cefuroxime	ADJ
ajlm-435	73	26	and	and	CCONJ
ajlm-435	73	27	oxacillin	oxacillin	PROPN
ajlm-435	73	28	)	)	PUNCT
ajlm-435	73	29	.	.	PUNCT
ajlm-435	74	1	in	in	ADP
ajlm-435	74	2	addition	addition	NOUN
ajlm-435	74	3	,	,	PUNCT
ajlm-435	74	4	it	it	PRON
ajlm-435	74	5	was	be	AUX
ajlm-435	74	6	non	non	ADJ
ajlm-435	74	7	-	-	ADJ
ajlm-435	74	8	susceptible	susceptible	ADJ
ajlm-435	74	9	to	to	PART
ajlm-435	74	10	glycopeptide	glycopeptide	VERB
ajlm-435	74	11	(	(	PUNCT
ajlm-435	74	12	vancomycin	vancomycin	PROPN
ajlm-435	74	13	)	)	PUNCT
ajlm-435	74	14	,	,	PUNCT
ajlm-435	74	15	aminoglycoside	aminoglycoside	ADJ
ajlm-435	74	16	(	(	PUNCT
ajlm-435	74	17	netilmicin	netilmicin	NOUN
ajlm-435	74	18	and	and	CCONJ
ajlm-435	74	19	gentamicin	gentamicin	NOUN
ajlm-435	74	20	)	)	PUNCT
ajlm-435	74	21	and	and	CCONJ
ajlm-435	74	22	macrolide	macrolide	NOUN
ajlm-435	74	23	(	(	PUNCT
ajlm-435	74	24	erythromycin	erythromycin	NOUN
ajlm-435	74	25	)	)	PUNCT
ajlm-435	74	26	antibiotics	antibiotic	NOUN
ajlm-435	74	27	.	.	PUNCT
ajlm-435	75	1	however	however	ADV
ajlm-435	75	2	,	,	PUNCT
ajlm-435	75	3	it	it	PRON
ajlm-435	75	4	was	be	AUX
ajlm-435	75	5	susceptible	susceptible	ADJ
ajlm-435	75	6	to	to	ADP
ajlm-435	75	7	nucleic	nucleic	ADJ
ajlm-435	75	8	acid	acid	NOUN
ajlm-435	75	9	synthesis	synthesis	NOUN
ajlm-435	75	10	inhibitors	inhibitor	NOUN
ajlm-435	75	11	(	(	PUNCT
ajlm-435	75	12	co	co	NOUN
ajlm-435	75	13	-	-	NOUN
ajlm-435	75	14	trimoxazole	trimoxazole	ADJ
ajlm-435	76	1	[	[	X
ajlm-435	76	2	trimethroprim	trimethroprim	NOUN
ajlm-435	76	3	-	-	PUNCT
ajlm-435	76	4	sulfamethoxazole	sulfamethoxazole	NOUN
ajlm-435	76	5	]	]	PUNCT
ajlm-435	76	6	)	)	PUNCT
ajlm-435	76	7	(	(	PUNCT
ajlm-435	76	8	figure	figure	NOUN
ajlm-435	76	9	2	2	NUM
ajlm-435	76	10	)	)	PUNCT
ajlm-435	76	11	.	.	PUNCT
ajlm-435	77	1	thus	thus	ADV
ajlm-435	77	2	,	,	PUNCT
ajlm-435	77	3	the	the	DET
ajlm-435	77	4	bacterial	bacterial	ADJ
ajlm-435	77	5	isolate	isolate	NOUN
ajlm-435	77	6	was	be	AUX
ajlm-435	77	7	considered	consider	VERB
ajlm-435	77	8	to	to	PART
ajlm-435	77	9	be	be	AUX
ajlm-435	77	10	multidrug	multidrug	NOUN
ajlm-435	77	11	-	-	PUNCT
ajlm-435	77	12	resistant	resistant	ADJ
ajlm-435	77	13	,	,	PUNCT
ajlm-435	77	14	as	as	SCONJ
ajlm-435	77	15	it	it	PRON
ajlm-435	77	16	was	be	AUX
ajlm-435	77	17	non	non	ADJ
ajlm-435	77	18	-	-	ADJ
ajlm-435	77	19	susceptible	susceptible	ADJ
ajlm-435	77	20	to	to	ADP
ajlm-435	77	21	more	more	ADJ
ajlm-435	77	22	than	than	ADP
ajlm-435	77	23	one	one	NUM
ajlm-435	77	24	class	class	NOUN
ajlm-435	77	25	of	of	ADP
ajlm-435	77	26	antibiotics	antibiotic	NOUN
ajlm-435	77	27	.	.	PUNCT
ajlm-435	78	1	figure	figure	NOUN
ajlm-435	78	2	2	2	NUM
ajlm-435	78	3	:	:	PUNCT
ajlm-435	78	4	antibiogram	antibiogram	PROPN
ajlm-435	78	5	test	test	NOUN
ajlm-435	78	6	of	of	ADP
ajlm-435	78	7	s.	s.	PROPN
ajlm-435	78	8	aureus	aureus	PROPN
ajlm-435	78	9	isolate	isolate	PROPN
ajlm-435	78	10	.	.	PUNCT
ajlm-435	79	1	the	the	DET
ajlm-435	79	2	isolate	isolate	NOUN
ajlm-435	79	3	was	be	AUX
ajlm-435	79	4	resistant	resistant	ADJ
ajlm-435	79	5	to	to	ADP
ajlm-435	79	6	:	:	PUNCT
ajlm-435	79	7	ceftazidime	ceftazidime	NOUN
ajlm-435	79	8	,	,	PUNCT
ajlm-435	79	9	30	30	NUM
ajlm-435	79	10	µg	µg	ADP
ajlm-435	79	11	(	(	PUNCT
ajlm-435	79	12	1	1	NUM
ajlm-435	79	13	)	)	PUNCT
ajlm-435	79	14	;	;	PUNCT
ajlm-435	79	15	oxacillin	oxacillin	PROPN
ajlm-435	79	16	,	,	PUNCT
ajlm-435	79	17	1	1	NUM
ajlm-435	79	18	µg	µg	ADP
ajlm-435	79	19	(	(	PUNCT
ajlm-435	79	20	2	2	NUM
ajlm-435	79	21	)	)	PUNCT
ajlm-435	79	22	;	;	PUNCT
ajlm-435	79	23	vancomycin	vancomycin	PROPN
ajlm-435	79	24	,	,	PUNCT
ajlm-435	79	25	30	30	NUM
ajlm-435	79	26	µg	µg	ADP
ajlm-435	79	27	(	(	PUNCT
ajlm-435	79	28	4	4	NUM
ajlm-435	79	29	)	)	PUNCT
ajlm-435	79	30	;	;	PUNCT
ajlm-435	79	31	netilmicin	netilmicin	NOUN
ajlm-435	79	32	,	,	PUNCT
ajlm-435	79	33	30	30	NUM
ajlm-435	79	34	µg	µg	ADP
ajlm-435	79	35	(	(	PUNCT
ajlm-435	79	36	6	6	NUM
ajlm-435	79	37	)	)	PUNCT
ajlm-435	79	38	;	;	PUNCT
ajlm-435	79	39	gentamicin	gentamicin	VERB
ajlm-435	79	40	,	,	PUNCT
ajlm-435	79	41	10	10	NUM
ajlm-435	79	42	µg	µg	ADP
ajlm-435	79	43	(	(	PUNCT
ajlm-435	79	44	7	7	NUM
ajlm-435	79	45	)	)	PUNCT
ajlm-435	79	46	;	;	PUNCT
ajlm-435	79	47	erythromycin	erythromycin	NOUN
ajlm-435	79	48	,	,	PUNCT
ajlm-435	79	49	15	15	NUM
ajlm-435	79	50	µg	µg	ADP
ajlm-435	79	51	(	(	PUNCT
ajlm-435	79	52	8)	8)	NUM
ajlm-435	79	53	;	;	PUNCT
ajlm-435	79	54	and	and	CCONJ
ajlm-435	79	55	cefuroxime	cefuroxime	ADJ
ajlm-435	79	56	,	,	PUNCT
ajlm-435	79	57	30	30	NUM
ajlm-435	79	58	µg	µg	ADP
ajlm-435	79	59	(	(	PUNCT
ajlm-435	79	60	5	5	NUM
ajlm-435	79	61	)	)	PUNCT
ajlm-435	79	62	.	.	PUNCT
ajlm-435	80	1	however	however	ADV
ajlm-435	80	2	,	,	PUNCT
ajlm-435	80	3	it	it	PRON
ajlm-435	80	4	was	be	AUX
ajlm-435	80	5	sensitive	sensitive	ADJ
ajlm-435	80	6	to	to	ADP
ajlm-435	80	7	trimethroprim	trimethroprim	NOUN
ajlm-435	80	8	-	-	PUNCT
ajlm-435	80	9	sulfamethoxazole	sulfamethoxazole	NOUN
ajlm-435	80	10	,	,	PUNCT
ajlm-435	80	11	25	25	NUM
ajlm-435	80	12	µg	µg	ADP
ajlm-435	80	13	(	(	PUNCT
ajlm-435	80	14	3	3	NUM
ajlm-435	80	15	)	)	PUNCT
ajlm-435	80	16	.	.	PUNCT
ajlm-435	81	1	phage	phage	NOUN
ajlm-435	81	2	isolation	isolation	NOUN
ajlm-435	81	3	and	and	CCONJ
ajlm-435	81	4	in	in	ADP
ajlm-435	81	5	vitro	vitro	X
ajlm-435	81	6	activities	activity	NOUN
ajlm-435	81	7	spot	spot	NOUN
ajlm-435	81	8	assays	assay	NOUN
ajlm-435	81	9	were	be	AUX
ajlm-435	81	10	used	use	VERB
ajlm-435	81	11	to	to	PART
ajlm-435	81	12	identify	identify	VERB
ajlm-435	81	13	10	10	NUM
ajlm-435	81	14	s.	s.	PROPN
ajlm-435	81	15	aureus	aureus	PROPN
ajlm-435	81	16	lytic	lytic	ADJ
ajlm-435	81	17	phages	phage	NOUN
ajlm-435	81	18	which	which	PRON
ajlm-435	81	19	produced	produce	VERB
ajlm-435	81	20	large	large	ADJ
ajlm-435	81	21	clear	clear	ADJ
ajlm-435	81	22	plaques	plaque	NOUN
ajlm-435	81	23	on	on	ADP
ajlm-435	81	24	the	the	DET
ajlm-435	81	25	mdrsa	mdrsa	PROPN
ajlm-435	81	26	lawn	lawn	NOUN
ajlm-435	81	27	(	(	PUNCT
ajlm-435	81	28	figure	figure	NOUN
ajlm-435	81	29	3	3	NUM
ajlm-435	81	30	)	)	PUNCT
ajlm-435	81	31	while	while	SCONJ
ajlm-435	81	32	other	other	ADJ
ajlm-435	81	33	isolates	isolate	NOUN
ajlm-435	81	34	failed	fail	VERB
ajlm-435	81	35	.	.	PUNCT
ajlm-435	82	1	of	of	ADP
ajlm-435	82	2	the	the	DET
ajlm-435	82	3	10	10	NUM
ajlm-435	82	4	phage	phage	NOUN
ajlm-435	82	5	isolates	isolate	NOUN
ajlm-435	82	6	,	,	PUNCT
ajlm-435	82	7	one	one	NUM
ajlm-435	82	8	created	create	VERB
ajlm-435	82	9	a	a	DET
ajlm-435	82	10	larger	large	ADJ
ajlm-435	82	11	patch	patch	NOUN
ajlm-435	82	12	on	on	ADP
ajlm-435	82	13	the	the	DET
ajlm-435	82	14	mdrsa	mdrsa	PROPN
ajlm-435	82	15	lawn	lawn	NOUN
ajlm-435	82	16	.	.	PUNCT
ajlm-435	83	1	its	its	PRON
ajlm-435	83	2	efficiency	efficiency	NOUN
ajlm-435	83	3	of	of	ADP
ajlm-435	83	4	plating	plating	NOUN
ajlm-435	83	5	analysis	analysis	NOUN
ajlm-435	83	6	showed	show	VERB
ajlm-435	83	7	that	that	SCONJ
ajlm-435	83	8	it	it	PRON
ajlm-435	83	9	had	have	VERB
ajlm-435	83	10	more	more	ADJ
ajlm-435	83	11	plaques	plaque	NOUN
ajlm-435	83	12	than	than	ADP
ajlm-435	83	13	other	other	ADJ
ajlm-435	83	14	phages	phage	NOUN
ajlm-435	83	15	.	.	PUNCT
ajlm-435	84	1	figure	figure	VERB
ajlm-435	84	2	3	3	NUM
ajlm-435	84	3	:	:	PUNCT
ajlm-435	84	4	spot	spot	NOUN
ajlm-435	84	5	assay	assay	NOUN
ajlm-435	84	6	showing	show	VERB
ajlm-435	84	7	most	most	ADJ
ajlm-435	84	8	virulent	virulent	ADJ
ajlm-435	84	9	phage	phage	NOUN
ajlm-435	84	10	isolate	isolate	NOUN
ajlm-435	84	11	.	.	PUNCT
ajlm-435	85	1	therapeutic	therapeutic	ADJ
ajlm-435	85	2	effects	effect	NOUN
ajlm-435	85	3	in	in	ADP
ajlm-435	85	4	mice	mice	NOUN
ajlm-435	85	5	two	two	NUM
ajlm-435	85	6	groups	group	NOUN
ajlm-435	85	7	of	of	ADP
ajlm-435	85	8	mice	mouse	NOUN
ajlm-435	85	9	had	have	VERB
ajlm-435	85	10	100	100	NUM
ajlm-435	85	11	%	%	NOUN
ajlm-435	85	12	survivorship	survivorship	NOUN
ajlm-435	85	13	(	(	PUNCT
ajlm-435	85	14	n	n	NOUN
ajlm-435	85	15	=	=	SYM
ajlm-435	85	16	5	5	NUM
ajlm-435	85	17	)	)	PUNCT
ajlm-435	85	18	,	,	PUNCT
ajlm-435	85	19	namely	namely	ADV
ajlm-435	85	20	,	,	PUNCT
ajlm-435	85	21	the	the	DET
ajlm-435	85	22	non	non	ADJ
ajlm-435	85	23	-	-	ADJ
ajlm-435	85	24	infected	infected	ADJ
ajlm-435	85	25	/	/	SYM
ajlm-435	85	26	non	non	ADJ
ajlm-435	85	27	-	-	ADJ
ajlm-435	85	28	treated	treat	VERB
ajlm-435	85	29	group	group	NOUN
ajlm-435	85	30	and	and	CCONJ
ajlm-435	85	31	the	the	DET
ajlm-435	85	32	phage	phage	NOUN
ajlm-435	85	33	-	-	PUNCT
ajlm-435	85	34	infected	infect	VERB
ajlm-435	85	35	mice	mouse	NOUN
ajlm-435	85	36	.	.	PUNCT
ajlm-435	86	1	only	only	ADV
ajlm-435	86	2	three	three	NUM
ajlm-435	86	3	mice	mouse	NOUN
ajlm-435	86	4	survived	survive	VERB
ajlm-435	86	5	in	in	ADP
ajlm-435	86	6	the	the	DET
ajlm-435	86	7	mdrsa	mdrsa	NOUN
ajlm-435	86	8	-	-	PUNCT
ajlm-435	86	9	infected	infect	VERB
ajlm-435	86	10	group	group	NOUN
ajlm-435	86	11	before	before	ADP
ajlm-435	86	12	treatment	treatment	NOUN
ajlm-435	86	13	(	(	PUNCT
ajlm-435	86	14	72	72	NUM
ajlm-435	86	15	hours	hour	NOUN
ajlm-435	86	16	post	post	ADJ
ajlm-435	86	17	-	-	ADJ
ajlm-435	86	18	infection	infection	NOUN
ajlm-435	86	19	)	)	PUNCT
ajlm-435	86	20	commenced	commenced	ADJ
ajlm-435	86	21	.	.	PUNCT
ajlm-435	87	1	all	all	DET
ajlm-435	87	2	the	the	DET
ajlm-435	87	3	mice	mouse	NOUN
ajlm-435	87	4	that	that	PRON
ajlm-435	87	5	were	be	AUX
ajlm-435	87	6	treated	treat	VERB
ajlm-435	87	7	with	with	ADP
ajlm-435	87	8	either	either	DET
ajlm-435	87	9	clindamycin	clindamycin	NOUN
ajlm-435	87	10	,	,	PUNCT
ajlm-435	87	11	phage	phage	NOUN
ajlm-435	87	12	or	or	CCONJ
ajlm-435	87	13	the	the	DET
ajlm-435	87	14	combination	combination	NOUN
ajlm-435	87	15	therapy	therapy	NOUN
ajlm-435	87	16	(	(	PUNCT
ajlm-435	87	17	clindamycin	clindamycin	NOUN
ajlm-435	87	18	plus	plus	CCONJ
ajlm-435	87	19	phage	phage	NOUN
ajlm-435	87	20	)	)	PUNCT
ajlm-435	87	21	survived	survive	VERB
ajlm-435	87	22	at	at	ADP
ajlm-435	87	23	day	day	NOUN
ajlm-435	87	24	7	7	NUM
ajlm-435	87	25	post	post	NOUN
ajlm-435	87	26	-	-	ADJ
ajlm-435	87	27	infection	infection	NOUN
ajlm-435	87	28	and	and	CCONJ
ajlm-435	87	29	each	each	DET
ajlm-435	87	30	group	group	NOUN
ajlm-435	87	31	had	have	VERB
ajlm-435	87	32	three	three	NUM
ajlm-435	87	33	mice	mouse	NOUN
ajlm-435	87	34	.	.	PUNCT
ajlm-435	88	1	mice	mouse	NOUN
ajlm-435	88	2	that	that	PRON
ajlm-435	88	3	had	have	VERB
ajlm-435	88	4	phage	phage	NOUN
ajlm-435	88	5	infection	infection	NOUN
ajlm-435	88	6	(	(	PUNCT
ajlm-435	88	7	phage	phage	NOUN
ajlm-435	88	8	control	control	NOUN
ajlm-435	88	9	group	group	NOUN
ajlm-435	88	10	)	)	PUNCT
ajlm-435	88	11	were	be	AUX
ajlm-435	88	12	more	more	ADV
ajlm-435	88	13	active	active	ADJ
ajlm-435	88	14	than	than	ADP
ajlm-435	88	15	mice	mouse	NOUN
ajlm-435	88	16	in	in	ADP
ajlm-435	88	17	other	other	ADJ
ajlm-435	88	18	treatment	treatment	NOUN
ajlm-435	88	19	groups	group	NOUN
ajlm-435	88	20	(	(	PUNCT
ajlm-435	88	21	clindamycin	clindamycin	NOUN
ajlm-435	88	22	,	,	PUNCT
ajlm-435	88	23	phage	phage	NOUN
ajlm-435	88	24	and	and	CCONJ
ajlm-435	88	25	combination	combination	NOUN
ajlm-435	88	26	)	)	PUNCT
ajlm-435	88	27	.	.	PUNCT
ajlm-435	89	1	only	only	ADV
ajlm-435	89	2	one	one	NUM
ajlm-435	89	3	mouse	mouse	NOUN
ajlm-435	89	4	in	in	ADP
ajlm-435	89	5	the	the	DET
ajlm-435	89	6	mdrsa	mdrsa	NOUN
ajlm-435	89	7	-	-	PUNCT
ajlm-435	89	8	infected	infect	VERB
ajlm-435	89	9	control	control	NOUN
ajlm-435	89	10	group	group	NOUN
ajlm-435	89	11	survived	survive	VERB
ajlm-435	89	12	at	at	ADP
ajlm-435	89	13	day	day	NOUN
ajlm-435	89	14	7	7	NUM
ajlm-435	89	15	post	post	NOUN
ajlm-435	89	16	-	-	NOUN
ajlm-435	89	17	infection	infection	NOUN
ajlm-435	89	18	and	and	CCONJ
ajlm-435	89	19	it	it	PRON
ajlm-435	89	20	was	be	AUX
ajlm-435	89	21	weak	weak	ADJ
ajlm-435	89	22	(	(	PUNCT
ajlm-435	89	23	table	table	NOUN
ajlm-435	89	24	1	1	NUM
ajlm-435	89	25	)	)	PUNCT
ajlm-435	89	26	.	.	PUNCT
ajlm-435	90	1	table	table	NOUN
ajlm-435	90	2	1	1	NUM
ajlm-435	90	3	:	:	PUNCT
ajlm-435	90	4	 	 	SPACE
ajlm-435	90	5	number	number	NOUN
ajlm-435	90	6	of	of	ADP
ajlm-435	90	7	surviving	survive	VERB
ajlm-435	90	8	mice	mouse	NOUN
ajlm-435	90	9	at	at	ADP
ajlm-435	90	10	72	72	NUM
ajlm-435	90	11	hours	hour	NOUN
ajlm-435	90	12	post	post	ADJ
ajlm-435	90	13	-	-	NOUN
ajlm-435	90	14	infection	infection	NOUN
ajlm-435	90	15	and	and	CCONJ
ajlm-435	90	16	7	7	NUM
ajlm-435	90	17	days	day	NOUN
ajlm-435	90	18	post	post	ADJ
ajlm-435	90	19	-	-	NOUN
ajlm-435	90	20	treatment	treatment	ADJ
ajlm-435	90	21	,	,	PUNCT
ajlm-435	90	22	nairobi	nairobi	PROPN
ajlm-435	90	23	,	,	PUNCT
ajlm-435	90	24	kenya	kenya	PROPN
ajlm-435	90	25	.	.	PUNCT
ajlm-435	91	1	viable	viable	ADJ
ajlm-435	91	2	bacteria	bacteria	NOUN
ajlm-435	91	3	levels	level	NOUN
ajlm-435	91	4	in	in	ADP
ajlm-435	91	5	mouse	mouse	NOUN
ajlm-435	91	6	lung	lung	NOUN
ajlm-435	91	7	homogenates	homogenate	NOUN
ajlm-435	91	8	the	the	DET
ajlm-435	91	9	number	number	NOUN
ajlm-435	91	10	of	of	ADP
ajlm-435	91	11	viable	viable	ADJ
ajlm-435	91	12	mdrsa	mdrsa	NOUN
ajlm-435	91	13	in	in	ADP
ajlm-435	91	14	mouse	mouse	NOUN
ajlm-435	91	15	lung	lung	NOUN
ajlm-435	91	16	homogenates	homogenate	NOUN
ajlm-435	91	17	was	be	AUX
ajlm-435	91	18	significantly	significantly	ADV
ajlm-435	91	19	lower	low	ADJ
ajlm-435	91	20	in	in	ADP
ajlm-435	91	21	mice	mouse	NOUN
ajlm-435	91	22	treated	treat	VERB
ajlm-435	91	23	with	with	ADP
ajlm-435	91	24	phage	phage	NOUN
ajlm-435	91	25	only	only	ADV
ajlm-435	91	26	(	(	PUNCT
ajlm-435	91	27	log10	log10	PROPN
ajlm-435	91	28	cfu	cfu	PROPN
ajlm-435	91	29	/	/	SYM
ajlm-435	91	30	gm	gm	PROPN
ajlm-435	91	31	=	=	NUM
ajlm-435	91	32	0.5	0.5	NUM
ajlm-435	91	33	±	±	NUM
ajlm-435	91	34	0.2	0.2	NUM
ajlm-435	91	35	)	)	PUNCT
ajlm-435	91	36	compared	compare	VERB
ajlm-435	91	37	with	with	ADP
ajlm-435	91	38	those	those	PRON
ajlm-435	91	39	in	in	ADP
ajlm-435	91	40	the	the	DET
ajlm-435	91	41	mdrsa	mdrsa	NOUN
ajlm-435	91	42	-	-	PUNCT
ajlm-435	91	43	infected	infect	VERB
ajlm-435	91	44	,	,	PUNCT
ajlm-435	91	45	non	non	ADJ
ajlm-435	91	46	-	-	ADJ
ajlm-435	91	47	treated	treat	VERB
ajlm-435	91	48	control	control	NOUN
ajlm-435	91	49	group	group	NOUN
ajlm-435	91	50	(	(	PUNCT
ajlm-435	91	51	log10	log10	PROPN
ajlm-435	91	52	cfu	cfu	PROPN
ajlm-435	91	53	/	/	SYM
ajlm-435	91	54	gm	gm	PROPN
ajlm-435	92	1	=	=	PUNCT
ajlm-435	92	2	8.0	8.0	NUM
ajlm-435	92	3	±	±	NUM
ajlm-435	92	4	0.2	0.2	NUM
ajlm-435	92	5	)	)	PUNCT
ajlm-435	92	6	(	(	PUNCT
ajlm-435	92	7	p	p	X
ajlm-435	92	8	<	<	X
ajlm-435	92	9	0.0001	0.0001	NUM
ajlm-435	92	10	)	)	PUNCT
ajlm-435	92	11	(	(	PUNCT
ajlm-435	92	12	figure	figure	NOUN
ajlm-435	92	13	4	4	NUM
ajlm-435	92	14	)	)	PUNCT
ajlm-435	92	15	.	.	PUNCT
ajlm-435	93	1	compared	compare	VERB
ajlm-435	93	2	with	with	ADP
ajlm-435	93	3	the	the	DET
ajlm-435	93	4	mdrsa	mdrsa	NOUN
ajlm-435	93	5	-	-	PUNCT
ajlm-435	93	6	infected	infect	VERB
ajlm-435	93	7	,	,	PUNCT
ajlm-435	93	8	non	non	ADJ
ajlm-435	93	9	-	-	ADJ
ajlm-435	93	10	treated	treat	VERB
ajlm-435	93	11	group	group	NOUN
ajlm-435	93	12	,	,	PUNCT
ajlm-435	93	13	statistically	statistically	ADV
ajlm-435	93	14	-	-	PUNCT
ajlm-435	93	15	significantly	significantly	ADV
ajlm-435	93	16	differences	difference	NOUN
ajlm-435	93	17	were	be	AUX
ajlm-435	93	18	observed	observe	VERB
ajlm-435	93	19	in	in	ADP
ajlm-435	93	20	the	the	DET
ajlm-435	93	21	viable	viable	ADJ
ajlm-435	93	22	bacterial	bacterial	ADJ
ajlm-435	93	23	counts	count	NOUN
ajlm-435	93	24	in	in	ADP
ajlm-435	93	25	the	the	DET
ajlm-435	93	26	mdrsa	mdrsa	NOUN
ajlm-435	93	27	-	-	PUNCT
ajlm-435	93	28	infected	infect	VERB
ajlm-435	93	29	,	,	PUNCT
ajlm-435	93	30	clindamycin	clindamycin	NOUN
ajlm-435	93	31	-	-	PUNCT
ajlm-435	93	32	treated	treat	VERB
ajlm-435	93	33	(	(	PUNCT
ajlm-435	93	34	log10	log10	PROPN
ajlm-435	93	35	cfu	cfu	PROPN
ajlm-435	93	36	/	/	SYM
ajlm-435	93	37	gm	gm	PROPN
ajlm-435	94	1	=	=	PUNCT
ajlm-435	94	2	4.4	4.4	NUM
ajlm-435	94	3	±	±	NUM
ajlm-435	94	4	0.2	0.2	NUM
ajlm-435	94	5	;	;	PUNCT
ajlm-435	94	6	p	p	X
ajlm-435	94	7	<	<	X
ajlm-435	94	8	0.05	0.05	NUM
ajlm-435	94	9	)	)	PUNCT
ajlm-435	94	10	and	and	CCONJ
ajlm-435	94	11	mdrsa	mdrsa	NOUN
ajlm-435	94	12	-	-	PUNCT
ajlm-435	94	13	infected	infect	VERB
ajlm-435	94	14	,	,	PUNCT
ajlm-435	94	15	combination	combination	NOUN
ajlm-435	94	16	-	-	PUNCT
ajlm-435	94	17	treated	treat	VERB
ajlm-435	94	18	groups	group	NOUN
ajlm-435	94	19	(	(	PUNCT
ajlm-435	94	20	log10	log10	X
ajlm-435	94	21	cfu	cfu	PROPN
ajlm-435	94	22	/	/	SYM
ajlm-435	94	23	gm	gm	PROPN
ajlm-435	94	24	=	=	PUNCT
ajlm-435	94	25	4.0	4.0	NUM
ajlm-435	94	26	±	±	NUM
ajlm-435	94	27	0.2	0.2	NUM
ajlm-435	94	28	;	;	PUNCT
ajlm-435	94	29	p	p	X
ajlm-435	94	30	<	<	X
ajlm-435	94	31	0.001	0.001	NUM
ajlm-435	94	32	)	)	PUNCT
ajlm-435	94	33	.	.	PUNCT
ajlm-435	95	1	the	the	DET
ajlm-435	95	2	differences	difference	NOUN
ajlm-435	95	3	in	in	ADP
ajlm-435	95	4	counts	count	NOUN
ajlm-435	95	5	between	between	ADP
ajlm-435	95	6	the	the	DET
ajlm-435	95	7	phage	phage	NOUN
ajlm-435	95	8	-	-	PUNCT
ajlm-435	95	9	treated	treat	VERB
ajlm-435	95	10	group	group	NOUN
ajlm-435	95	11	and	and	CCONJ
ajlm-435	95	12	groups	group	NOUN
ajlm-435	95	13	treated	treat	VERB
ajlm-435	95	14	with	with	ADP
ajlm-435	95	15	clindamycin	clindamycin	NOUN
ajlm-435	95	16	and	and	CCONJ
ajlm-435	95	17	the	the	DET
ajlm-435	95	18	combination	combination	NOUN
ajlm-435	95	19	therapy	therapy	NOUN
ajlm-435	95	20	were	be	AUX
ajlm-435	95	21	also	also	ADV
ajlm-435	95	22	statistically	statistically	ADV
ajlm-435	95	23	significant	significant	ADJ
ajlm-435	95	24	(	(	PUNCT
ajlm-435	95	25	p	p	X
ajlm-435	95	26	<	<	X
ajlm-435	95	27	0.0001	0.0001	NUM
ajlm-435	95	28	)	)	PUNCT
ajlm-435	95	29	.	.	PUNCT
ajlm-435	96	1	figure	figure	VERB
ajlm-435	96	2	4	4	NUM
ajlm-435	96	3	:	:	PUNCT
ajlm-435	96	4	mean	mean	VERB
ajlm-435	96	5	bacterial	bacterial	ADJ
ajlm-435	96	6	count	count	NOUN
ajlm-435	96	7	(	(	PUNCT
ajlm-435	96	8	mean	mean	INTJ
ajlm-435	96	9	log10	log10	PROPN
ajlm-435	96	10	cfu	cfu	PROPN
ajlm-435	96	11	/	/	SYM
ajlm-435	96	12	gm	gm	PROPN
ajlm-435	96	13	±	±	NUM
ajlm-435	96	14	se	se	PROPN
ajlm-435	96	15	)	)	PUNCT
ajlm-435	96	16	in	in	ADP
ajlm-435	96	17	lung	lung	NOUN
ajlm-435	96	18	tissue	tissue	NOUN
ajlm-435	96	19	from	from	ADP
ajlm-435	96	20	mdrsa	mdrsa	NOUN
ajlm-435	96	21	-	-	PUNCT
ajlm-435	96	22	infected	infect	VERB
ajlm-435	96	23	mice	mouse	NOUN
ajlm-435	96	24	.	.	PUNCT
ajlm-435	97	1	controls	control	NOUN
ajlm-435	97	2	received	receive	VERB
ajlm-435	97	3	no	no	DET
ajlm-435	97	4	treatment	treatment	NOUN
ajlm-435	97	5	,	,	PUNCT
ajlm-435	97	6	remaining	remain	VERB
ajlm-435	97	7	infected	infected	ADJ
ajlm-435	97	8	mice	mouse	NOUN
ajlm-435	97	9	were	be	AUX
ajlm-435	97	10	treated	treat	VERB
ajlm-435	97	11	with	with	ADP
ajlm-435	97	12	clindamycin	clindamycin	NOUN
ajlm-435	97	13	,	,	PUNCT
ajlm-435	97	14	phage	phage	NOUN
ajlm-435	97	15	,	,	PUNCT
ajlm-435	97	16	or	or	CCONJ
ajlm-435	97	17	a	a	DET
ajlm-435	97	18	combination	combination	NOUN
ajlm-435	97	19	therapy	therapy	NOUN
ajlm-435	97	20	(	(	PUNCT
ajlm-435	97	21	clindamycin	clindamycin	NOUN
ajlm-435	97	22	plus	plus	CCONJ
ajlm-435	97	23	phage	phage	NOUN
ajlm-435	97	24	)	)	PUNCT
ajlm-435	97	25	.	.	PUNCT
ajlm-435	98	1	each	each	DET
ajlm-435	98	2	group	group	NOUN
ajlm-435	98	3	had	have	VERB
ajlm-435	98	4	five	five	NUM
ajlm-435	98	5	mice	mouse	NOUN
ajlm-435	98	6	.	.	PUNCT
ajlm-435	99	1	levels	level	NOUN
ajlm-435	99	2	of	of	ADP
ajlm-435	99	3	significance	significance	NOUN
ajlm-435	99	4	:	:	PUNCT
ajlm-435	99	5	*	*	PUNCT
ajlm-435	99	6	p	p	X
ajlm-435	99	7	<	<	X
ajlm-435	99	8	0.05	0.05	NUM
ajlm-435	99	9	;	;	PUNCT
ajlm-435	99	10	*	*	PUNCT
ajlm-435	99	11	*	*	PUNCT
ajlm-435	99	12	p	p	X
ajlm-435	99	13	<	<	X
ajlm-435	99	14	0.001	0.001	NUM
ajlm-435	99	15	;	;	PUNCT
ajlm-435	99	16	and	and	CCONJ
ajlm-435	99	17	*	*	PUNCT
ajlm-435	99	18	*	*	PUNCT
ajlm-435	99	19	*	*	PUNCT
ajlm-435	99	20	p	p	X
ajlm-435	99	21	<	<	X
ajlm-435	99	22	0.0001	0.0001	NUM
ajlm-435	99	23	;	;	PUNCT
ajlm-435	99	24	each	each	PRON
ajlm-435	99	25	was	be	AUX
ajlm-435	99	26	compared	compare	VERB
ajlm-435	99	27	with	with	ADP
ajlm-435	99	28	mdrsa	mdrsa	PROPN
ajlm-435	99	29	control	control	NOUN
ajlm-435	99	30	.	.	PUNCT
ajlm-435	100	1	histopathological	histopathological	ADJ
ajlm-435	100	2	examination	examination	NOUN
ajlm-435	100	3	the	the	DET
ajlm-435	100	4	lung	lung	NOUN
ajlm-435	100	5	tissues	tissue	NOUN
ajlm-435	100	6	of	of	ADP
ajlm-435	100	7	mice	mouse	NOUN
ajlm-435	100	8	in	in	ADP
ajlm-435	100	9	the	the	DET
ajlm-435	100	10	phage	phage	NOUN
ajlm-435	100	11	-	-	PUNCT
ajlm-435	100	12	infected	infect	VERB
ajlm-435	100	13	group	group	NOUN
ajlm-435	100	14	were	be	AUX
ajlm-435	100	15	relatively	relatively	ADV
ajlm-435	100	16	normal	normal	ADJ
ajlm-435	100	17	,	,	PUNCT
ajlm-435	100	18	with	with	ADP
ajlm-435	100	19	minor	minor	ADJ
ajlm-435	100	20	focal	focal	ADJ
ajlm-435	100	21	congestion	congestion	NOUN
ajlm-435	100	22	compared	compare	VERB
ajlm-435	100	23	with	with	ADP
ajlm-435	100	24	tissue	tissue	NOUN
ajlm-435	100	25	from	from	ADP
ajlm-435	100	26	mice	mouse	NOUN
ajlm-435	100	27	in	in	ADP
ajlm-435	100	28	the	the	DET
ajlm-435	100	29	mdrsa	mdrsa	NOUN
ajlm-435	100	30	-	-	PUNCT
ajlm-435	100	31	infected	infect	VERB
ajlm-435	100	32	non	non	ADJ
ajlm-435	100	33	-	-	ADJ
ajlm-435	100	34	treated	treat	VERB
ajlm-435	100	35	group	group	NOUN
ajlm-435	100	36	,	,	PUNCT
ajlm-435	100	37	which	which	PRON
ajlm-435	100	38	had	have	AUX
ajlm-435	100	39	deflated	deflate	VERB
ajlm-435	100	40	alveoli	alveolus	NOUN
ajlm-435	100	41	congested	congest	VERB
ajlm-435	100	42	with	with	ADP
ajlm-435	100	43	mucus	mucus	NOUN
ajlm-435	100	44	,	,	PUNCT
ajlm-435	100	45	lymphocyte	lymphocyte	NOUN
ajlm-435	100	46	-	-	PUNCT
ajlm-435	100	47	infiltrated	infiltrate	VERB
ajlm-435	100	48	septa	septum	NOUN
ajlm-435	100	49	and	and	CCONJ
ajlm-435	100	50	pockets	pocket	NOUN
ajlm-435	100	51	of	of	ADP
ajlm-435	100	52	serous	serous	ADJ
ajlm-435	100	53	fluid	fluid	NOUN
ajlm-435	100	54	.	.	PUNCT
ajlm-435	101	1	the	the	DET
ajlm-435	101	2	lung	lung	NOUN
ajlm-435	101	3	tissue	tissue	NOUN
ajlm-435	101	4	of	of	ADP
ajlm-435	101	5	mdrsa	mdrsa	NOUN
ajlm-435	101	6	-	-	PUNCT
ajlm-435	101	7	infected	infect	VERB
ajlm-435	101	8	,	,	PUNCT
ajlm-435	101	9	non	non	ADJ
ajlm-435	101	10	-	-	ADJ
ajlm-435	101	11	treated	treat	VERB
ajlm-435	101	12	mice	mouse	NOUN
ajlm-435	101	13	were	be	AUX
ajlm-435	101	14	similar	similar	ADJ
ajlm-435	101	15	to	to	ADP
ajlm-435	101	16	lung	lung	NOUN
ajlm-435	101	17	tissue	tissue	NOUN
ajlm-435	101	18	from	from	ADP
ajlm-435	101	19	clindamycin	clindamycin	NOUN
ajlm-435	101	20	-	-	PUNCT
ajlm-435	101	21	treated	treat	VERB
ajlm-435	101	22	mice	mouse	NOUN
ajlm-435	101	23	.	.	PUNCT
ajlm-435	102	1	however	however	ADV
ajlm-435	102	2	,	,	PUNCT
ajlm-435	102	3	lung	lung	NOUN
ajlm-435	102	4	tissue	tissue	NOUN
ajlm-435	102	5	from	from	ADP
ajlm-435	102	6	the	the	DET
ajlm-435	102	7	clindamycin	clindamycin	NOUN
ajlm-435	102	8	-	-	PUNCT
ajlm-435	102	9	treated	treat	VERB
ajlm-435	102	10	group	group	NOUN
ajlm-435	102	11	(	(	PUNCT
ajlm-435	102	12	n	n	NOUN
ajlm-435	102	13	=	=	SYM
ajlm-435	102	14	3	3	NUM
ajlm-435	102	15	)	)	PUNCT
ajlm-435	102	16	overall	overall	NOUN
ajlm-435	102	17	was	be	AUX
ajlm-435	102	18	graded	grade	VERB
ajlm-435	102	19	as	as	ADV
ajlm-435	102	20	bad	bad	ADJ
ajlm-435	102	21	,	,	PUNCT
ajlm-435	102	22	since	since	SCONJ
ajlm-435	102	23	they	they	PRON
ajlm-435	102	24	had	have	VERB
ajlm-435	102	25	less	less	ADJ
ajlm-435	102	26	congestion	congestion	NOUN
ajlm-435	102	27	,	,	PUNCT
ajlm-435	102	28	fewer	few	ADJ
ajlm-435	102	29	pockets	pocket	NOUN
ajlm-435	102	30	of	of	ADP
ajlm-435	102	31	serous	serous	ADJ
ajlm-435	102	32	fluid	fluid	NOUN
ajlm-435	102	33	and	and	CCONJ
ajlm-435	102	34	deflated	deflate	VERB
ajlm-435	102	35	alveoli	alveolus	NOUN
ajlm-435	102	36	compared	compare	VERB
ajlm-435	102	37	with	with	ADP
ajlm-435	102	38	the	the	DET
ajlm-435	102	39	non	non	ADJ
ajlm-435	102	40	-	-	ADJ
ajlm-435	102	41	treated	treat	VERB
ajlm-435	102	42	mdrsa	mdrsa	NOUN
ajlm-435	102	43	infected	infect	VERB
ajlm-435	102	44	mice	mouse	NOUN
ajlm-435	102	45	.	.	PUNCT
ajlm-435	103	1	mice	mouse	NOUN
ajlm-435	103	2	that	that	PRON
ajlm-435	103	3	received	receive	VERB
ajlm-435	103	4	the	the	DET
ajlm-435	103	5	combination	combination	NOUN
ajlm-435	103	6	therapy	therapy	NOUN
ajlm-435	103	7	(	(	PUNCT
ajlm-435	103	8	n	n	NOUN
ajlm-435	103	9	=	=	SYM
ajlm-435	103	10	3	3	X
ajlm-435	103	11	)	)	PUNCT
ajlm-435	103	12	showed	show	VERB
ajlm-435	103	13	inflammation	inflammation	NOUN
ajlm-435	103	14	of	of	ADP
ajlm-435	103	15	the	the	DET
ajlm-435	103	16	septa	septum	NOUN
ajlm-435	103	17	and	and	CCONJ
ajlm-435	103	18	blood	blood	NOUN
ajlm-435	103	19	vessel	vessel	NOUN
ajlm-435	103	20	walls	wall	NOUN
ajlm-435	103	21	,	,	PUNCT
ajlm-435	103	22	moderately	moderately	ADV
ajlm-435	103	23	deflated	deflate	VERB
ajlm-435	103	24	alveoli	alveolus	NOUN
ajlm-435	103	25	and	and	CCONJ
ajlm-435	103	26	several	several	ADJ
ajlm-435	103	27	serous	serous	ADJ
ajlm-435	103	28	fluid	fluid	ADJ
ajlm-435	103	29	pockets	pocket	NOUN
ajlm-435	103	30	compared	compare	VERB
ajlm-435	103	31	with	with	ADP
ajlm-435	103	32	the	the	DET
ajlm-435	103	33	non	non	ADJ
ajlm-435	103	34	-	-	ADJ
ajlm-435	103	35	infected	infected	ADJ
ajlm-435	103	36	(	(	PUNCT
ajlm-435	103	37	n	n	NOUN
ajlm-435	103	38	=	=	SYM
ajlm-435	103	39	5	5	NUM
ajlm-435	103	40	)	)	PUNCT
ajlm-435	103	41	and	and	CCONJ
ajlm-435	103	42	phage	phage	NOUN
ajlm-435	103	43	-	-	PUNCT
ajlm-435	103	44	infected	infect	VERB
ajlm-435	103	45	mice	mouse	NOUN
ajlm-435	103	46	(	(	PUNCT
ajlm-435	103	47	n	n	NOUN
ajlm-435	103	48	=	=	SYM
ajlm-435	103	49	5	5	NUM
ajlm-435	103	50	)	)	PUNCT
ajlm-435	103	51	(	(	PUNCT
ajlm-435	103	52	p	p	X
ajlm-435	103	53	<	<	X
ajlm-435	103	54	0.0001	0.0001	NUM
ajlm-435	103	55	)	)	PUNCT
ajlm-435	103	56	(	(	PUNCT
ajlm-435	103	57	figure	figure	NOUN
ajlm-435	103	58	5	5	NUM
ajlm-435	103	59	)	)	PUNCT
ajlm-435	103	60	.	.	PUNCT
ajlm-435	104	1	figure	figure	VERB
ajlm-435	104	2	5	5	NUM
ajlm-435	104	3	:	:	PUNCT
ajlm-435	104	4	mouse	mouse	NOUN
ajlm-435	104	5	lung	lung	NOUN
ajlm-435	104	6	tissue	tissue	NOUN
ajlm-435	104	7	slides	slide	NOUN
ajlm-435	104	8	(	(	PUNCT
ajlm-435	104	9	40x	40x	NOUN
ajlm-435	104	10	magnification	magnification	NOUN
ajlm-435	104	11	)	)	PUNCT
ajlm-435	104	12	.	.	PUNCT
ajlm-435	105	1	tissue	tissue	NOUN
ajlm-435	105	2	from	from	ADP
ajlm-435	105	3	non	non	ADJ
ajlm-435	105	4	-	-	ADJ
ajlm-435	105	5	infected	infected	ADJ
ajlm-435	105	6	,	,	PUNCT
ajlm-435	105	7	non	non	ADJ
ajlm-435	105	8	-	-	ADJ
ajlm-435	105	9	treated	treat	VERB
ajlm-435	105	10	mice	mouse	NOUN
ajlm-435	105	11	(	(	PUNCT
ajlm-435	105	12	a	a	NOUN
ajlm-435	105	13	)	)	PUNCT
ajlm-435	105	14	and	and	CCONJ
ajlm-435	105	15	phage	phage	NOUN
ajlm-435	105	16	-	-	PUNCT
ajlm-435	105	17	infected	infect	VERB
ajlm-435	105	18	,	,	PUNCT
ajlm-435	105	19	non	non	ADJ
ajlm-435	105	20	-	-	ADJ
ajlm-435	105	21	treated	treat	VERB
ajlm-435	105	22	mice	mouse	NOUN
ajlm-435	105	23	(	(	PUNCT
ajlm-435	105	24	b	b	NOUN
ajlm-435	105	25	)	)	PUNCT
ajlm-435	105	26	were	be	AUX
ajlm-435	105	27	well	well	ADV
ajlm-435	105	28	ventilated	ventilate	VERB
ajlm-435	105	29	.	.	PUNCT
ajlm-435	106	1	tissue	tissue	NOUN
ajlm-435	106	2	from	from	ADP
ajlm-435	106	3	mdrsa	mdrsa	NOUN
ajlm-435	106	4	-	-	PUNCT
ajlm-435	106	5	infected	infect	VERB
ajlm-435	106	6	,	,	PUNCT
ajlm-435	106	7	non	non	ADJ
ajlm-435	106	8	-	-	ADJ
ajlm-435	106	9	treated	treat	VERB
ajlm-435	106	10	control	control	NOUN
ajlm-435	106	11	mice	mouse	NOUN
ajlm-435	106	12	(	(	PUNCT
ajlm-435	106	13	c	c	NOUN
ajlm-435	106	14	)	)	PUNCT
ajlm-435	106	15	had	have	VERB
ajlm-435	106	16	pockets	pocket	NOUN
ajlm-435	106	17	of	of	ADP
ajlm-435	106	18	serous	serous	ADJ
ajlm-435	106	19	fluid	fluid	NOUN
ajlm-435	106	20	(	(	PUNCT
ajlm-435	106	21	pneumonia	pneumonia	NOUN
ajlm-435	106	22	)	)	PUNCT
ajlm-435	106	23	(	(	PUNCT
ajlm-435	106	24	1	1	NUM
ajlm-435	106	25	)	)	PUNCT
ajlm-435	106	26	,	,	PUNCT
ajlm-435	106	27	lymphocyte	lymphocyte	NOUN
ajlm-435	106	28	-	-	PUNCT
ajlm-435	106	29	infiltrated	infiltrate	VERB
ajlm-435	106	30	(	(	PUNCT
ajlm-435	106	31	inflamed	inflame	VERB
ajlm-435	106	32	)	)	PUNCT
ajlm-435	106	33	septa	septum	NOUN
ajlm-435	106	34	(	(	PUNCT
ajlm-435	106	35	2	2	NUM
ajlm-435	106	36	)	)	PUNCT
ajlm-435	106	37	,	,	PUNCT
ajlm-435	106	38	deflated	deflate	VERB
ajlm-435	106	39	alveoli	alveolus	NOUN
ajlm-435	106	40	(	(	PUNCT
ajlm-435	106	41	3	3	NUM
ajlm-435	106	42	)	)	PUNCT
ajlm-435	106	43	and	and	CCONJ
ajlm-435	106	44	alveoli	alveolus	NOUN
ajlm-435	106	45	full	full	ADJ
ajlm-435	106	46	of	of	ADP
ajlm-435	106	47	mucus	mucus	NOUN
ajlm-435	106	48	(	(	PUNCT
ajlm-435	106	49	4	4	NUM
ajlm-435	106	50	)	)	PUNCT
ajlm-435	106	51	.	.	PUNCT
ajlm-435	107	1	tissue	tissue	NOUN
ajlm-435	107	2	from	from	ADP
ajlm-435	107	3	mdrsa	mdrsa	NOUN
ajlm-435	107	4	-	-	PUNCT
ajlm-435	107	5	infected	infect	VERB
ajlm-435	107	6	,	,	PUNCT
ajlm-435	107	7	clindamycin	clindamycin	NOUN
ajlm-435	107	8	-	-	PUNCT
ajlm-435	107	9	treated	treat	VERB
ajlm-435	107	10	mice	mouse	NOUN
ajlm-435	107	11	(	(	PUNCT
ajlm-435	107	12	d	d	X
ajlm-435	107	13	)	)	PUNCT
ajlm-435	107	14	had	have	VERB
ajlm-435	107	15	pockets	pocket	NOUN
ajlm-435	107	16	of	of	ADP
ajlm-435	107	17	pneumonia	pneumonia	NOUN
ajlm-435	107	18	(	(	PUNCT
ajlm-435	107	19	1	1	NUM
ajlm-435	107	20	)	)	PUNCT
ajlm-435	107	21	,	,	PUNCT
ajlm-435	107	22	inflamed	inflame	VERB
ajlm-435	107	23	septa	septum	NOUN
ajlm-435	107	24	and	and	CCONJ
ajlm-435	107	25	perivascular	perivascular	ADJ
ajlm-435	107	26	fibrosis	fibrosis	NOUN
ajlm-435	107	27	of	of	ADP
ajlm-435	107	28	blood	blood	NOUN
ajlm-435	107	29	vessels	vessel	NOUN
ajlm-435	107	30	(	(	PUNCT
ajlm-435	107	31	5	5	NUM
ajlm-435	107	32	)	)	PUNCT
ajlm-435	107	33	.	.	PUNCT
ajlm-435	108	1	tissue	tissue	NOUN
ajlm-435	108	2	from	from	ADP
ajlm-435	108	3	mdrsa	mdrsa	NOUN
ajlm-435	108	4	-	-	PUNCT
ajlm-435	108	5	infected	infect	VERB
ajlm-435	108	6	,	,	PUNCT
ajlm-435	108	7	phage	phage	NOUN
ajlm-435	108	8	-	-	PUNCT
ajlm-435	108	9	treated	treat	VERB
ajlm-435	108	10	mice	mouse	NOUN
ajlm-435	108	11	(	(	PUNCT
ajlm-435	108	12	e	e	NOUN
ajlm-435	108	13	)	)	PUNCT
ajlm-435	108	14	was	be	AUX
ajlm-435	108	15	well	well	ADV
ajlm-435	108	16	ventilated	ventilate	VERB
ajlm-435	108	17	with	with	ADP
ajlm-435	108	18	resolved	resolved	ADJ
ajlm-435	108	19	inflammation	inflammation	NOUN
ajlm-435	108	20	.	.	PUNCT
ajlm-435	109	1	tissue	tissue	NOUN
ajlm-435	109	2	from	from	ADP
ajlm-435	109	3	mdrsa	mdrsa	NOUN
ajlm-435	109	4	-	-	PUNCT
ajlm-435	109	5	infected	infect	VERB
ajlm-435	109	6	mice	mouse	NOUN
ajlm-435	109	7	treated	treat	VERB
ajlm-435	109	8	with	with	ADP
ajlm-435	109	9	a	a	DET
ajlm-435	109	10	combination	combination	NOUN
ajlm-435	109	11	of	of	ADP
ajlm-435	109	12	clindamycin	clindamycin	NOUN
ajlm-435	109	13	and	and	CCONJ
ajlm-435	109	14	phage	phage	NOUN
ajlm-435	109	15	(	(	PUNCT
ajlm-435	109	16	f	f	X
ajlm-435	109	17	)	)	PUNCT
ajlm-435	109	18	had	have	VERB
ajlm-435	109	19	pockets	pocket	NOUN
ajlm-435	109	20	of	of	ADP
ajlm-435	109	21	pneumonia	pneumonia	NOUN
ajlm-435	109	22	(	(	PUNCT
ajlm-435	109	23	1	1	NUM
ajlm-435	109	24	)	)	PUNCT
ajlm-435	109	25	,	,	PUNCT
ajlm-435	109	26	inflamed	inflame	VERB
ajlm-435	109	27	septa	septum	NOUN
ajlm-435	109	28	(	(	PUNCT
ajlm-435	109	29	2	2	NUM
ajlm-435	109	30	)	)	PUNCT
ajlm-435	109	31	and	and	CCONJ
ajlm-435	109	32	deflated	deflate	VERB
ajlm-435	109	33	alveoli	alveolus	NOUN
ajlm-435	109	34	(	(	PUNCT
ajlm-435	109	35	3	3	NUM
ajlm-435	109	36	)	)	PUNCT
ajlm-435	109	37	.	.	PUNCT
ajlm-435	110	1	discussion	discussion	NOUN
ajlm-435	110	2	this	this	DET
ajlm-435	110	3	study	study	NOUN
ajlm-435	110	4	found	find	VERB
ajlm-435	110	5	that	that	SCONJ
ajlm-435	110	6	s.	s.	PROPN
ajlm-435	110	7	aureus	aureus	PROPN
ajlm-435	110	8	isolates	isolate	NOUN
ajlm-435	110	9	collected	collect	VERB
ajlm-435	110	10	from	from	ADP
ajlm-435	110	11	sewage	sewage	NOUN
ajlm-435	110	12	water	water	NOUN
ajlm-435	110	13	and	and	CCONJ
ajlm-435	110	14	found	find	VERB
ajlm-435	110	15	to	to	PART
ajlm-435	110	16	be	be	AUX
ajlm-435	110	17	resistant	resistant	ADJ
ajlm-435	110	18	to	to	ADP
ajlm-435	110	19	multiple	multiple	ADJ
ajlm-435	110	20	drug	drug	NOUN
ajlm-435	110	21	therapies	therapy	NOUN
ajlm-435	110	22	caused	cause	VERB
ajlm-435	110	23	haematogenous	haematogenous	ADJ
ajlm-435	110	24	pneumonia	pneumonia	NOUN
ajlm-435	110	25	in	in	ADP
ajlm-435	110	26	mice	mouse	NOUN
ajlm-435	110	27	,	,	PUNCT
ajlm-435	110	28	which	which	PRON
ajlm-435	110	29	was	be	AUX
ajlm-435	110	30	characterised	characterise	VERB
ajlm-435	110	31	by	by	ADP
ajlm-435	110	32	infiltration	infiltration	NOUN
ajlm-435	110	33	of	of	ADP
ajlm-435	110	34	immune	immune	ADJ
ajlm-435	110	35	cells	cell	NOUN
ajlm-435	110	36	and	and	CCONJ
ajlm-435	110	37	accumulation	accumulation	NOUN
ajlm-435	110	38	of	of	ADP
ajlm-435	110	39	serous	serous	ADJ
ajlm-435	110	40	fluid	fluid	NOUN
ajlm-435	110	41	in	in	ADP
ajlm-435	110	42	the	the	DET
ajlm-435	110	43	lungs	lung	NOUN
ajlm-435	110	44	.	.	PUNCT
ajlm-435	111	1	this	this	PRON
ajlm-435	111	2	confirmed	confirm	VERB
ajlm-435	111	3	that	that	SCONJ
ajlm-435	111	4	the	the	DET
ajlm-435	111	5	isolated	isolated	ADJ
ajlm-435	111	6	bacterium	bacterium	NOUN
ajlm-435	111	7	was	be	AUX
ajlm-435	111	8	pathogenic	pathogenic	ADJ
ajlm-435	111	9	and	and	CCONJ
ajlm-435	111	10	able	able	ADJ
ajlm-435	111	11	to	to	PART
ajlm-435	111	12	cause	cause	VERB
ajlm-435	111	13	sepsis	sepsis	NOUN
ajlm-435	111	14	,	,	PUNCT
ajlm-435	111	15	then	then	ADV
ajlm-435	111	16	was	be	AUX
ajlm-435	111	17	further	far	ADV
ajlm-435	111	18	confirmed	confirm	VERB
ajlm-435	111	19	by	by	ADP
ajlm-435	111	20	isolation	isolation	NOUN
ajlm-435	111	21	of	of	ADP
ajlm-435	111	22	viable	viable	ADJ
ajlm-435	111	23	mdrsa	mdrsa	NOUN
ajlm-435	111	24	bacteria	bacteria	NOUN
ajlm-435	111	25	from	from	ADP
ajlm-435	111	26	the	the	DET
ajlm-435	111	27	lung	lung	NOUN
ajlm-435	111	28	homogenates	homogenate	NOUN
ajlm-435	111	29	.	.	PUNCT
ajlm-435	112	1	the	the	DET
ajlm-435	112	2	accumulation	accumulation	NOUN
ajlm-435	112	3	of	of	ADP
ajlm-435	112	4	serous	serous	ADJ
ajlm-435	112	5	fluid	fluid	NOUN
ajlm-435	112	6	and	and	CCONJ
ajlm-435	112	7	pus	pus	NOUN
ajlm-435	112	8	in	in	ADP
ajlm-435	112	9	the	the	DET
ajlm-435	112	10	lungs	lung	NOUN
ajlm-435	112	11	indicated	indicate	VERB
ajlm-435	112	12	that	that	SCONJ
ajlm-435	112	13	the	the	DET
ajlm-435	112	14	mice	mouse	NOUN
ajlm-435	112	15	induced	induce	VERB
ajlm-435	112	16	an	an	DET
ajlm-435	112	17	innate	innate	ADJ
ajlm-435	112	18	immune	immune	ADJ
ajlm-435	112	19	response	response	NOUN
ajlm-435	112	20	toward	toward	ADP
ajlm-435	112	21	multiplying	multiply	VERB
ajlm-435	112	22	mdrsa	mdrsa	PROPN
ajlm-435	112	23	bacteria.24	bacteria.24	NOUN
ajlm-435	112	24	this	this	DET
ajlm-435	112	25	inflammatory	inflammatory	ADJ
ajlm-435	112	26	immunological	immunological	ADJ
ajlm-435	112	27	phenomenon	phenomenon	NOUN
ajlm-435	112	28	may	may	AUX
ajlm-435	112	29	have	have	AUX
ajlm-435	112	30	led	lead	VERB
ajlm-435	112	31	to	to	ADP
ajlm-435	112	32	the	the	DET
ajlm-435	112	33	inflammation	inflammation	NOUN
ajlm-435	112	34	observed	observe	VERB
ajlm-435	112	35	in	in	ADP
ajlm-435	112	36	the	the	DET
ajlm-435	112	37	bronchi	bronchi	NOUN
ajlm-435	112	38	,	,	PUNCT
ajlm-435	112	39	bronchioles	bronchiole	NOUN
ajlm-435	112	40	,	,	PUNCT
ajlm-435	112	41	alveoli	alveoli	NOUN
ajlm-435	112	42	and	and	CCONJ
ajlm-435	112	43	septa	septum	NOUN
ajlm-435	112	44	,	,	PUNCT
ajlm-435	112	45	as	as	ADV
ajlm-435	112	46	well	well	ADV
ajlm-435	112	47	as	as	ADP
ajlm-435	112	48	blood	blood	NOUN
ajlm-435	112	49	vessels	vessel	NOUN
ajlm-435	112	50	.	.	PUNCT
ajlm-435	113	1	our	our	PRON
ajlm-435	113	2	findings	finding	NOUN
ajlm-435	113	3	agree	agree	VERB
ajlm-435	113	4	with	with	ADP
ajlm-435	113	5	other	other	ADJ
ajlm-435	113	6	studies	study	NOUN
ajlm-435	113	7	in	in	ADP
ajlm-435	113	8	which	which	PRON
ajlm-435	113	9	mice	mouse	NOUN
ajlm-435	113	10	were	be	AUX
ajlm-435	113	11	infected	infect	VERB
ajlm-435	113	12	intravenously	intravenously	ADV
ajlm-435	113	13	with	with	ADP
ajlm-435	113	14	methicillin	methicillin	NOUN
ajlm-435	113	15	-	-	PUNCT
ajlm-435	113	16	resistant	resistant	ADJ
ajlm-435	113	17	s.	s.	PROPN
ajlm-435	113	18	aureus	aureus	PROPN
ajlm-435	113	19	,	,	PUNCT
ajlm-435	113	20	then	then	ADV
ajlm-435	113	21	administered	administer	VERB
ajlm-435	113	22	a	a	DET
ajlm-435	113	23	dose	dose	NOUN
ajlm-435	113	24	of	of	ADP
ajlm-435	113	25	antibiotic	antibiotic	NOUN
ajlm-435	113	26	on	on	ADP
ajlm-435	113	27	a	a	DET
ajlm-435	113	28	daily	daily	ADJ
ajlm-435	113	29	basis	basis	NOUN
ajlm-435	113	30	for	for	ADP
ajlm-435	113	31	a	a	DET
ajlm-435	113	32	week.25,26,27	week.25,26,27	NOUN
ajlm-435	113	33	however	however	ADV
ajlm-435	113	34	,	,	PUNCT
ajlm-435	113	35	in	in	ADP
ajlm-435	113	36	our	our	PRON
ajlm-435	113	37	study	study	NOUN
ajlm-435	113	38	we	we	PRON
ajlm-435	113	39	used	use	VERB
ajlm-435	113	40	a	a	DET
ajlm-435	113	41	single	single	ADJ
ajlm-435	113	42	dose	dose	NOUN
ajlm-435	113	43	of	of	ADP
ajlm-435	113	44	s.	s.	PROPN
ajlm-435	113	45	aureus	aureus	PROPN
ajlm-435	113	46	-	-	PUNCT
ajlm-435	113	47	specific	specific	ADJ
ajlm-435	113	48	lytic	lytic	ADJ
ajlm-435	113	49	phage	phage	NOUN
ajlm-435	113	50	.	.	PUNCT
ajlm-435	114	1	the	the	DET
ajlm-435	114	2	use	use	NOUN
ajlm-435	114	3	of	of	ADP
ajlm-435	114	4	phage	phage	NOUN
ajlm-435	114	5	as	as	ADP
ajlm-435	114	6	a	a	DET
ajlm-435	114	7	treatment	treatment	NOUN
ajlm-435	114	8	method	method	NOUN
ajlm-435	114	9	attained	attain	VERB
ajlm-435	114	10	100	100	NUM
ajlm-435	114	11	%	%	NOUN
ajlm-435	114	12	efficacy	efficacy	NOUN
ajlm-435	114	13	,	,	PUNCT
ajlm-435	114	14	an	an	DET
ajlm-435	114	15	indication	indication	NOUN
ajlm-435	114	16	that	that	SCONJ
ajlm-435	114	17	the	the	DET
ajlm-435	114	18	single	single	ADJ
ajlm-435	114	19	dose	dose	NOUN
ajlm-435	114	20	administered	administer	VERB
ajlm-435	114	21	was	be	AUX
ajlm-435	114	22	enough	enough	ADJ
ajlm-435	114	23	to	to	PART
ajlm-435	114	24	clear	clear	VERB
ajlm-435	114	25	the	the	DET
ajlm-435	114	26	bacteria	bacteria	NOUN
ajlm-435	114	27	from	from	ADP
ajlm-435	114	28	the	the	DET
ajlm-435	114	29	infected	infected	ADJ
ajlm-435	114	30	mice	mouse	NOUN
ajlm-435	114	31	.	.	PUNCT
ajlm-435	115	1	this	this	PRON
ajlm-435	115	2	is	be	AUX
ajlm-435	115	3	probably	probably	ADV
ajlm-435	115	4	due	due	ADJ
ajlm-435	115	5	to	to	ADP
ajlm-435	115	6	the	the	DET
ajlm-435	115	7	auto	auto	NOUN
ajlm-435	115	8	-	-	PUNCT
ajlm-435	115	9	dosing	dose	VERB
ajlm-435	115	10	properties	property	NOUN
ajlm-435	115	11	of	of	ADP
ajlm-435	115	12	phages	phage	NOUN
ajlm-435	115	13	,	,	PUNCT
ajlm-435	115	14	whereby	whereby	SCONJ
ajlm-435	115	15	they	they	PRON
ajlm-435	115	16	increase	increase	VERB
ajlm-435	115	17	in	in	ADP
ajlm-435	115	18	numbers	number	NOUN
ajlm-435	115	19	at	at	ADP
ajlm-435	115	20	the	the	DET
ajlm-435	115	21	site	site	NOUN
ajlm-435	115	22	of	of	ADP
ajlm-435	115	23	an	an	DET
ajlm-435	115	24	infection.28	infection.28	NOUN
ajlm-435	115	25	the	the	DET
ajlm-435	115	26	mode	mode	NOUN
ajlm-435	115	27	of	of	ADP
ajlm-435	115	28	phage	phage	NOUN
ajlm-435	115	29	administration	administration	NOUN
ajlm-435	115	30	,	,	PUNCT
ajlm-435	115	31	concentration	concentration	NOUN
ajlm-435	115	32	,	,	PUNCT
ajlm-435	115	33	dosage	dosage	NOUN
ajlm-435	115	34	and	and	CCONJ
ajlm-435	115	35	timing	timing	NOUN
ajlm-435	115	36	of	of	ADP
ajlm-435	115	37	treatments	treatment	NOUN
ajlm-435	115	38	and	and	CCONJ
ajlm-435	115	39	resistance	resistance	NOUN
ajlm-435	115	40	to	to	ADP
ajlm-435	115	41	phages	phage	NOUN
ajlm-435	115	42	by	by	ADP
ajlm-435	115	43	the	the	DET
ajlm-435	115	44	pathogenic	pathogenic	ADJ
ajlm-435	115	45	bacteria	bacteria	NOUN
ajlm-435	115	46	are	be	AUX
ajlm-435	115	47	some	some	PRON
ajlm-435	115	48	of	of	ADP
ajlm-435	115	49	the	the	DET
ajlm-435	115	50	factors	factor	NOUN
ajlm-435	115	51	that	that	PRON
ajlm-435	115	52	determine	determine	VERB
ajlm-435	115	53	the	the	DET
ajlm-435	115	54	efficacy	efficacy	NOUN
ajlm-435	115	55	and	and	CCONJ
ajlm-435	115	56	safety	safety	NOUN
ajlm-435	115	57	of	of	ADP
ajlm-435	115	58	phage	phage	NOUN
ajlm-435	115	59	therapy.29	therapy.29	NOUN
ajlm-435	115	60	these	these	DET
ajlm-435	115	61	factors	factor	NOUN
ajlm-435	115	62	may	may	AUX
ajlm-435	115	63	be	be	AUX
ajlm-435	115	64	responsible	responsible	ADJ
ajlm-435	115	65	for	for	ADP
ajlm-435	115	66	the	the	DET
ajlm-435	115	67	differences	difference	NOUN
ajlm-435	115	68	between	between	ADP
ajlm-435	115	69	our	our	PRON
ajlm-435	115	70	findings	finding	NOUN
ajlm-435	115	71	and	and	CCONJ
ajlm-435	115	72	those	those	PRON
ajlm-435	115	73	of	of	ADP
ajlm-435	115	74	other	other	ADJ
ajlm-435	115	75	studies,30,31	studies,30,31	NOUN
ajlm-435	115	76	in	in	ADP
ajlm-435	115	77	which	which	PRON
ajlm-435	115	78	methicillin	methicillin	NOUN
ajlm-435	115	79	-	-	PUNCT
ajlm-435	115	80	resistant	resistant	ADJ
ajlm-435	115	81	s.	s.	PROPN
ajlm-435	115	82	aureus	aureus	PROPN
ajlm-435	115	83	-	-	PUNCT
ajlm-435	115	84	infected	infect	VERB
ajlm-435	115	85	mice	mouse	NOUN
ajlm-435	115	86	were	be	AUX
ajlm-435	115	87	treated	treat	VERB
ajlm-435	115	88	immediately	immediately	ADV
ajlm-435	115	89	or	or	CCONJ
ajlm-435	115	90	six	six	NUM
ajlm-435	115	91	hours	hour	NOUN
ajlm-435	115	92	after	after	ADP
ajlm-435	115	93	infection	infection	NOUN
ajlm-435	115	94	with	with	ADP
ajlm-435	115	95	phage	phage	NOUN
ajlm-435	115	96	to	to	PART
ajlm-435	115	97	achieve	achieve	VERB
ajlm-435	115	98	a	a	DET
ajlm-435	115	99	100	100	NUM
ajlm-435	115	100	%	%	NOUN
ajlm-435	115	101	efficacy	efficacy	NOUN
ajlm-435	115	102	.	.	PUNCT
ajlm-435	116	1	the	the	DET
ajlm-435	116	2	timing	timing	NOUN
ajlm-435	116	3	of	of	ADP
ajlm-435	116	4	the	the	DET
ajlm-435	116	5	initiation	initiation	NOUN
ajlm-435	116	6	of	of	ADP
ajlm-435	116	7	treatment	treatment	NOUN
ajlm-435	116	8	may	may	AUX
ajlm-435	116	9	be	be	AUX
ajlm-435	116	10	the	the	DET
ajlm-435	116	11	crucial	crucial	ADJ
ajlm-435	116	12	factor	factor	NOUN
ajlm-435	116	13	in	in	ADP
ajlm-435	116	14	achieving	achieve	VERB
ajlm-435	116	15	100	100	NUM
ajlm-435	116	16	%	%	NOUN
ajlm-435	116	17	efficacy	efficacy	NOUN
ajlm-435	116	18	.	.	PUNCT
ajlm-435	117	1	however	however	ADV
ajlm-435	117	2	,	,	PUNCT
ajlm-435	117	3	we	we	PRON
ajlm-435	117	4	can	can	AUX
ajlm-435	117	5	not	not	PART
ajlm-435	117	6	rule	rule	VERB
ajlm-435	117	7	out	out	ADP
ajlm-435	117	8	the	the	DET
ajlm-435	117	9	role	role	NOUN
ajlm-435	117	10	of	of	ADP
ajlm-435	117	11	immunity	immunity	NOUN
ajlm-435	117	12	in	in	ADP
ajlm-435	117	13	clearing	clear	VERB
ajlm-435	117	14	the	the	DET
ajlm-435	117	15	bacteria	bacteria	NOUN
ajlm-435	117	16	,	,	PUNCT
ajlm-435	117	17	considering	consider	VERB
ajlm-435	117	18	that	that	SCONJ
ajlm-435	117	19	yao	yao	PROPN
ajlm-435	117	20	et	et	PROPN
ajlm-435	117	21	al.32	al.32	PROPN
ajlm-435	117	22	established	establish	VERB
ajlm-435	117	23	that	that	SCONJ
ajlm-435	117	24	within	within	ADP
ajlm-435	117	25	72	72	NUM
ajlm-435	117	26	hours	hour	NOUN
ajlm-435	117	27	of	of	ADP
ajlm-435	117	28	infection	infection	NOUN
ajlm-435	117	29	the	the	DET
ajlm-435	117	30	mouse	mouse	NOUN
ajlm-435	117	31	immune	immune	ADJ
ajlm-435	117	32	system	system	NOUN
ajlm-435	117	33	has	have	VERB
ajlm-435	117	34	the	the	DET
ajlm-435	117	35	capacity	capacity	NOUN
ajlm-435	117	36	to	to	PART
ajlm-435	117	37	clear	clear	ADJ
ajlm-435	117	38	bacteria	bacteria	NOUN
ajlm-435	117	39	from	from	ADP
ajlm-435	117	40	the	the	DET
ajlm-435	117	41	system	system	NOUN
ajlm-435	117	42	.	.	PUNCT
ajlm-435	118	1	in	in	ADP
ajlm-435	118	2	our	our	PRON
ajlm-435	118	3	study	study	NOUN
ajlm-435	118	4	,	,	PUNCT
ajlm-435	118	5	the	the	DET
ajlm-435	118	6	combination	combination	NOUN
ajlm-435	118	7	therapy	therapy	NOUN
ajlm-435	118	8	(	(	PUNCT
ajlm-435	118	9	clindamycin	clindamycin	NOUN
ajlm-435	118	10	plus	plus	CCONJ
ajlm-435	118	11	phage	phage	NOUN
ajlm-435	118	12	)	)	PUNCT
ajlm-435	118	13	reduced	reduce	VERB
ajlm-435	118	14	the	the	DET
ajlm-435	118	15	efficacy	efficacy	NOUN
ajlm-435	118	16	of	of	ADP
ajlm-435	118	17	the	the	DET
ajlm-435	118	18	phage	phage	NOUN
ajlm-435	118	19	to	to	ADP
ajlm-435	118	20	about	about	ADV
ajlm-435	118	21	60	60	NUM
ajlm-435	118	22	%	%	NOUN
ajlm-435	118	23	,	,	PUNCT
ajlm-435	118	24	indicating	indicate	VERB
ajlm-435	118	25	that	that	SCONJ
ajlm-435	118	26	clindamycin	clindamycin	NOUN
ajlm-435	118	27	may	may	AUX
ajlm-435	118	28	have	have	VERB
ajlm-435	118	29	an	an	DET
ajlm-435	118	30	antagonist	antagonist	NOUN
ajlm-435	118	31	effect	effect	NOUN
ajlm-435	118	32	on	on	ADP
ajlm-435	118	33	phage	phage	NOUN
ajlm-435	118	34	lytic	lytic	ADJ
ajlm-435	118	35	activity	activity	NOUN
ajlm-435	118	36	.	.	PUNCT
ajlm-435	119	1	clindamycin	clindamycin	NOUN
ajlm-435	119	2	is	be	AUX
ajlm-435	119	3	a	a	DET
ajlm-435	119	4	bacteriostatic	bacteriostatic	ADJ
ajlm-435	119	5	antibiotic	antibiotic	NOUN
ajlm-435	119	6	;	;	PUNCT
ajlm-435	119	7	thus	thus	ADV
ajlm-435	119	8	,	,	PUNCT
ajlm-435	119	9	it	it	PRON
ajlm-435	119	10	may	may	AUX
ajlm-435	119	11	interfere	interfere	VERB
ajlm-435	119	12	with	with	ADP
ajlm-435	119	13	phage	phage	NOUN
ajlm-435	119	14	protein	protein	NOUN
ajlm-435	119	15	synthesis	synthesis	NOUN
ajlm-435	119	16	,	,	PUNCT
ajlm-435	119	17	which	which	PRON
ajlm-435	119	18	would	would	AUX
ajlm-435	119	19	interrupt	interrupt	VERB
ajlm-435	119	20	the	the	DET
ajlm-435	119	21	phage	phage	NOUN
ajlm-435	119	22	auto	auto	NOUN
ajlm-435	119	23	-	-	PUNCT
ajlm-435	119	24	dosing	dose	VERB
ajlm-435	119	25	mechanism	mechanism	NOUN
ajlm-435	119	26	.	.	PUNCT
ajlm-435	120	1	limitations	limitation	NOUN
ajlm-435	120	2	of	of	ADP
ajlm-435	120	3	the	the	DET
ajlm-435	120	4	study	study	NOUN
ajlm-435	120	5	our	our	PRON
ajlm-435	120	6	study	study	NOUN
ajlm-435	120	7	results	result	NOUN
ajlm-435	120	8	were	be	AUX
ajlm-435	120	9	generated	generate	VERB
ajlm-435	120	10	in	in	ADP
ajlm-435	120	11	mice	mouse	NOUN
ajlm-435	120	12	.	.	PUNCT
ajlm-435	121	1	while	while	SCONJ
ajlm-435	121	2	our	our	PRON
ajlm-435	121	3	findings	finding	NOUN
ajlm-435	121	4	provide	provide	VERB
ajlm-435	121	5	vital	vital	ADJ
ajlm-435	121	6	information	information	NOUN
ajlm-435	121	7	on	on	ADP
ajlm-435	121	8	the	the	DET
ajlm-435	121	9	antimicrobial	antimicrobial	ADJ
ajlm-435	121	10	resistance	resistance	NOUN
ajlm-435	121	11	profile	profile	NOUN
ajlm-435	121	12	in	in	ADP
ajlm-435	121	13	kenya	kenya	PROPN
ajlm-435	121	14	,	,	PUNCT
ajlm-435	121	15	they	they	PRON
ajlm-435	121	16	can	can	AUX
ajlm-435	121	17	not	not	PART
ajlm-435	121	18	be	be	AUX
ajlm-435	121	19	translated	translate	VERB
ajlm-435	121	20	directly	directly	ADV
ajlm-435	121	21	to	to	ADP
ajlm-435	121	22	humans	human	NOUN
ajlm-435	121	23	.	.	PUNCT
ajlm-435	122	1	however	however	ADV
ajlm-435	122	2	,	,	PUNCT
ajlm-435	122	3	comparative	comparative	ADJ
ajlm-435	122	4	animal	animal	NOUN
ajlm-435	122	5	models	model	NOUN
ajlm-435	122	6	can	can	AUX
ajlm-435	122	7	be	be	AUX
ajlm-435	122	8	utilised	utilise	VERB
ajlm-435	122	9	to	to	PART
ajlm-435	122	10	ascertain	ascertain	VERB
ajlm-435	122	11	the	the	DET
ajlm-435	122	12	safety	safety	NOUN
ajlm-435	122	13	and	and	CCONJ
ajlm-435	122	14	therapeutic	therapeutic	ADJ
ajlm-435	122	15	potential	potential	NOUN
ajlm-435	122	16	of	of	ADP
ajlm-435	122	17	environmentally	environmentally	ADV
ajlm-435	122	18	-	-	PUNCT
ajlm-435	122	19	available	available	ADJ
ajlm-435	122	20	phages	phage	NOUN
ajlm-435	122	21	against	against	ADP
ajlm-435	122	22	infections	infection	NOUN
ajlm-435	122	23	caused	cause	VERB
ajlm-435	122	24	by	by	ADP
ajlm-435	122	25	multidrug	multidrug	NOUN
ajlm-435	122	26	-	-	PUNCT
ajlm-435	122	27	resistant	resistant	ADJ
ajlm-435	122	28	bacteria	bacteria	NOUN
ajlm-435	122	29	.	.	PUNCT
ajlm-435	123	1	conclusion	conclusion	NOUN
ajlm-435	123	2	in	in	ADP
ajlm-435	123	3	conclusion	conclusion	NOUN
ajlm-435	123	4	,	,	PUNCT
ajlm-435	123	5	we	we	PRON
ajlm-435	123	6	report	report	VERB
ajlm-435	123	7	for	for	ADP
ajlm-435	123	8	the	the	DET
ajlm-435	123	9	first	first	ADJ
ajlm-435	123	10	time	time	NOUN
ajlm-435	123	11	that	that	PRON
ajlm-435	123	12	a	a	DET
ajlm-435	123	13	single	single	ADJ
ajlm-435	123	14	dose	dose	NOUN
ajlm-435	123	15	of	of	ADP
ajlm-435	123	16	mdrsa	mdrsa	NOUN
ajlm-435	123	17	-	-	PUNCT
ajlm-435	123	18	specific	specific	ADJ
ajlm-435	123	19	lytic	lytic	ADJ
ajlm-435	123	20	phage	phage	NOUN
ajlm-435	123	21	is	be	AUX
ajlm-435	123	22	efficacious	efficacious	ADJ
ajlm-435	123	23	against	against	ADP
ajlm-435	123	24	haematogenous	haematogenous	ADJ
ajlm-435	123	25	pneumonia	pneumonia	NOUN
ajlm-435	123	26	caused	cause	VERB
ajlm-435	123	27	by	by	ADP
ajlm-435	123	28	multidrug	multidrug	NOUN
ajlm-435	123	29	-	-	PUNCT
ajlm-435	123	30	resistant	resistant	ADJ
ajlm-435	123	31	s.	s.	PROPN
ajlm-435	123	32	aureus	aureus	PROPN
ajlm-435	123	33	in	in	ADP
ajlm-435	123	34	mice	mouse	NOUN
ajlm-435	123	35	.	.	PUNCT
ajlm-435	124	1	acknowledgements	acknowledgement	NOUN
ajlm-435	124	2	we	we	PRON
ajlm-435	124	3	acknowledge	acknowledge	VERB
ajlm-435	124	4	the	the	DET
ajlm-435	124	5	institute	institute	PROPN
ajlm-435	124	6	of	of	ADP
ajlm-435	124	7	primate	primate	PROPN
ajlm-435	124	8	research	research	NOUN
ajlm-435	124	9	staff	staff	NOUN
ajlm-435	124	10	for	for	ADP
ajlm-435	124	11	providing	provide	VERB
ajlm-435	124	12	logistical	logistical	ADJ
ajlm-435	124	13	support	support	NOUN
ajlm-435	124	14	during	during	ADP
ajlm-435	124	15	experimentation	experimentation	NOUN
ajlm-435	124	16	;	;	PUNCT
ajlm-435	124	17	dr	dr	PROPN
ajlm-435	124	18	geoffrey	geoffrey	PROPN
ajlm-435	124	19	omuse	omuse	ADV
ajlm-435	124	20	and	and	CCONJ
ajlm-435	124	21	dr	dr	PROPN
ajlm-435	124	22	allan	allan	PROPN
ajlm-435	124	23	njoroge	njoroge	PROPN
ajlm-435	124	24	(	(	PUNCT
ajlm-435	124	25	aga	aga	PROPN
ajlm-435	124	26	khan	khan	PROPN
ajlm-435	124	27	university	university	PROPN
ajlm-435	124	28	hospital	hospital	NOUN
ajlm-435	124	29	,	,	PUNCT
ajlm-435	124	30	nairobi	nairobi	PROPN
ajlm-435	124	31	,	,	PUNCT
ajlm-435	124	32	kenya	kenya	PROPN
ajlm-435	124	33	)	)	PUNCT
ajlm-435	124	34	for	for	ADP
ajlm-435	124	35	donating	donate	VERB
ajlm-435	124	36	atcc	atcc	NOUN
ajlm-435	124	37	43300	43300	NUM
ajlm-435	124	38	;	;	PUNCT
ajlm-435	124	39	prof	prof	PROPN
ajlm-435	124	40	w.	w.	PROPN
ajlm-435	124	41	jaoko	jaoko	PROPN
ajlm-435	124	42	and	and	CCONJ
ajlm-435	124	43	mr	mr	PROPN
ajlm-435	124	44	j.	j.	PROPN
ajlm-435	124	45	oloo	oloo	PROPN
ajlm-435	124	46	(	(	PUNCT
ajlm-435	124	47	university	university	PROPN
ajlm-435	124	48	of	of	ADP
ajlm-435	124	49	nairobi	nairobi	PROPN
ajlm-435	124	50	,	,	PUNCT
ajlm-435	124	51	medical	medical	ADJ
ajlm-435	124	52	school	school	NOUN
ajlm-435	124	53	,	,	PUNCT
ajlm-435	124	54	kenya	kenya	PROPN
ajlm-435	124	55	)	)	PUNCT
ajlm-435	124	56	for	for	ADP
ajlm-435	124	57	donating	donate	VERB
ajlm-435	124	58	atcc	atcc	ADJ
ajlm-435	124	59	29213	29213	NUM
ajlm-435	124	60	;	;	PUNCT
ajlm-435	124	61	and	and	CCONJ
ajlm-435	124	62	prof	prof	PROPN
ajlm-435	124	63	.	.	PUNCT
ajlm-435	125	1	b.	b.	PROPN
ajlm-435	125	2	weber	weber	PROPN
ajlm-435	125	3	-	-	PUNCT
ajlm-435	125	4	dabrowska	dabrowska	PROPN
ajlm-435	125	5	and	and	CCONJ
ajlm-435	125	6	mr	mr	PROPN
ajlm-435	125	7	m.	m.	PROPN
ajlm-435	125	8	lusiak	lusiak	PROPN
ajlm-435	125	9	-	-	PUNCT
ajlm-435	125	10	szelachowska	szelachowska	NOUN
ajlm-435	125	11	(	(	PUNCT
ajlm-435	125	12	institute	institute	NOUN
ajlm-435	125	13	of	of	ADP
ajlm-435	125	14	immunology	immunology	NOUN
ajlm-435	125	15	and	and	CCONJ
ajlm-435	125	16	experimental	experimental	ADJ
ajlm-435	125	17	therapy	therapy	NOUN
ajlm-435	125	18	,	,	PUNCT
ajlm-435	125	19	wroclaw	wroclaw	NOUN
ajlm-435	125	20	,	,	PUNCT
ajlm-435	125	21	poland	poland	PROPN
ajlm-435	125	22	)	)	PUNCT
ajlm-435	125	23	for	for	ADP
ajlm-435	125	24	providing	provide	VERB
ajlm-435	125	25	phage	phage	NOUN
ajlm-435	125	26	isolation	isolation	NOUN
ajlm-435	125	27	protocols	protocol	NOUN
ajlm-435	125	28	.	.	PUNCT
ajlm-435	126	1	this	this	DET
ajlm-435	126	2	study	study	NOUN
ajlm-435	126	3	was	be	AUX
ajlm-435	126	4	approved	approve	VERB
ajlm-435	126	5	by	by	ADP
ajlm-435	126	6	the	the	DET
ajlm-435	126	7	ethics	ethic	NOUN
ajlm-435	126	8	committees	committee	NOUN
ajlm-435	126	9	of	of	ADP
ajlm-435	126	10	the	the	DET
ajlm-435	126	11	institute	institute	PROPN
ajlm-435	126	12	of	of	ADP
ajlm-435	126	13	primate	primate	PROPN
ajlm-435	126	14	research	research	NOUN
ajlm-435	126	15	(	(	PUNCT
ajlm-435	126	16	ref	ref	NOUN
ajlm-435	126	17	no	no	NOUN
ajlm-435	126	18	:	:	PUNCT
ajlm-435	126	19	irc/02/14	irc/02/14	NUM
ajlm-435	126	20	)	)	PUNCT
ajlm-435	126	21	.	.	PUNCT
ajlm-435	127	1	all	all	DET
ajlm-435	127	2	institutional	institutional	ADJ
ajlm-435	127	3	and	and	CCONJ
ajlm-435	127	4	national	national	ADJ
ajlm-435	127	5	guidelines	guideline	NOUN
ajlm-435	127	6	for	for	ADP
ajlm-435	127	7	the	the	DET
ajlm-435	127	8	care	care	NOUN
ajlm-435	127	9	and	and	CCONJ
ajlm-435	127	10	use	use	NOUN
ajlm-435	127	11	of	of	ADP
ajlm-435	127	12	animals	animal	NOUN
ajlm-435	127	13	were	be	AUX
ajlm-435	127	14	followed	follow	VERB
ajlm-435	127	15	.	.	PUNCT
ajlm-435	128	1	competing	compete	VERB
ajlm-435	128	2	interests	interest	NOUN
ajlm-435	128	3	the	the	DET
ajlm-435	128	4	authors	author	NOUN
ajlm-435	128	5	declare	declare	VERB
ajlm-435	128	6	that	that	SCONJ
ajlm-435	128	7	they	they	PRON
ajlm-435	128	8	have	have	VERB
ajlm-435	128	9	no	no	DET
ajlm-435	128	10	financial	financial	ADJ
ajlm-435	128	11	or	or	CCONJ
ajlm-435	128	12	personal	personal	ADJ
ajlm-435	128	13	relationship(s	relationship(s	NOUN
ajlm-435	128	14	)	)	PUNCT
ajlm-435	128	15	that	that	PRON
ajlm-435	128	16	may	may	AUX
ajlm-435	128	17	have	have	AUX
ajlm-435	128	18	inappropriately	inappropriately	ADV
ajlm-435	128	19	influenced	influence	VERB
ajlm-435	128	20	them	they	PRON
ajlm-435	128	21	in	in	ADP
ajlm-435	128	22	writing	write	VERB
ajlm-435	128	23	this	this	DET
ajlm-435	128	24	article	article	NOUN
ajlm-435	128	25	.	.	PUNCT
ajlm-435	129	1	sources	source	NOUN
ajlm-435	129	2	of	of	ADP
ajlm-435	129	3	support	support	NOUN
ajlm-435	129	4	none	none	NOUN
ajlm-435	129	5	.	.	PUNCT
ajlm-435	130	1	authors	author	NOUN
ajlm-435	130	2	’	'	PUNCT
ajlm-435	130	3	contributions	contribution	NOUN
ajlm-435	130	4	j.m.o.o	j.m.o.o	PROPN
ajlm-435	130	5	.	.	PROPN
ajlm-435	130	6	made	make	VERB
ajlm-435	130	7	conceptual	conceptual	ADJ
ajlm-435	130	8	contributions	contribution	NOUN
ajlm-435	130	9	.	.	PUNCT
ajlm-435	131	1	j.m.o.o	j.m.o.o	PROPN
ajlm-435	131	2	.	.	PROPN
ajlm-435	131	3	and	and	CCONJ
ajlm-435	131	4	a.n	a.n	PROPN
ajlm-435	131	5	.	.	PROPN
ajlm-435	131	6	designed	design	VERB
ajlm-435	131	7	the	the	DET
ajlm-435	131	8	study	study	NOUN
ajlm-435	131	9	and	and	CCONJ
ajlm-435	131	10	the	the	DET
ajlm-435	131	11	experimental	experimental	ADJ
ajlm-435	131	12	protocols	protocol	NOUN
ajlm-435	131	13	.	.	PUNCT
ajlm-435	132	1	j.m.o.o	j.m.o.o	PROPN
ajlm-435	132	2	.	.	PROPN
ajlm-435	132	3	collected	collect	VERB
ajlm-435	132	4	the	the	DET
ajlm-435	132	5	samples	sample	NOUN
ajlm-435	132	6	,	,	PUNCT
ajlm-435	132	7	performed	perform	VERB
ajlm-435	132	8	the	the	DET
ajlm-435	132	9	experimentation	experimentation	NOUN
ajlm-435	132	10	,	,	PUNCT
ajlm-435	132	11	and	and	CCONJ
ajlm-435	132	12	collected	collect	VERB
ajlm-435	132	13	and	and	CCONJ
ajlm-435	132	14	analysed	analyse	VERB
ajlm-435	132	15	the	the	DET
ajlm-435	132	16	data	datum	NOUN
ajlm-435	132	17	.	.	PUNCT
ajlm-435	133	1	f.m	f.m	PROPN
ajlm-435	133	2	.	.	PROPN
ajlm-435	133	3	assisted	assist	VERB
ajlm-435	133	4	in	in	ADP
ajlm-435	133	5	reading	read	VERB
ajlm-435	133	6	the	the	DET
ajlm-435	133	7	histology	histology	NOUN
ajlm-435	133	8	slides	slide	NOUN
ajlm-435	133	9	.	.	PUNCT
ajlm-435	134	1	j.m.o.o	j.m.o.o	PROPN
ajlm-435	134	2	.	.	PROPN
ajlm-435	134	3	and	and	CCONJ
ajlm-435	134	4	n.o	n.o	PROPN
ajlm-435	134	5	.	.	PROPN
ajlm-435	134	6	wrote	write	VERB
ajlm-435	134	7	the	the	DET
ajlm-435	134	8	article	article	NOUN
ajlm-435	134	9	.	.	PUNCT
ajlm-435	135	1	all	all	DET
ajlm-435	135	2	authors	author	NOUN
ajlm-435	135	3	read	read	VERB
ajlm-435	135	4	and	and	CCONJ
ajlm-435	135	5	approved	approve	VERB
ajlm-435	135	6	the	the	DET
ajlm-435	135	7	final	final	ADJ
ajlm-435	135	8	article	article	NOUN
ajlm-435	135	9	for	for	ADP
ajlm-435	135	10	publication	publication	NOUN
ajlm-435	135	11	.	.	PUNCT
ajlm-435	136	1	references	reference	NOUN
ajlm-435	136	2	alcón	alcón	VERB
ajlm-435	136	3	a	a	PRON
ajlm-435	136	4	,	,	PUNCT
ajlm-435	136	5	fàbregas	fàbregas	X
ajlm-435	136	6	n	n	CCONJ
ajlm-435	136	7	,	,	PUNCT
ajlm-435	136	8	torres	torre	VERB
ajlm-435	136	9	a.	a.	NOUN
ajlm-435	136	10	pathophysiology	pathophysiology	NOUN
ajlm-435	136	11	of	of	ADP
ajlm-435	136	12	pneumonia	pneumonia	NOUN
ajlm-435	136	13	.	.	PUNCT
ajlm-435	137	1	clin	clin	PROPN
ajlm-435	137	2	chest	chest	PROPN
ajlm-435	137	3	med	me	VERB
ajlm-435	137	4	.	.	PUNCT
ajlm-435	138	1	2005;26(1):39–46	2005;26(1):39–46	NUM
ajlm-435	138	2	.	.	PUNCT
ajlm-435	139	1	http://dx.doi.org/10.1016/j.ccm.2004.10.013	http://dx.doi.org/10.1016/j.ccm.2004.10.013	PROPN
ajlm-435	139	2	köksal	köksal	PROPN
ajlm-435	139	3	i	i	PROPN
ajlm-435	139	4	,	,	PUNCT
ajlm-435	139	5	oslü	oslü	PROPN
ajlm-435	139	6	t	t	PROPN
ajlm-435	139	7	,	,	PUNCT
ajlm-435	139	8	bayraktar	bayraktar	PROPN
ajlm-435	139	9	o	o	NOUN
ajlm-435	139	10	,	,	PUNCT
ajlm-435	139	11	et	et	PROPN
ajlm-435	139	12	al	al	PROPN
ajlm-435	139	13	.	.	PROPN
ajlm-435	139	14	etiological	etiological	ADJ
ajlm-435	139	15	agents	agent	NOUN
ajlm-435	139	16	of	of	ADP
ajlm-435	139	17	community	community	NOUN
ajlm-435	139	18	-	-	PUNCT
ajlm-435	139	19	acquired	acquire	VERB
ajlm-435	139	20	pneumonia	pneumonia	NOUN
ajlm-435	139	21	in	in	ADP
ajlm-435	139	22	adult	adult	NOUN
ajlm-435	139	23	patients	patient	NOUN
ajlm-435	139	24	in	in	ADP
ajlm-435	139	25	turkey	turkey	PROPN
ajlm-435	139	26	;	;	PUNCT
ajlm-435	139	27	a	a	DET
ajlm-435	139	28	multicentric	multicentric	NOUN
ajlm-435	139	29	,	,	PUNCT
ajlm-435	139	30	cross	cross	ADJ
ajlm-435	139	31	-	-	ADJ
ajlm-435	139	32	sectional	sectional	ADJ
ajlm-435	139	33	study	study	NOUN
ajlm-435	139	34	.	.	PUNCT
ajlm-435	140	1	tuberk	tuberk	NOUN
ajlm-435	140	2	toraks	torak	NOUN
ajlm-435	140	3	.	.	PUNCT
ajlm-435	141	1	2010;58(2):119–127	2010;58(2):119–127	NUM
ajlm-435	141	2	.	.	PUNCT
ajlm-435	142	1	kyaw	kyaw	PROPN
ajlm-435	142	2	mh	mh	PROPN
ajlm-435	142	3	,	,	PUNCT
ajlm-435	142	4	kern	kern	PROPN
ajlm-435	142	5	dm	dm	PROPN
ajlm-435	142	6	,	,	PUNCT
ajlm-435	142	7	zhou	zhou	PROPN
ajlm-435	142	8	s	s	PROPN
ajlm-435	142	9	,	,	PUNCT
ajlm-435	142	10	et	et	PROPN
ajlm-435	142	11	al	al	PROPN
ajlm-435	142	12	.	.	PUNCT
ajlm-435	143	1	healthcare	healthcare	NOUN
ajlm-435	143	2	utilization	utilization	NOUN
ajlm-435	143	3	and	and	CCONJ
ajlm-435	143	4	costs	cost	NOUN
ajlm-435	143	5	associated	associate	VERB
ajlm-435	143	6	with	with	ADP
ajlm-435	143	7	s.	s.	PROPN
ajlm-435	143	8	aureus	aureus	PROPN
ajlm-435	143	9	and	and	CCONJ
ajlm-435	143	10	p.	p.	NOUN
ajlm-435	143	11	aeruginosa	aeruginosa	PROPN
ajlm-435	143	12	pneumonia	pneumonia	NOUN
ajlm-435	143	13	in	in	ADP
ajlm-435	143	14	the	the	DET
ajlm-435	143	15	intensive	intensive	ADJ
ajlm-435	143	16	care	care	NOUN
ajlm-435	143	17	unit	unit	NOUN
ajlm-435	143	18	:	:	PUNCT
ajlm-435	143	19	a	a	DET
ajlm-435	143	20	retrospective	retrospective	ADJ
ajlm-435	143	21	observational	observational	ADJ
ajlm-435	143	22	cohort	cohort	NOUN
ajlm-435	143	23	study	study	NOUN
ajlm-435	143	24	in	in	ADP
ajlm-435	143	25	a	a	DET
ajlm-435	143	26	us	us	PROPN
ajlm-435	143	27	claims	claim	NOUN
ajlm-435	143	28	database	database	NOUN
ajlm-435	143	29	.	.	PUNCT
ajlm-435	144	1	bmc	bmc	PROPN
ajlm-435	144	2	health	health	PROPN
ajlm-435	144	3	serv	serv	PROPN
ajlm-435	144	4	res	res	PROPN
ajlm-435	144	5	.	.	PUNCT
ajlm-435	145	1	2015;15:241	2015;15:241	X
ajlm-435	145	2	.	.	PUNCT
ajlm-435	145	3	http://dx.doi.org/10.1186/s12913-015-0917-x	http://dx.doi.org/10.1186/s12913-015-0917-x	VERB
ajlm-435	145	4	rubinstein	rubinstein	PROPN
ajlm-435	145	5	e	e	PROPN
ajlm-435	145	6	,	,	PUNCT
ajlm-435	145	7	kollef	kollef	PROPN
ajlm-435	145	8	mh	mh	PROPN
ajlm-435	145	9	,	,	PUNCT
ajlm-435	145	10	nathwani	nathwani	PROPN
ajlm-435	145	11	d.	d.	PROPN
ajlm-435	145	12	pneumonia	pneumonia	PROPN
ajlm-435	145	13	caused	cause	VERB
ajlm-435	145	14	by	by	ADP
ajlm-435	145	15	methicillin	methicillin	NOUN
ajlm-435	145	16	-	-	PUNCT
ajlm-435	145	17	resistant	resistant	ADJ
ajlm-435	145	18	staphylococcus	staphylococcus	NOUN
ajlm-435	145	19	aureus	aureus	NOUN
ajlm-435	145	20	.	.	PUNCT
ajlm-435	146	1	clin	clin	PROPN
ajlm-435	146	2	infect	infect	PROPN
ajlm-435	146	3	dis	dis	PROPN
ajlm-435	146	4	.	.	PUNCT
ajlm-435	147	1	2008;46(suppl	2008;46(suppl	PROPN
ajlm-435	147	2	5):s378	5):s378	NUM
ajlm-435	147	3	–	–	PUNCT
ajlm-435	147	4	s385	s385	PROPN
ajlm-435	147	5	.	.	PUNCT
ajlm-435	148	1	doi	doi	PROPN
ajlm-435	148	2	:	:	PUNCT
ajlm-435	148	3	10.1086/533594	10.1086/533594	NUM
ajlm-435	148	4	dicpinigaitis	dicpinigaitis	NOUN
ajlm-435	148	5	pv	pv	NOUN
ajlm-435	148	6	,	,	PUNCT
ajlm-435	148	7	levy	levy	NOUN
ajlm-435	148	8	de	de	PROPN
ajlm-435	148	9	,	,	PUNCT
ajlm-435	148	10	gnass	gnass	PROPN
ajlm-435	148	11	rd	rd	PROPN
ajlm-435	148	12	,	,	PUNCT
ajlm-435	148	13	et	et	PROPN
ajlm-435	148	14	al	al	PROPN
ajlm-435	148	15	.	.	PUNCT
ajlm-435	149	1	pneumonia	pneumonia	NOUN
ajlm-435	149	2	due	due	ADP
ajlm-435	149	3	to	to	ADP
ajlm-435	149	4	staphylococcus	staphylococcus	NOUN
ajlm-435	149	5	aureus	aureus	NOUN
ajlm-435	149	6	in	in	ADP
ajlm-435	149	7	a	a	DET
ajlm-435	149	8	patient	patient	NOUN
ajlm-435	149	9	with	with	ADP
ajlm-435	149	10	aids	aid	NOUN
ajlm-435	149	11	:	:	PUNCT
ajlm-435	149	12	review	review	NOUN
ajlm-435	149	13	of	of	ADP
ajlm-435	149	14	incidence	incidence	NOUN
ajlm-435	149	15	and	and	CCONJ
ajlm-435	149	16	report	report	NOUN
ajlm-435	149	17	of	of	ADP
ajlm-435	149	18	an	an	DET
ajlm-435	149	19	atypical	atypical	ADJ
ajlm-435	149	20	roentgenographic	roentgenographic	ADJ
ajlm-435	149	21	presentation	presentation	NOUN
ajlm-435	149	22	.	.	PUNCT
ajlm-435	150	1	south	south	PROPN
ajlm-435	150	2	med	med	PROPN
ajlm-435	150	3	j.	j.	PROPN
ajlm-435	150	4	1995;88(5):586–590	1995;88(5):586–590	PROPN
ajlm-435	150	5	.	.	PUNCT
ajlm-435	151	1	http://dx.doi.org/10.1097/00007611-199505000-00017	http://dx.doi.org/10.1097/00007611-199505000-00017	PROPN
ajlm-435	151	2	monecke	monecke	PRON
ajlm-435	151	3	s	s	PROPN
ajlm-435	151	4	,	,	PUNCT
ajlm-435	151	5	coombs	coombs	PROPN
ajlm-435	151	6	g	g	PROPN
ajlm-435	151	7	,	,	PUNCT
ajlm-435	151	8	shore	shore	PROPN
ajlm-435	151	9	ac	ac	PROPN
ajlm-435	151	10	,	,	PUNCT
ajlm-435	151	11	et	et	PROPN
ajlm-435	151	12	al	al	PROPN
ajlm-435	151	13	.	.	PUNCT
ajlm-435	152	1	a	a	DET
ajlm-435	152	2	field	field	NOUN
ajlm-435	152	3	guide	guide	NOUN
ajlm-435	152	4	to	to	ADP
ajlm-435	152	5	pandemic	pandemic	ADJ
ajlm-435	152	6	,	,	PUNCT
ajlm-435	152	7	epidemic	epidemic	NOUN
ajlm-435	152	8	and	and	CCONJ
ajlm-435	152	9	sporadic	sporadic	ADJ
ajlm-435	152	10	clones	clone	NOUN
ajlm-435	152	11	of	of	ADP
ajlm-435	152	12	methicillin	methicillin	NOUN
ajlm-435	152	13	-	-	PUNCT
ajlm-435	152	14	resistant	resistant	ADJ
ajlm-435	152	15	staphylococcus	staphylococcus	NOUN
ajlm-435	152	16	aureus	aureus	NOUN
ajlm-435	152	17	.	.	PUNCT
ajlm-435	153	1	plos	plos	PROPN
ajlm-435	153	2	one	one	NUM
ajlm-435	153	3	.	.	PUNCT
ajlm-435	154	1	2011;6(4):e17936	2011;6(4):e17936	X
ajlm-435	154	2	.	.	PUNCT
ajlm-435	155	1	http://dx.doi.org/10.1371/journal.pone.0017936	http://dx.doi.org/10.1371/journal.pone.0017936	PROPN
ajlm-435	155	2	yu	yu	PROPN
ajlm-435	156	1	f	f	PROPN
ajlm-435	156	2	,	,	PUNCT
ajlm-435	156	3	lu	lu	PROPN
ajlm-435	156	4	c	c	NOUN
ajlm-435	156	5	,	,	PUNCT
ajlm-435	156	6	liu	liu	PROPN
ajlm-435	156	7	y	y	PROPN
ajlm-435	156	8	,	,	PUNCT
ajlm-435	156	9	et	et	PROPN
ajlm-435	156	10	al	al	PROPN
ajlm-435	156	11	.	.	PROPN
ajlm-435	157	1	emergence	emergence	NOUN
ajlm-435	157	2	of	of	ADP
ajlm-435	157	3	quinupristin	quinupristin	PROPN
ajlm-435	157	4	/	/	SYM
ajlm-435	157	5	dalfopristin	dalfopristin	NOUN
ajlm-435	157	6	resistance	resistance	NOUN
ajlm-435	157	7	among	among	ADP
ajlm-435	157	8	livestock	livestock	NOUN
ajlm-435	157	9	-	-	PUNCT
ajlm-435	157	10	associated	associate	VERB
ajlm-435	157	11	staphylococcus	staphylococcus	NOUN
ajlm-435	157	12	aureus	aureus	NOUN
ajlm-435	157	13	st9	st9	VERB
ajlm-435	157	14	clinical	clinical	ADJ
ajlm-435	157	15	isolates	isolate	NOUN
ajlm-435	157	16	.	.	PUNCT
ajlm-435	158	1	int	int	NOUN
ajlm-435	158	2	j	j	PROPN
ajlm-435	158	3	antimicrob	antimicrob	PROPN
ajlm-435	158	4	agents	agent	NOUN
ajlm-435	158	5	.	.	PUNCT
ajlm-435	159	1	2014;44(5):416–419	2014;44(5):416–419	NUM
ajlm-435	159	2	.	.	PUNCT
ajlm-435	160	1	http://dx.doi.org/10.1016/j.ijantimicag.2014.06.020	http://dx.doi.org/10.1016/j.ijantimicag.2014.06.020	PROPN
ajlm-435	160	2	.	.	PUNCT
ajlm-435	161	1	epub	epub	PROPN
ajlm-435	161	2	2014	2014	NUM
ajlm-435	161	3	aug	aug	PROPN
ajlm-435	161	4	17	17	NUM
ajlm-435	161	5	.	.	PUNCT
ajlm-435	162	1	rasmussen	rasmussen	PROPN
ajlm-435	162	2	rv	rv	PROPN
ajlm-435	162	3	,	,	PUNCT
ajlm-435	162	4	fowler	fowler	PROPN
ajlm-435	162	5	vg	vg	PROPN
ajlm-435	162	6	,	,	PUNCT
ajlm-435	162	7	skov	skov	NOUN
ajlm-435	162	8	r	r	NOUN
ajlm-435	162	9	,	,	PUNCT
ajlm-435	162	10	et	et	PROPN
ajlm-435	162	11	al	al	PROPN
ajlm-435	162	12	.	.	PUNCT
ajlm-435	163	1	future	future	ADJ
ajlm-435	163	2	challenges	challenge	NOUN
ajlm-435	163	3	and	and	CCONJ
ajlm-435	163	4	treatment	treatment	NOUN
ajlm-435	163	5	of	of	ADP
ajlm-435	163	6	staphylococcus	staphylococcus	NOUN
ajlm-435	163	7	aureus	aureus	NOUN
ajlm-435	163	8	bacteremia	bacteremia	NOUN
ajlm-435	163	9	with	with	ADP
ajlm-435	163	10	emphasis	emphasis	NOUN
ajlm-435	163	11	on	on	ADP
ajlm-435	163	12	mrsa	mrsa	NOUN
ajlm-435	163	13	.	.	PUNCT
ajlm-435	164	1	future	future	ADJ
ajlm-435	164	2	microbiol	microbiol	PROPN
ajlm-435	164	3	.	.	PUNCT
ajlm-435	165	1	2011;6(1):43–56	2011;6(1):43–56	NUM
ajlm-435	165	2	.	.	PUNCT
ajlm-435	166	1	http://dx.doi.org/10.2217/fmb.10.155	http://dx.doi.org/10.2217/fmb.10.155	PROPN
ajlm-435	166	2	westwood	westwood	PROPN
ajlm-435	166	3	j	j	PROPN
ajlm-435	166	4	,	,	PUNCT
ajlm-435	166	5	burnett	burnett	PROPN
ajlm-435	166	6	m	m	PROPN
ajlm-435	166	7	,	,	PUNCT
ajlm-435	166	8	spratt	spratt	PROPN
ajlm-435	166	9	d	d	PROPN
ajlm-435	166	10	,	,	PUNCT
ajlm-435	166	11	et	et	PROPN
ajlm-435	166	12	al	al	PROPN
ajlm-435	166	13	.	.	PUNCT
ajlm-435	167	1	the	the	DET
ajlm-435	167	2	hospital	hospital	NOUN
ajlm-435	167	3	microbiome	microbiome	NOUN
ajlm-435	167	4	project	project	NOUN
ajlm-435	167	5	:	:	PUNCT
ajlm-435	167	6	meeting	meet	VERB
ajlm-435	167	7	report	report	NOUN
ajlm-435	167	8	for	for	ADP
ajlm-435	167	9	the	the	DET
ajlm-435	167	10	uk	uk	PROPN
ajlm-435	167	11	science	science	NOUN
ajlm-435	167	12	and	and	CCONJ
ajlm-435	167	13	innovation	innovation	NOUN
ajlm-435	167	14	network	network	PROPN
ajlm-435	167	15	uk	uk	PROPN
ajlm-435	167	16	-	-	PROPN
ajlm-435	167	17	usa	usa	PROPN
ajlm-435	167	18	workshop	workshop	NOUN
ajlm-435	167	19	‘	'	PUNCT
ajlm-435	167	20	beating	beat	VERB
ajlm-435	167	21	the	the	DET
ajlm-435	167	22	superbugs	superbug	NOUN
ajlm-435	167	23	:	:	PUNCT
ajlm-435	167	24	hospital	hospital	NOUN
ajlm-435	167	25	microbiome	microbiome	NOUN
ajlm-435	167	26	studies	study	NOUN
ajlm-435	167	27	for	for	ADP
ajlm-435	167	28	tackling	tackle	VERB
ajlm-435	167	29	antimicrobial	antimicrobial	ADJ
ajlm-435	167	30	resistance	resistance	NOUN
ajlm-435	167	31	’	'	PUNCT
ajlm-435	167	32	,	,	PUNCT
ajlm-435	167	33	october	october	PROPN
ajlm-435	167	34	14th	14th	NOUN
ajlm-435	167	35	2013	2013	NUM
ajlm-435	167	36	.	.	PUNCT
ajlm-435	168	1	stand	stand	VERB
ajlm-435	168	2	genomic	genomic	PROPN
ajlm-435	168	3	sci	sci	PROPN
ajlm-435	168	4	.	.	PUNCT
ajlm-435	168	5	2014;9:12	2014;9:12	PROPN
ajlm-435	168	6	.	.	PUNCT
ajlm-435	169	1	http://dx.doi.org/10.1186/1944-3277-9-12	http://dx.doi.org/10.1186/1944-3277-9-12	PROPN
ajlm-435	169	2	ferrara	ferrara	NOUN
ajlm-435	169	3	am	be	AUX
ajlm-435	169	4	.	.	PUNCT
ajlm-435	170	1	treatment	treatment	NOUN
ajlm-435	170	2	of	of	ADP
ajlm-435	170	3	hospital	hospital	NOUN
ajlm-435	170	4	-	-	PUNCT
ajlm-435	170	5	acquired	acquire	VERB
ajlm-435	170	6	pneumonia	pneumonia	NOUN
ajlm-435	170	7	caused	cause	VERB
ajlm-435	170	8	by	by	ADP
ajlm-435	170	9	methicillin	methicillin	NOUN
ajlm-435	170	10	-	-	PUNCT
ajlm-435	170	11	resistant	resistant	ADJ
ajlm-435	170	12	staphylococcus	staphylococcus	NOUN
ajlm-435	170	13	aureus	aureus	NOUN
ajlm-435	170	14	.	.	PUNCT
ajlm-435	171	1	int	int	PROPN
ajlm-435	171	2	j	j	PROPN
ajlm-435	171	3	antimicrob	antimicrob	PROPN
ajlm-435	171	4	agents	agent	NOUN
ajlm-435	171	5	.	.	PUNCT
ajlm-435	172	1	2007;30(1):19–24	2007;30(1):19–24	X
ajlm-435	172	2	.	.	PUNCT
ajlm-435	173	1	epub	epub	NOUN
ajlm-435	173	2	2007	2007	NUM
ajlm-435	173	3	may	may	PROPN
ajlm-435	173	4	1	1	NUM
ajlm-435	173	5	.	.	PUNCT
ajlm-435	174	1	http://dx.doi.org/10.1016/j.ijantimicag.2007.02.011	http://dx.doi.org/10.1016/j.ijantimicag.2007.02.011	PROPN
ajlm-435	174	2	khan	khan	PROPN
ajlm-435	174	3	sn	sn	PROPN
ajlm-435	174	4	,	,	PUNCT
ajlm-435	174	5	khan	khan	PROPN
ajlm-435	174	6	au	au	PROPN
ajlm-435	174	7	.	.	PUNCT
ajlm-435	175	1	breaking	break	VERB
ajlm-435	175	2	the	the	DET
ajlm-435	175	3	spell	spell	NOUN
ajlm-435	175	4	:	:	PUNCT
ajlm-435	175	5	combating	combat	VERB
ajlm-435	175	6	multidrug	multidrug	NOUN
ajlm-435	175	7	resistant	resistant	ADJ
ajlm-435	175	8	‘	'	PUNCT
ajlm-435	175	9	superbugs	superbug	NOUN
ajlm-435	175	10	’	'	PUNCT
ajlm-435	175	11	.	.	PUNCT
ajlm-435	176	1	front	front	PROPN
ajlm-435	176	2	microbiol	microbiol	PROPN
ajlm-435	176	3	.	.	PUNCT
ajlm-435	177	1	2016;7:174	2016;7:174	PROPN
ajlm-435	177	2	.	.	PUNCT
ajlm-435	178	1	http://dx.doi.org/10.3389/fmicb.2016.00174	http://dx.doi.org/10.3389/fmicb.2016.00174	PROPN
ajlm-435	178	2	.	.	PUNCT
ajlm-435	179	1	ecollection	ecollection	NOUN
ajlm-435	179	2	2016	2016	NUM
ajlm-435	179	3	.	.	PUNCT
ajlm-435	180	1	clokie	clokie	PROPN
ajlm-435	180	2	mr	mr	PROPN
ajlm-435	180	3	,	,	PUNCT
ajlm-435	180	4	millard	millard	PROPN
ajlm-435	180	5	ad	ad	NOUN
ajlm-435	180	6	,	,	PUNCT
ajlm-435	180	7	letarov	letarov	PROPN
ajlm-435	180	8	av	av	PROPN
ajlm-435	180	9	,	,	PUNCT
ajlm-435	180	10	et	et	PROPN
ajlm-435	180	11	al	al	PROPN
ajlm-435	180	12	.	.	PUNCT
ajlm-435	180	13	phages	phage	NOUN
ajlm-435	180	14	in	in	ADP
ajlm-435	180	15	nature	nature	NOUN
ajlm-435	180	16	.	.	PUNCT
ajlm-435	181	1	bacteriophage	bacteriophage	NOUN
ajlm-435	181	2	.	.	PUNCT
ajlm-435	182	1	2011;1(1):31–45	2011;1(1):31–45	X
ajlm-435	182	2	.	.	PUNCT
ajlm-435	183	1	http://dx.doi.org/10.4161/bact.1.1.14942	http://dx.doi.org/10.4161/bact.1.1.14942	VERB
ajlm-435	183	2	abedon	abedon	PROPN
ajlm-435	183	3	st	st	PROPN
ajlm-435	183	4	,	,	PUNCT
ajlm-435	183	5	kuhl	kuhl	PROPN
ajlm-435	183	6	sj	sj	PROPN
ajlm-435	183	7	,	,	PUNCT
ajlm-435	183	8	blasdel	blasdel	PROPN
ajlm-435	183	9	bg	bg	PROPN
ajlm-435	183	10	,	,	PUNCT
ajlm-435	183	11	et	et	PROPN
ajlm-435	183	12	al	al	PROPN
ajlm-435	183	13	.	.	PUNCT
ajlm-435	183	14	phage	phage	NOUN
ajlm-435	183	15	treatment	treatment	NOUN
ajlm-435	183	16	of	of	ADP
ajlm-435	183	17	human	human	ADJ
ajlm-435	183	18	infections	infection	NOUN
ajlm-435	183	19	.	.	PUNCT
ajlm-435	184	1	bacteriophage	bacteriophage	NOUN
ajlm-435	184	2	.	.	PUNCT
ajlm-435	185	1	2011;1(2):66–85	2011;1(2):66–85	NUM
ajlm-435	185	2	.	.	PUNCT
ajlm-435	186	1	http://dx.doi.org/10.4161/bact.1.2.15845	http://dx.doi.org/10.4161/bact.1.2.15845	PROPN
ajlm-435	186	2	matsuzaki	matsuzaki	PROPN
ajlm-435	186	3	s	s	PROPN
ajlm-435	186	4	,	,	PUNCT
ajlm-435	186	5	uchiyama	uchiyama	PROPN
ajlm-435	186	6	j	j	PROPN
ajlm-435	186	7	,	,	PUNCT
ajlm-435	186	8	takemura	takemura	NOUN
ajlm-435	186	9	-	-	NOUN
ajlm-435	186	10	uchiyama	uchiyama	NOUN
ajlm-435	186	11	i	i	PRON
ajlm-435	186	12	,	,	PUNCT
ajlm-435	186	13	et	et	PROPN
ajlm-435	186	14	al	al	PROPN
ajlm-435	186	15	.	.	PROPN
ajlm-435	186	16	perspective	perspective	PROPN
ajlm-435	186	17	:	:	PUNCT
ajlm-435	186	18	the	the	DET
ajlm-435	186	19	age	age	NOUN
ajlm-435	186	20	of	of	ADP
ajlm-435	186	21	the	the	DET
ajlm-435	186	22	phage	phage	NOUN
ajlm-435	186	23	.	.	PUNCT
ajlm-435	187	1	nature	nature	NOUN
ajlm-435	187	2	.	.	PUNCT
ajlm-435	188	1	2014;509(7498):s9	2014;509(7498):s9	NOUN
ajlm-435	188	2	.	.	PUNCT
ajlm-435	189	1	http://dx.doi.org/10.1038/509s9a	http://dx.doi.org/10.1038/509s9a	PROPN
ajlm-435	189	2	reardon	reardon	PROPN
ajlm-435	189	3	s.	s.	PROPN
ajlm-435	189	4	phage	phage	PROPN
ajlm-435	189	5	therapy	therapy	NOUN
ajlm-435	189	6	gets	get	AUX
ajlm-435	189	7	revitalized	revitalize	VERB
ajlm-435	189	8	.	.	PUNCT
ajlm-435	190	1	nature	nature	NOUN
ajlm-435	190	2	.	.	PUNCT
ajlm-435	191	1	2014;510(7503):15–16	2014;510(7503):15–16	NOUN
ajlm-435	191	2	.	.	PUNCT
ajlm-435	192	1	http://dx.doi.org/10.1038/510015a	http://dx.doi.org/10.1038/510015a	PROPN
ajlm-435	192	2	sulakvelidze	sulakvelidze	NOUN
ajlm-435	192	3	a	a	PRON
ajlm-435	192	4	,	,	PUNCT
ajlm-435	192	5	alavidze	alavidze	PROPN
ajlm-435	192	6	z	z	PROPN
ajlm-435	192	7	,	,	PUNCT
ajlm-435	192	8	morris	morris	PROPN
ajlm-435	192	9	jg	jg	PROPN
ajlm-435	192	10	.	.	PUNCT
ajlm-435	192	11	bacteriophage	bacteriophage	NOUN
ajlm-435	192	12	therapy	therapy	NOUN
ajlm-435	192	13	.	.	PUNCT
ajlm-435	193	1	antimicrob	antimicrob	PROPN
ajlm-435	193	2	agents	agents	PROPN
ajlm-435	193	3	chemother	chemother	PROPN
ajlm-435	193	4	.	.	PUNCT
ajlm-435	194	1	2001;45(3):649–659	2001;45(3):649–659	NUM
ajlm-435	194	2	.	.	PUNCT
ajlm-435	194	3	http://dx.doi.org/10.1128/aac.45.3.649-659.2001	http://dx.doi.org/10.1128/aac.45.3.649-659.2001	PUNCT
ajlm-435	194	4	miedzybrodzki	miedzybrodzki	PROPN
ajlm-435	194	5	r	r	PROPN
ajlm-435	194	6	,	,	PUNCT
ajlm-435	194	7	fortuna	fortuna	PROPN
ajlm-435	194	8	w	w	PROPN
ajlm-435	194	9	,	,	PUNCT
ajlm-435	194	10	weber	weber	NOUN
ajlm-435	194	11	-	-	PUNCT
ajlm-435	194	12	dabrowska	dabrowska	NOUN
ajlm-435	194	13	b	b	NOUN
ajlm-435	194	14	,	,	PUNCT
ajlm-435	194	15	et	et	PROPN
ajlm-435	194	16	al	al	PROPN
ajlm-435	194	17	.	.	PUNCT
ajlm-435	194	18	phage	phage	NOUN
ajlm-435	194	19	therapy	therapy	NOUN
ajlm-435	194	20	of	of	ADP
ajlm-435	194	21	staphylococcal	staphylococcal	ADJ
ajlm-435	194	22	infections	infection	NOUN
ajlm-435	194	23	(	(	PUNCT
ajlm-435	194	24	including	include	VERB
ajlm-435	194	25	mrsa	mrsa	NOUN
ajlm-435	194	26	)	)	PUNCT
ajlm-435	194	27	may	may	AUX
ajlm-435	194	28	be	be	AUX
ajlm-435	194	29	less	less	ADV
ajlm-435	194	30	expensive	expensive	ADJ
ajlm-435	194	31	than	than	ADP
ajlm-435	194	32	antibiotic	antibiotic	ADJ
ajlm-435	194	33	treatment	treatment	NOUN
ajlm-435	194	34	.	.	PUNCT
ajlm-435	195	1	postepy	postepy	PROPN
ajlm-435	195	2	hig	hig	PROPN
ajlm-435	195	3	med	med	PROPN
ajlm-435	195	4	.	.	PUNCT
ajlm-435	196	1	dosw	dosw	NOUN
ajlm-435	196	2	(	(	PUNCT
ajlm-435	196	3	online	online	ADJ
ajlm-435	196	4	)	)	PUNCT
ajlm-435	196	5	.	.	PUNCT
ajlm-435	197	1	2007;61:461–465	2007;61:461–465	NUM
ajlm-435	197	2	.	.	PUNCT
ajlm-435	198	1	ouko	ouko	PROPN
ajlm-435	198	2	tt	tt	PROPN
ajlm-435	198	3	,	,	PUNCT
ajlm-435	198	4	ngeranwa	ngeranwa	PROPN
ajlm-435	198	5	jn	jn	PROPN
ajlm-435	198	6	,	,	PUNCT
ajlm-435	198	7	orinda	orinda	PROPN
ajlm-435	198	8	go	go	VERB
ajlm-435	198	9	,	,	PUNCT
ajlm-435	198	10	et	et	PROPN
ajlm-435	198	11	al	al	PROPN
ajlm-435	198	12	.	.	PROPN
ajlm-435	199	1	oxacillin	oxacillin	PROPN
ajlm-435	199	2	resistant	resistant	ADJ
ajlm-435	199	3	staphylococcus	staphylococcus	NOUN
ajlm-435	199	4	aureus	aureus	NOUN
ajlm-435	199	5	among	among	ADP
ajlm-435	199	6	hiv	hiv	PROPN
ajlm-435	199	7	infected	infected	ADJ
ajlm-435	199	8	and	and	CCONJ
ajlm-435	199	9	non	non	ADJ
ajlm-435	199	10	-	-	ADJ
ajlm-435	199	11	infected	infected	ADJ
ajlm-435	199	12	kenyan	kenyan	ADJ
ajlm-435	199	13	patients	patient	NOUN
ajlm-435	199	14	.	.	PUNCT
ajlm-435	200	1	east	east	PROPN
ajlm-435	200	2	afr	afr	PROPN
ajlm-435	200	3	med	med	PROPN
ajlm-435	200	4	j.	j.	PROPN
ajlm-435	200	5	2010;87(5):179–186	2010;87(5):179–186	PROPN
ajlm-435	200	6	.	.	PUNCT
ajlm-435	201	1	kilkenny	kilkenny	PROPN
ajlm-435	201	2	c	c	PROPN
ajlm-435	201	3	,	,	PUNCT
ajlm-435	201	4	browne	browne	PROPN
ajlm-435	201	5	w	w	PROPN
ajlm-435	201	6	,	,	PUNCT
ajlm-435	201	7	cuthill	cuthill	PROPN
ajlm-435	201	8	ic	ic	PROPN
ajlm-435	201	9	,	,	PUNCT
ajlm-435	201	10	et	et	PROPN
ajlm-435	201	11	al	al	PROPN
ajlm-435	201	12	.	.	PROPN
ajlm-435	201	13	animal	animal	NOUN
ajlm-435	201	14	research	research	NOUN
ajlm-435	201	15	:	:	PUNCT
ajlm-435	201	16	reporting	report	VERB
ajlm-435	201	17	in	in	ADP
ajlm-435	201	18	vivo	vivo	ADJ
ajlm-435	201	19	experiments	experiment	NOUN
ajlm-435	201	20	:	:	PUNCT
ajlm-435	201	21	the	the	DET
ajlm-435	201	22	arrive	arrive	ADJ
ajlm-435	201	23	guidelines	guideline	NOUN
ajlm-435	201	24	.	.	PUNCT
ajlm-435	202	1	br	br	PROPN
ajlm-435	202	2	j	j	PROPN
ajlm-435	202	3	pharmacol	pharmacol	PROPN
ajlm-435	202	4	.	.	PUNCT
ajlm-435	203	1	2010;160(7):1577–1579	2010;160(7):1577–1579	NUM
ajlm-435	203	2	.	.	PUNCT
ajlm-435	204	1	http://dx.doi.org/10.1111/j.1476-5381.2010.00872.x	http://dx.doi.org/10.1111/j.1476-5381.2010.00872.x	ADJ
ajlm-435	204	2	clinical	clinical	ADJ
ajlm-435	204	3	laboratory	laboratory	NOUN
ajlm-435	204	4	standards	standard	NOUN
ajlm-435	204	5	institute	institute	PROPN
ajlm-435	204	6	.	.	PUNCT
ajlm-435	205	1	m100	m100	PROPN
ajlm-435	205	2	-	-	PUNCT
ajlm-435	205	3	s17	s17	NOUN
ajlm-435	205	4	:	:	PUNCT
ajlm-435	205	5	performance	performance	NOUN
ajlm-435	205	6	standards	standard	NOUN
ajlm-435	205	7	for	for	ADP
ajlm-435	205	8	antimicrobial	antimicrobial	ADJ
ajlm-435	205	9	susceptibility	susceptibility	NOUN
ajlm-435	205	10	testing	testing	NOUN
ajlm-435	205	11	;	;	PUNCT
ajlm-435	205	12	seventeenth	seventeenth	ADJ
ajlm-435	205	13	informational	informational	ADJ
ajlm-435	205	14	supplement	supplement	NOUN
ajlm-435	205	15	.	.	PUNCT
ajlm-435	206	1	wayne	wayne	PROPN
ajlm-435	206	2	,	,	PUNCT
ajlm-435	206	3	pa	pa	PROPN
ajlm-435	206	4	:	:	PUNCT
ajlm-435	206	5	clsi	clsi	ADJ
ajlm-435	206	6	;	;	PUNCT
ajlm-435	206	7	2007	2007	NUM
ajlm-435	206	8	.	.	PUNCT
ajlm-435	207	1	anany	anany	ADJ
ajlm-435	207	2	h	h	NOUN
ajlm-435	207	3	,	,	PUNCT
ajlm-435	207	4	lingohr	lingohr	PROPN
ajlm-435	207	5	ej	ej	PROPN
ajlm-435	207	6	,	,	PUNCT
ajlm-435	207	7	villegas	villegas	PROPN
ajlm-435	207	8	a	a	PROPN
ajlm-435	207	9	,	,	PUNCT
ajlm-435	207	10	et	et	PROPN
ajlm-435	207	11	al	al	PROPN
ajlm-435	207	12	.	.	PUNCT
ajlm-435	208	1	a	a	DET
ajlm-435	208	2	shigella	shigella	ADJ
ajlm-435	208	3	boydii	boydii	ADJ
ajlm-435	208	4	bacteriophage	bacteriophage	NOUN
ajlm-435	208	5	which	which	PRON
ajlm-435	208	6	resembles	resemble	VERB
ajlm-435	208	7	salmonella	salmonella	NOUN
ajlm-435	208	8	phage	phage	NOUN
ajlm-435	209	1	vii	vii	PROPN
ajlm-435	209	2	.	.	PUNCT
ajlm-435	209	3	virol	virol	PROPN
ajlm-435	209	4	j.	j.	PROPN
ajlm-435	209	5	2011;8:242	2011;8:242	PROPN
ajlm-435	209	6	.	.	PUNCT
ajlm-435	210	1	http://dx.doi.org/10.1186/1743-422x-8-242	http://dx.doi.org/10.1186/1743-422x-8-242	VERB
ajlm-435	210	2	khan	khan	PROPN
ajlm-435	210	3	mirzaei	mirzaei	PROPN
ajlm-435	210	4	m	m	PROPN
ajlm-435	210	5	,	,	PUNCT
ajlm-435	210	6	nilsson	nilsson	PROPN
ajlm-435	210	7	as	as	ADP
ajlm-435	210	8	.	.	PUNCT
ajlm-435	210	9	isolation	isolation	NOUN
ajlm-435	210	10	of	of	ADP
ajlm-435	210	11	phages	phage	NOUN
ajlm-435	210	12	for	for	ADP
ajlm-435	210	13	phage	phage	NOUN
ajlm-435	210	14	therapy	therapy	NOUN
ajlm-435	210	15	:	:	PUNCT
ajlm-435	210	16	a	a	DET
ajlm-435	210	17	comparison	comparison	NOUN
ajlm-435	210	18	of	of	ADP
ajlm-435	210	19	spot	spot	NOUN
ajlm-435	210	20	tests	test	NOUN
ajlm-435	210	21	and	and	CCONJ
ajlm-435	210	22	efficiency	efficiency	NOUN
ajlm-435	210	23	of	of	ADP
ajlm-435	210	24	plating	plating	NOUN
ajlm-435	210	25	analyses	analysis	NOUN
ajlm-435	210	26	for	for	ADP
ajlm-435	210	27	determination	determination	NOUN
ajlm-435	210	28	of	of	ADP
ajlm-435	210	29	host	host	NOUN
ajlm-435	210	30	range	range	NOUN
ajlm-435	210	31	and	and	CCONJ
ajlm-435	210	32	efficacy	efficacy	NOUN
ajlm-435	210	33	.	.	PUNCT
ajlm-435	211	1	plos	plos	PROPN
ajlm-435	211	2	one	one	NUM
ajlm-435	211	3	.	.	PUNCT
ajlm-435	212	1	2015;10(3):e0118557	2015;10(3):e0118557	X
ajlm-435	212	2	.	.	PUNCT
ajlm-435	213	1	http://dx.doi.org/10.1371/journal.pone.0118557	http://dx.doi.org/10.1371/journal.pone.0118557	PROPN
ajlm-435	213	2	.	.	PUNCT
ajlm-435	214	1	ecollection	ecollection	NOUN
ajlm-435	214	2	2015	2015	NUM
ajlm-435	214	3	.	.	PUNCT
ajlm-435	215	1	schünemann	schünemann	PROPN
ajlm-435	215	2	hj	hj	PROPN
ajlm-435	215	3	,	,	PUNCT
ajlm-435	215	4	jaeschke	jaeschke	ADV
ajlm-435	215	5	r	r	NOUN
ajlm-435	215	6	,	,	PUNCT
ajlm-435	215	7	cook	cook	NOUN
ajlm-435	215	8	dj	dj	NOUN
ajlm-435	215	9	,	,	PUNCT
ajlm-435	215	10	et	et	PROPN
ajlm-435	215	11	al	al	PROPN
ajlm-435	215	12	.	.	PUNCT
ajlm-435	216	1	an	an	DET
ajlm-435	216	2	official	official	ADJ
ajlm-435	216	3	ats	ats	PROPN
ajlm-435	216	4	statement	statement	NOUN
ajlm-435	216	5	:	:	PUNCT
ajlm-435	216	6	grading	grade	VERB
ajlm-435	216	7	the	the	DET
ajlm-435	216	8	quality	quality	NOUN
ajlm-435	216	9	of	of	ADP
ajlm-435	216	10	eevidence	eevidence	NOUN
ajlm-435	216	11	and	and	CCONJ
ajlm-435	216	12	strength	strength	NOUN
ajlm-435	216	13	of	of	ADP
ajlm-435	216	14	recommendations	recommendation	NOUN
ajlm-435	216	15	in	in	ADP
ajlm-435	216	16	ats	ats	PROPN
ajlm-435	216	17	guidelines	guideline	NOUN
ajlm-435	216	18	and	and	CCONJ
ajlm-435	216	19	recommendations	recommendation	NOUN
ajlm-435	216	20	.	.	PUNCT
ajlm-435	217	1	am	be	AUX
ajlm-435	217	2	j	j	PROPN
ajlm-435	217	3	respir	respir	NOUN
ajlm-435	217	4	crit	crit	PROPN
ajlm-435	217	5	care	care	NOUN
ajlm-435	217	6	med	me	VERB
ajlm-435	217	7	.	.	PUNCT
ajlm-435	218	1	2006;174(5):605–614	2006;174(5):605–614	NUM
ajlm-435	218	2	.	.	PUNCT
ajlm-435	218	3	http://dx.doi.org/10.1164/rccm.200602-197st	http://dx.doi.org/10.1164/rccm.200602-197st	X
ajlm-435	219	1	wardenburg	wardenburg	PROPN
ajlm-435	219	2	jb	jb	PROPN
ajlm-435	219	3	,	,	PUNCT
ajlm-435	219	4	patel	patel	PROPN
ajlm-435	219	5	rj	rj	PROPN
ajlm-435	219	6	,	,	PUNCT
ajlm-435	219	7	schneewind	schneewind	NOUN
ajlm-435	219	8	o.	o.	PROPN
ajlm-435	219	9	surface	surface	NOUN
ajlm-435	219	10	proteins	protein	NOUN
ajlm-435	219	11	and	and	CCONJ
ajlm-435	219	12	exotoxins	exotoxin	NOUN
ajlm-435	219	13	are	be	AUX
ajlm-435	219	14	required	require	VERB
ajlm-435	219	15	for	for	ADP
ajlm-435	219	16	the	the	DET
ajlm-435	219	17	pathogenesis	pathogenesis	NOUN
ajlm-435	219	18	of	of	ADP
ajlm-435	219	19	staphylococcus	staphylococcus	NOUN
ajlm-435	219	20	aureus	aureus	NOUN
ajlm-435	219	21	pneumonia	pneumonia	NOUN
ajlm-435	219	22	.	.	PUNCT
ajlm-435	220	1	infect	infect	VERB
ajlm-435	220	2	immun	immun	PROPN
ajlm-435	220	3	.	.	PUNCT
ajlm-435	221	1	2007;75(2):1040–1044	2007;75(2):1040–1044	PROPN
ajlm-435	221	2	.	.	PUNCT
ajlm-435	221	3	http://dx.doi.org/10.1128/iai.01313-06	http://dx.doi.org/10.1128/iai.01313-06	PROPN
ajlm-435	221	4	yanagihara	yanagihara	PROPN
ajlm-435	222	1	k	k	PROPN
ajlm-435	222	2	,	,	PUNCT
ajlm-435	222	3	ohnishi	ohnishi	PROPN
ajlm-435	222	4	y	y	PROPN
ajlm-435	222	5	,	,	PUNCT
ajlm-435	222	6	morinaga	morinaga	NOUN
ajlm-435	222	7	y	y	PROPN
ajlm-435	222	8	,	,	PUNCT
ajlm-435	222	9	et	et	PROPN
ajlm-435	222	10	al	al	PROPN
ajlm-435	222	11	.	.	PROPN
ajlm-435	222	12	efficacy	efficacy	NOUN
ajlm-435	222	13	of	of	ADP
ajlm-435	222	14	me1036	me1036	NOUN
ajlm-435	222	15	against	against	ADP
ajlm-435	222	16	meticillin	meticillin	NOUN
ajlm-435	222	17	-	-	PUNCT
ajlm-435	222	18	resistant	resistant	ADJ
ajlm-435	222	19	staphylococcus	staphylococcus	NOUN
ajlm-435	222	20	aureus	aureus	NOUN
ajlm-435	222	21	and	and	CCONJ
ajlm-435	222	22	vancomycin	vancomycin	PROPN
ajlm-435	222	23	-	-	PUNCT
ajlm-435	222	24	insensitive	insensitive	ADJ
ajlm-435	222	25	s.	s.	PROPN
ajlm-435	222	26	aureus	aureus	PROPN
ajlm-435	222	27	in	in	ADP
ajlm-435	222	28	a	a	DET
ajlm-435	222	29	model	model	NOUN
ajlm-435	222	30	of	of	ADP
ajlm-435	222	31	haematogenous	haematogenous	ADJ
ajlm-435	222	32	pulmonary	pulmonary	ADJ
ajlm-435	222	33	infection	infection	NOUN
ajlm-435	222	34	.	.	PUNCT
ajlm-435	223	1	int	int	NOUN
ajlm-435	223	2	j	j	PROPN
ajlm-435	223	3	antimicrob	antimicrob	PROPN
ajlm-435	223	4	agents	agent	NOUN
ajlm-435	223	5	.	.	PUNCT
ajlm-435	224	1	32(5):401–404	32(5):401–404	PROPN
ajlm-435	224	2	.	.	PUNCT
ajlm-435	225	1	http://dx.doi.org/10.1016/j.ijantimicag.2008.04.030	http://dx.doi.org/10.1016/j.ijantimicag.2008.04.030	PROPN
ajlm-435	225	2	epub	epub	PROPN
ajlm-435	225	3	2008	2008	NUM
ajlm-435	225	4	aug	aug	PROPN
ajlm-435	225	5	19	19	NUM
ajlm-435	225	6	.	.	PROPN
ajlm-435	225	7	oduor	oduor	PROPN
ajlm-435	225	8	jmo	jmo	PROPN
ajlm-435	225	9	,	,	PUNCT
ajlm-435	225	10	onkoba	onkoba	PROPN
ajlm-435	225	11	wn	wn	PROPN
ajlm-435	225	12	,	,	PUNCT
ajlm-435	225	13	maloba	maloba	PROPN
ajlm-435	225	14	f	f	PROPN
ajlm-435	225	15	,	,	PUNCT
ajlm-435	225	16	et	et	PROPN
ajlm-435	225	17	al	al	PROPN
ajlm-435	225	18	.	.	PROPN
ajlm-435	225	19	safety	safety	NOUN
ajlm-435	225	20	and	and	CCONJ
ajlm-435	225	21	therapeutic	therapeutic	ADJ
ajlm-435	225	22	efficacy	efficacy	NOUN
ajlm-435	225	23	of	of	ADP
ajlm-435	225	24	staphylococcus	staphylococcus	NOUN
ajlm-435	225	25	aureus	aureus	PROPN
ajlm-435	225	26	specific	specific	ADJ
ajlm-435	225	27	lytic	lytic	ADJ
ajlm-435	225	28	phage	phage	NOUN
ajlm-435	225	29	against	against	ADP
ajlm-435	225	30	multidrug	multidrug	NOUN
ajlm-435	225	31	-	-	PUNCT
ajlm-435	225	32	resistant	resistant	ADJ
ajlm-435	225	33	s.	s.	PROPN
ajlm-435	225	34	aureus	aureus	PROPN
ajlm-435	225	35	(	(	PUNCT
ajlm-435	225	36	mdrsa	mdrsa	NOUN
ajlm-435	225	37	)	)	PUNCT
ajlm-435	225	38	in	in	ADP
ajlm-435	225	39	balb	balb	ADJ
ajlm-435	225	40	/	/	SYM
ajlm-435	225	41	c	c	NOUN
ajlm-435	225	42	mice	mouse	NOUN
ajlm-435	225	43	:	:	PUNCT
ajlm-435	225	44	a	a	DET
ajlm-435	225	45	prospective	prospective	ADJ
ajlm-435	225	46	study	study	NOUN
ajlm-435	225	47	.	.	PUNCT
ajlm-435	226	1	int	int	PROPN
ajlm-435	226	2	j	j	PROPN
ajlm-435	226	3	infect	infect	VERB
ajlm-435	226	4	dis	dis	PROPN
ajlm-435	226	5	.	.	PUNCT
ajlm-435	227	1	2016;45(suppl	2016;45(suppl	PROPN
ajlm-435	227	2	1):108	1):108	NUM
ajlm-435	227	3	.	.	PUNCT
ajlm-435	228	1	chhibber	chhibber	PROPN
ajlm-435	228	2	s	s	PROPN
ajlm-435	228	3	,	,	PUNCT
ajlm-435	228	4	kaur	kaur	PROPN
ajlm-435	228	5	t	t	PROPN
ajlm-435	228	6	,	,	PUNCT
ajlm-435	228	7	kaur	kaur	PROPN
ajlm-435	228	8	s.	s.	PROPN
ajlm-435	228	9	co	co	PROPN
ajlm-435	228	10	-	-	NOUN
ajlm-435	228	11	therapy	therapy	NOUN
ajlm-435	228	12	using	use	VERB
ajlm-435	228	13	lytic	lytic	ADJ
ajlm-435	228	14	bacteriophage	bacteriophage	NOUN
ajlm-435	228	15	and	and	CCONJ
ajlm-435	228	16	linezolid	linezolid	NOUN
ajlm-435	228	17	:	:	PUNCT
ajlm-435	228	18	effective	effective	ADJ
ajlm-435	228	19	treatment	treatment	NOUN
ajlm-435	228	20	in	in	ADP
ajlm-435	228	21	eliminating	eliminate	VERB
ajlm-435	228	22	methicillin	methicillin	NOUN
ajlm-435	228	23	resistant	resistant	ADJ
ajlm-435	228	24	staphylococcus	staphylococcus	NOUN
ajlm-435	228	25	aureus	aureus	NOUN
ajlm-435	228	26	(	(	PUNCT
ajlm-435	228	27	mrsa	mrsa	NOUN
ajlm-435	228	28	)	)	PUNCT
ajlm-435	228	29	from	from	ADP
ajlm-435	228	30	diabetic	diabetic	ADJ
ajlm-435	228	31	foot	foot	NOUN
ajlm-435	228	32	infections	infection	NOUN
ajlm-435	228	33	.	.	PUNCT
ajlm-435	229	1	plos	plos	PROPN
ajlm-435	229	2	one	one	NUM
ajlm-435	229	3	.	.	PUNCT
ajlm-435	230	1	2013;8(2):e56022	2013;8(2):e56022	PROPN
ajlm-435	230	2	.	.	PUNCT
ajlm-435	231	1	http://dx.doi.org/10.1371/journal.pone.0056022	http://dx.doi.org/10.1371/journal.pone.0056022	PROPN
ajlm-435	231	2	.	.	PUNCT
ajlm-435	232	1	epub	epub	PROPN
ajlm-435	232	2	2013	2013	NUM
ajlm-435	232	3	feb	feb	NOUN
ajlm-435	232	4	13	13	NUM
ajlm-435	232	5	.	.	PUNCT
ajlm-435	233	1	chhibber	chhibber	PROPN
ajlm-435	233	2	,	,	PUNCT
ajlm-435	233	3	s.	s.	PROPN
ajlm-435	233	4	&	&	CCONJ
ajlm-435	233	5	kumari	kumari	PROPN
ajlm-435	233	6	,	,	PUNCT
ajlm-435	233	7	s.	s.	PROPN
ajlm-435	233	8	in	in	ADP
ajlm-435	233	9	bacteriophages	bacteriophage	NOUN
ajlm-435	233	10	(	(	PUNCT
ajlm-435	233	11	ed	ed	NOUN
ajlm-435	233	12	.	.	PUNCT
ajlm-435	233	13	kurtoboke	kurtoboke	PROPN
ajlm-435	233	14	,	,	PUNCT
ajlm-435	233	15	i.	i.	NOUN
ajlm-435	233	16	)	)	PUNCT
ajlm-435	233	17	139–158	139–158	NUM
ajlm-435	233	18	(	(	PUNCT
ajlm-435	233	19	intech	intech	PROPN
ajlm-435	233	20	,	,	PUNCT
ajlm-435	233	21	2012	2012	NUM
ajlm-435	233	22	)	)	PUNCT
ajlm-435	233	23	.	.	PUNCT
ajlm-435	234	1	ly	ly	X
ajlm-435	234	2	-	-	PUNCT
ajlm-435	234	3	chatain	chatain	NOUN
ajlm-435	234	4	mh	mh	PROPN
ajlm-435	234	5	.	.	PUNCT
ajlm-435	235	1	the	the	DET
ajlm-435	235	2	factors	factor	NOUN
ajlm-435	235	3	affecting	affect	VERB
ajlm-435	235	4	effectiveness	effectiveness	NOUN
ajlm-435	235	5	of	of	ADP
ajlm-435	235	6	treatment	treatment	NOUN
ajlm-435	235	7	in	in	ADP
ajlm-435	235	8	phages	phage	NOUN
ajlm-435	235	9	therapy	therapy	NOUN
ajlm-435	235	10	.	.	PUNCT
ajlm-435	236	1	front	front	PROPN
ajlm-435	236	2	microbiol	microbiol	PROPN
ajlm-435	236	3	.	.	PUNCT
ajlm-435	237	1	2014;5:51	2014;5:51	PROPN
ajlm-435	237	2	.	.	PUNCT
ajlm-435	238	1	http://dx.doi.org/10.3389/fmicb.2014.00051	http://dx.doi.org/10.3389/fmicb.2014.00051	PROPN
ajlm-435	238	2	matsuzaki	matsuzaki	PROPN
ajlm-435	238	3	s	s	PROPN
ajlm-435	238	4	,	,	PUNCT
ajlm-435	238	5	yasuda	yasuda	PROPN
ajlm-435	238	6	m	m	PROPN
ajlm-435	238	7	,	,	PUNCT
ajlm-435	238	8	nishikawa	nishikawa	PROPN
ajlm-435	238	9	h	h	PROPN
ajlm-435	238	10	,	,	PUNCT
ajlm-435	238	11	et	et	PROPN
ajlm-435	238	12	al	al	PROPN
ajlm-435	238	13	.	.	PUNCT
ajlm-435	239	1	experimental	experimental	ADJ
ajlm-435	239	2	protection	protection	NOUN
ajlm-435	239	3	of	of	ADP
ajlm-435	239	4	mice	mouse	NOUN
ajlm-435	239	5	against	against	ADP
ajlm-435	239	6	lethal	lethal	ADJ
ajlm-435	239	7	staphylococcus	staphylococcus	NOUN
ajlm-435	239	8	aureus	aureus	NOUN
ajlm-435	239	9	infection	infection	NOUN
ajlm-435	239	10	by	by	ADP
ajlm-435	239	11	novel	novel	ADJ
ajlm-435	239	12	bacteriophage	bacteriophage	NOUN
ajlm-435	239	13	phi	phi	NOUN
ajlm-435	239	14	mr11	mr11	PROPN
ajlm-435	239	15	.	.	PUNCT
ajlm-435	240	1	j	j	PROPN
ajlm-435	240	2	infect	infect	VERB
ajlm-435	240	3	dis	dis	PROPN
ajlm-435	240	4	.	.	PUNCT
ajlm-435	241	1	2003;187(4):613–624	2003;187(4):613–624	NUM
ajlm-435	241	2	.	.	PUNCT
ajlm-435	242	1	epub	epub	PROPN
ajlm-435	242	2	2003	2003	NUM
ajlm-435	242	3	feb	feb	NOUN
ajlm-435	242	4	7	7	NUM
ajlm-435	242	5	.	.	PUNCT
ajlm-435	242	6	http://dx.doi.org/10.1086/374001	http://dx.doi.org/10.1086/374001	PROPN
ajlm-435	242	7	thiel	thiel	PROPN
ajlm-435	242	8	k.	k.	PROPN
ajlm-435	242	9	old	old	ADJ
ajlm-435	242	10	dogma	dogma	NOUN
ajlm-435	242	11	,	,	PUNCT
ajlm-435	242	12	new	new	ADJ
ajlm-435	242	13	tricks—21st	tricks—21st	PROPN
ajlm-435	242	14	century	century	NOUN
ajlm-435	242	15	phage	phage	NOUN
ajlm-435	242	16	therapy	therapy	NOUN
ajlm-435	242	17	.	.	PUNCT
ajlm-435	243	1	nat	nat	PROPN
ajlm-435	243	2	biotechnol	biotechnol	NOUN
ajlm-435	243	3	.	.	PUNCT
ajlm-435	244	1	2004;22(1):31–36	2004;22(1):31–36	NUM
ajlm-435	244	2	.	.	PUNCT
ajlm-435	245	1	http://dx.doi.org/10.1038/nbt0104-31	http://dx.doi.org/10.1038/nbt0104-31	PROPN
ajlm-435	245	2	yao	yao	PROPN
ajlm-435	245	3	l	l	NOUN
ajlm-435	245	4	,	,	PUNCT
ajlm-435	245	5	berman	berman	PROPN
ajlm-435	245	6	jw	jw	PROPN
ajlm-435	245	7	,	,	PUNCT
ajlm-435	245	8	factor	factor	NOUN
ajlm-435	245	9	sm	sm	PROPN
ajlm-435	245	10	,	,	PUNCT
ajlm-435	245	11	et	et	PROPN
ajlm-435	245	12	al	al	PROPN
ajlm-435	245	13	.	.	PUNCT
ajlm-435	245	14	correlation	correlation	NOUN
ajlm-435	245	15	of	of	ADP
ajlm-435	245	16	histopathologic	histopathologic	NOUN
ajlm-435	245	17	and	and	CCONJ
ajlm-435	245	18	bacteriologic	bacteriologic	ADJ
ajlm-435	245	19	changes	change	NOUN
ajlm-435	245	20	with	with	ADP
ajlm-435	245	21	cytokine	cytokine	ADJ
ajlm-435	245	22	expression	expression	NOUN
ajlm-435	245	23	in	in	ADP
ajlm-435	245	24	an	an	DET
ajlm-435	245	25	experimental	experimental	ADJ
ajlm-435	245	26	murine	murine	ADJ
ajlm-435	245	27	model	model	NOUN
ajlm-435	245	28	of	of	ADP
ajlm-435	245	29	bacteremic	bacteremic	ADJ
ajlm-435	245	30	staphylococcus	staphylococcus	NOUN
ajlm-435	245	31	aureus	aureus	NOUN
ajlm-435	245	32	infection	infection	NOUN
ajlm-435	245	33	.	.	PUNCT
ajlm-435	246	1	infect	infect	VERB
ajlm-435	246	2	immun	immun	PROPN
ajlm-435	246	3	.	.	PUNCT
ajlm-435	247	1	1997;65(9):3889–3895	1997;65(9):3889–3895	PROPN
ajlm-435	247	2	.	.	PUNCT